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Problem 
Scholars and policy makers have highlighted the importance of preventing hospital 
admissions and readmissions for individuals with a chronic condition, who account for a 
large percentage of the nation’s healthcare spending. Providing effective care management 
strategies can help reduce emergency department use, inpatient admissions or readmissions, 
thereby reducing rising health care costs. However, implementing effective care management 
strategies may be more difficult for Independent Physician Associations (IPAs) that contract 
with multiple insurers and managed care organizations. 
Methodology 
The research synthesized peer-reviewed literature to identify best practices in 
chronic-disease management for Medicare beneficiaries. A series of key informant interviews 
were conducted to explore barriers and facilitators to adapting two of these best practices, 
home visits and multi-disciplinary care teams, in IPA settings. The key informant interviews 
were conducted with executives, medical directors, and care managers who had significant 
experience in implementing best practices in IPA environments.  
Results 
Several themes were identified in the key informant interviews and include improved 




optimizing outreach to patients in IPAs that cover large geographic rations, use of provider 
incentives to increase participation in best practices, and understanding the structure of the 
revenue model for each IPA.  
Recommendations 
The research suggests the need to: augment the existing communication strategy 
between the IPA central administrative office and the provider network, assess the IPA’s 
revenue model to determine readiness to implement best practices, evaluate the number of 
high volume providers affiliated with the IPA in order to assess ease of implementation of 
best practices, employ a robust risk stratification system to determine which patients should 
receive best practice related interventions, include a social worker and pharmacist on care 
teams, conduct face-to-face patient visits in the home settings of high-risk patients, 
incorporate transitional care into best practice interventions, and encourage consistent 
provider involvement as it relates to best practice interventions.  
Additional research is needed among IPAs nationally to further explore the effects of 
best practices on vulnerable populations. A particular area that needs attention is 
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CHAPTER 1: INTRODUCTION 
The purpose of this dissertation is to learn more about the implementation of best 
care-management practices among elderly (65 and older) public program beneficiaries. Best 
practices in outpatient care management are processes that are successfully and reliably able 
to improve both the quality of health services provided and the associated health care 
outcomes. Ideally, these practices also reduce net costs by eliminating unnecessary hospital 
visits, preventable emergency care, or other unnecessary services. Reduced inpatient 
utilization has been achieved in different settings by implementing evidence-based care 
delivery processes that address root drivers of healthcare system utilization at both the 
individual and population level. 
According to the Centers for Medicare and Medicaid Services (CMS), the cost of 
healthcare nationally grew approximately 5.8% in 2016 to a total of $3.2 trillion in health 
expenditures. Health care costs are projected to continue growing at this rate until 2025.1 
Healthcare spending is expected to outpace Gross Domestic Product (GDP) by 1.2% per year 
and comprise 19.9% of GDP by 2025. Through 2025, Medicare spending alone is projected 
to increase by an average of 7.1% per year, and Medicaid spending by an average of 6.0% 
per year.2 As a national priority, we need reliable methods for more cost-effectively managing 
the population contributing to a significant portion of this healthcare spending. 
According to the Robert Wood Johnson Foundation (RWJF), people with a chronic 
condition are the heaviest users of healthcare services, spending over 7 times more than those 
without chronic conditions.3 Eighty-six percent of healthcare spending in 2012 was for 
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individuals with one or more chronic conditions.4 The percentages of enrollees with a chronic 
condition in 2006 in Medicare and Duals were 88% and 91%, respectively.3 The Agency for 
Healthcare Research and Quality (AHRQ) cites that two-thirds of Medicare beneficiaries 
have two or more chronic conditions.5 Ninety-nine percent of spending for Medicare, and 
100% of spending for dual beneficiaries in 2010 was attributed to people with chronic 
conditions.3 Furthermore, 171 million people are expected to have a chronic conditions by 
2030, an increase of 37% from 2000.3 According to the United Health Foundation, this is due 
to both an aging American population and an increase in prevalence in chronic diseases for 
the same age groups year-over-year.6 
The National Public Engagement Campaign on Chronic Illness-Physician Survey, a 
nationally representative survey of 1500 physicians, indicated that 66% of physicians 
surveyed reported that they are not adequately prepared to coordinate in-home and 
community services for patients with chronic disease, and 64% are not prepared to manage 
the psychological and social aspects of chronic care.7 In the same survey, a majority of 
physicians reported that poor coordination in the chronic disease population leads to adverse 
outcomes, and subsequently higher costs.7 This highlights the need to cost-effectively 
manage chronic conditions through the implementation of well-designed and targeted care 
delivery systems that support physicians and other providers and enhance the coordination of 
services provided.  
State and federal governments, as well as risk-bearing organizations must implement 
cost-effective care management models with the purpose of improving quality and health 
outcomes to mitigate future costs across a variety of settings, including the Independent 
Physician Association (IPA) network structure. As defined by the American Academy of 
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Family Physician (AAFP), an IPA is a business entity organized and owned by a network of 
independent physician practices for the purpose of reducing overhead or pursuing business 
ventures such as contracts with employers, accountable care organizations (ACO) and/or 
managed care organizations (MCOs).8 Unlike staff or group model Health Maintenance 
Organizations (HMOs; where the managed care entity employs or has exclusive 
arrangements with providers), IPA model MCOs have contractual relationships with 
physicians which allow the physicians to see patients that originate from different payer 
sources (including straight fee-for-service Medicare, and health plans). Individual physician 
practices often have non-exclusive contracts with multiple managed care plans. The managed 
care organization may only cover (insure) a small proportion of the patients that any specific 
medical practice has enrolled. Thus, managed care entities have more limited control over 
how these IPA practices operate. This makes it difficult for both physicians and managed care 
plans to streamline disease and care management practices, as physicians have less incentive 
to follow any particular guideline or care management strategy for only a small proportion of 
their membership panel. Often times, the MCO will develop and implement their own care 
management system somewhat independently from the physician, further fragmenting care. 
In managed care, this can happen at the medical group level (contracting with the 
physicians), or at the plan level (contracting with the medical group).   
Thirty-three percent, or 19 million Medicare recipients are in managed care plans 
(also called Medicare Advantage) delivered through MCOs and this number has been steadily 
increasing from only 13% since 2004.9 Most MCOs employ IPA network models to manage 
their patients. Generally, this is the fastest way to grow a network and has thus become the 
predominant means of contracting with providers nationally. Out of American’s participating 
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in plans through an MCO (70 million in HMO’s, and 90 million in PPO’s), 54% a-re part of 
an IPA model MCO, while only 23% are part of a staff/group model MCO; the remaining 
23% of individuals are in point of service plans, or open-ended HMO’s of which 90% are 
composed of IPA networks.10,11 Therefore, integration of best practices into the IPA setting 
will allow for the largest national impact in managed care.  
Improved care management can be measured, in part, through the reduction of 
unnecessary utilization of health services and improved health outcomes including reduced 
admissions, readmissions, and emergency department (ED) visits. Increased numbers of 
chronic conditions are positively correlated with an increased number of preventable 
hospitalizations. Chronic diseases on average increase the likelihood of a preventable 
admission by 35%, while respiratory and circulatory system chronic diseases increase the 
likelihood of a preventable admission eight-fold.12 The largest portion of expenses in 
Medicare programs can be attributed to hospital admissions and readmissions.13 Although not 
all admissions or readmissions are preventable, focusing on reducing unnecessary admissions 
and readmissions can help reduce overall costs in Medicare beneficiaries as well as duals. 
While there are some studies that show successful strategies to improve care coordination 
and reduce unnecessary hospitalizations (as discussed more fully below), many of these 
studies were done in a setting where the organization doing the intervention had increased 
control over the physician practice. Thus, it is unclear whether these strategies will work 
equally well in a more fragmented IPA model HMO.  
Despite the fact that the effectiveness of the Medicare programs, as well as private 
payer managed care risk models, depends on our ability to manage patients with chronic 
conditions, and despite the fact that governments have funded a host of care management 
 
5 
programs and policies, there has been little or no synthesis of available information on 
chronic disease management for these high-cost populations in IPA settings. This dissertation 
intends to augment the body of research synthesizing existing high-quality evidence, to 
support a subsequent set of recommendations for an improved approach to chronic disease 
management within an IPA setting.  
It is essential that we continue to create a robust evidence base for developing, 
implementing and streamlining best practices in care management and delivery across IPA 
settings for high-need populations. Adding to this research means that we are continually 
evaluating what works, why, in what environment, and for which populations. It is important 
to compile that information so that practitioners can implement best practices in the 
appropriate settings. This is particularly important in managed care IPA models which serve 
high-cost, high-risk public program beneficiaries with chronic disease. Understanding which 
care management practices are cost-effective and improve quality, and in what settings these 
practices apply will be imperative to reduce state and national healthcare spending. Because 
of the number of physicians participating in IPA networks, these model are positioned to 
reach a large number of patients. Thus, implementing best practices in IPA settings could 
have a significant impact on costs and quality nationally. 
The dissertation is intended to answer how these identified successful care 








CHAPTER 2: LITERATURE REVIEW 
Introduction 
A literature review was conducted to answer the research question, what evidence-
based interventions can IPA model MCOs use to most effectively reduce inpatient utilization 
in Medicare beneficiaries with chronic disease? The purpose of this literature review was to 
aggregate information on best practices in case management which reduce net health 
expenditure and maintain or increase quality within large MCOs. This literature review was 
intended to aggregate information from high-quality meta-analyses and evidence syntheses 
with statistically significant cost-savings and/or reduced acute utilization (admissions, 
readmissions, and emergency department (ED) visits) attributed to effectively managing the 
delivery of care for elderly, multimorbid chronic disease patients in Medicare or Duals 
populations.i
 Individual study results can be difficult to replicate. I examined acute care utilization 
as the outcome of interest, because reducing unnecessary ED use, inpatient utilization, or 
readmissions is generally considered effective proxies for improved quality, health outcomes 
and reduced cost.14 As such, meta-studies were used in lieu of individual studies to increase 
the power of and confidence in the conclusions resulting from the research. Results from the 
dissertation can be used to implement the identified best practices in a fully capitated (full-
risk), independent physician association (IPA network). 
                                                 
i Duals refers to a category of health insurance beneficiaries eligible for both Medicaid and 
Medicare programs due to age or disability and income level.  
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Literature Review Methods 
The search strategy for this literature review used the search terms shown in Table 1, 
within four prominent databases (PubMed, CINHAL and Scopus and ProQuest Health) to 
acquire the broadest, yet relevant, collection of literature possible. The search identified a 
total of 508 articles. Articles were subsequently screened for duplicates, title relevance, and 





Concept Key words, search terms 
  
Population “Dual eligible” OR Medicaid OR Medicare OR Medi-Cal OR 
“managed care” OR “high-need patient” OR “complex patient” 
  
 AND 
   
Care management “Case management” OR “medical home” OR “integrated care” 




Outcomes Utilization OR admission OR re-admission OR “cost-savings” 




Primary care setting “Primary care provider” OR “primary care”  
  
Note. English only.  
Meta-studies are comprised of both systematic evidence reviews and meta-analyses. 
Evidence reviews, also referred to as evidence syntheses, differ from meta-analyses in a few 
primary ways. First, meta-analyses take the data produced by other studies and pool it with 
like studies to increase the statistical power of the conclusions. Second, in many meta-
analyses researchers conduct subgroup analysis which allows the researchers to ask and 
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answer new research questions from the pooled datasets. In contrast, evidence reviews 
compile and compare data from studies on a particular topic, but do not use quantitative 
methods to perform further analysis from the underlying data. Collectively, I will refer to the 
studies included in this review as meta-studies even though they may be either meta-analyses 
or evidence syntheses.  
Another reason meta-studies were targeted in this review is that many of the 
individual studies that were produced in the literature search were also captured and 
reviewed within the meta-studies. The remaining seven meta-studies (in addition to the five 
already identified through the literature review) were found through the snowball approach 
(where the citations in other studies recommended additional studies that met the 
inclusion/exclusion criteria). 
Inclusion and exclusion criteria. Studies were examined based on the inclusion and 
exclusion criteria listed below. Studies that examined pediatric populations were removed, 
due to the inability to generalize the results to adult populations. Studies with isolated (rural) 
or institutionalized populations were removed from the review due to the inability to assure 
generalizability to the majority of Medicare beneficiaries. Studies with an N less than 100 
were also removed due to statistical reliability concerns. Selection of best practices was 
based on high-quality (as defined by the authors of the meta-studies), consistent statistical 
evidence reported in at least two independent meta-studies. Studies included in the literature 
review are written in English only, with populations similar to the population for which the 
best practices are intended to be implemented. Both qualitative and quantitative studies were 
accepted. All studies included were required to report at least one relevant cost outcome 
measure in the form of admissions, readmissions, total cost, or ED utilization.  
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A date range of 2000 to 2017 was used to limit the research to more recent evidence 
that includes modern (last 15–20 years) technological advances, like that of electronic 
medical records, which can alter the ways in which health care is delivered.  
It is important to note that the date range for included studies (2000–2017) in this 
literature review spanned the implementation of the Patient Protection and Affordable Care 
Act (ACA) (2010). This law significantly altered the way that care was delivered nationally. 
Even though there were significant modifications to how care was delivered, there is no 
evidence that this law would impact the effectiveness of the best practices extracted from this 
literature review. In fact, there are reasons to suspect that the information gleaned from this 
literature review about best practices to reduce costs and improve outcomes have been 
adopted more widely as a result of some of the ACA provisions moving towards value based 
purchasing (such as Accountable Care Organizations and bundled payments). Therefore, I do 
not believe that the implementation of the ACA warrants any material changes to the 
recommendations provided in this dissertation. Inclusion criteria are as follows:  
• Published in English 
• Meta-analysis or evidence synthesis of more than 5 underlying studies 
• The criteria for evaluating the quality of study was reported in the publication 
• Medicare/dual eligible populations, or populations with characteristics reasonably 
homogenous to the elderly with  occurring chronic diseases 
• Qualitative, quantitative or mixed method studies 
• Outpatient: majority of the intervention occurred outside of the acute care facility 
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• At least one cost outcome or relevant proxy for cost was provided. Examples 
include net cost, or inpatient utilization such as admissions, readmissions and/or 
ER visits.  
• Elderly populations (average age > 65) 
Exclusion criteria are as follows: 
• Pediatric populations 
• Populations with known terminal diseases, or hospice eligibility 
• Studies that only target mental disease or behavioral health conditions 
• Institutionalized populations (psychiatric institutions, or custodial care)  
• Studies that target individuals on hospice 
• Isolated populations living in environments not generalizable to the US 
population 
• Studies with an N < 100 in each study group 
• Studies with less than 30 day follow-up periods 
Additional meta-studies were found through the snowball approach for a total of 12. 
Additional meta-study inclusion and exclusion criteria. Several meta-studies had a 
mix of populations that met inclusion criteria and populations that did not. Therefore, within 
the meta-studies an additional set of criteria were applied to select the subpopulations most 
similar to the population of interest-elderly with multiple chronic diseases. In addition to the 
inclusion criteria noted above, meta-studies of mixed populations that met and did not meet 
inclusion criteria had to include more than one eligible study upon which the author based his 




Figure 1. PRISMA diagram. 
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I examined the following factors in assessing the impact of best practices on 
outcomes, to the extent they were available in the meta-studies:  
1. Timing 
a. When did the intervention start? 
b. How long was the intervention?  
c. How long was the study period (including poststudy follow-up)?  
d. What was the time period for measuring specific metrics (e.g., 30 vs. 60 
vs. 90 day admissions)  
2. Population selection  
a. Did the model use an evidenced-based form of targeting/risk 
stratification?  
b. How was the intervention population selected? (e.g., diagnosis, utilization 
triggered, geography, cost, insurance source (line of business), through 
affiliation with a health system, or combination.) 
c. How was the control or comparator group selected?  
d. Was the selection for population due to a recent utilization pattern, or a 
chronic diagnosis?  
i. chronic diagnoses are more likely to be permanent not temporary 
increases in intensity of medical care, and this can affect the 
sustainability of results: (Ex., chronic disease diagnosis versus 3 ER 
visits in the past 30 days)  
3. Measurement and Baseline/Comparator 
a. How were baseline metrics calculated?  
b. How were comparator metrics calculated?  
c. Data sources 
4. Analytical considerations 
a. Size of comparator/control and intervention  
b. Propensity and control for bias 
c. Reporting of all outcomes measured versus cherry picking 
d. Post hoc statistical control techniques 
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e. Post hoc analysis/subgroup comparison quality 
5. Setting  
a. In what setting was the intervention delivered? (e.g., home, office, clinic, 
combination) 
6. Funding 
a. How was the intervention funded?  
b. Were certain parties at-risk for positive or negative results?  
c. What were the payment mechanisms in relation to standard compensation 
measures?  
7. Availability of information reported on intervention activities 
a. Frequency of activity 
b. Engagement of population in activity (e.g., contact rate for telephonic 
CM) 
c. Differences reported in delivery of activity (e.g., education tools used 
when engaging in health information education sessions) 
d. Reported details of the intervention for ease of comparison among like-
interventions 
8. Staff 
a. Identification of healthcare provider participants 
b. Training of staff (academic and intervention specific) 
c. Continuity of staff contact with patients 
d. Staff level of engagement with intervention 
e. Staff turnover 
Based on these criteria, I identified 12 meta-studies: 8 meta-analyses and 4 evidence 
reviews (Table 2). These 12 meta-studies include a total of 517 individual studies. For each 
meta-study reviewed, I have included the number of studies, type of study, populations of 
interest, intervention, quality of study, and outcomes. Detailed results can be found in 
Appendix I. All studies included in this review were required to be robustly evaluated for 
quality by a peer reviewed quality methodology. Pooled meta-analyses were controlled for 
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heterogeneity to help ensure the studies measured against one another had as similar 
characteristics as possible for accurate comparative evaluation. 
Table 2 
 
Description of Meta-Studies 
Study name Year Author(s) 




     
Effectiveness of Outpatient Case Management for Adults 
With Medical Illness and Complex Care Needs 
Research  
2013 Hickam et al. 109 Meta-
analysis 
     
Working Paper Series Congressional Budget Office 
Lessons from Medicare's Demonstration Projects on 
Disease Management and Care Coordination Lessons 
From Medicare's Demonstration Projects on Disease 
Management and Care Coordination  
2012 Nelson et al. 34 Meta-
analysis 
     
Effectiveness of Case Management for “At Risk” Patients 
in Primary Care: A Systematic Review and Meta-Analysis 
2015 Stokes et al. 36 Meta-
Analysis 
     
Models of Care for High-Need, High-Cost Patients: An 
Evidence Synthesis.  
2015 McCarthy et al. 123 Evidence 
Review 
     
Caring for High-Need, High-Cost Patients: What Makes 
for a Successful Care Management Program?  
2014 Hong et al. 18 Evidence 
Review 
     
Case Management Effectiveness in Reducing Hospital use: 
A Systematic Review  
2016 Joo et al. 10 Evidence 
Review  
     
A Systematic Meta-Analysis of the Efficacy and 
Heterogeneity of Disease Management Programs in 
Congestive Heart Failure  
2006 Göhler, et al. 36 Meta-
analysis 
     
Evidence-based Synthesis Program Evidence Brief: 
Effectiveness of Intensive Primary Care Programs  
2011 Peterson et al. 20 Meta-
analysis 
     
Innovative Home Visit Models Associated With 
Reductions In Costs, Hospitalizations, And Emergency 
Department Use  
2017 Ruiz et al. 6 Evidence 
review 
     
Clinical Service Organisation for Heart Failure: A 
Cochrane Review  
2012 Takeda et al. 25 Meta-
analysis 
     
Transitional Care Interventions to Prevent Re-Admissions 
for Persons With Heart Failure: A Systematic Review and 
Meta-Analysis  
2014 C. Feltner et al. 47 Meta-
analysis 
     
Comparative Effectiveness of Transitional Care Services 
in Patients Discharged From the Hospital With Heart 
Failure: A Systematic Review and Network Meta-Analysis 
2017 Van Spall et al.  53 Meta-
analysis 
     
 
15 
As mentioned previously, several of the meta-studies broke their populations down 
into subcategories defined by population type. Some subcategories included: older adults (65 
and older) with one or more chronic diseases, the frail elderly, patients with dementia, 
patients with congestive heart failure, patients with diabetes mellitus, patients with cancer, 
patients with serious chronic infections and patients with other medical problems. The 
subcategories that were relevant to the research questions of this dissertation were reviewed 
and included: older adults with one or more chronic disease, the frail elderly, patients with 
congestive heart failure, patients with diabetes mellitus, and a subset of relevant studies 
within the patients with other medical problems category. For example, within the AHRQ 
analysis, the one or more chronic disease study category was selected because this population 
contributes most to the increase in healthcare spending.15 This one or more chronic disease 
category also represents the highest proportion of cost attributed to readmissions and 
admissions, the outcomes of interest for this review.15,16 Additionally, within the AHRQ 
analysis, the frail elderly category was selected because this population shares many of the 
same characteristics as the one or more chronic disease group with the exception of a higher 
prevalence of functional deficiencies.15  
Some of the meta-studies review interventions which targeted a single chronic disease 
diagnosis. The single chronic disease only intervention studies (CHF, COPD and diabetes) 
were selected for inclusion in this review because they are reported to be among the top 10 
prevalent US chronic diseases and also comprise the conditions that may be most impacted 







This section summarizes the high-quality meta-analyses and evidence reviews which 
synthesize results on outpatient care models for elderly populations with comorbid chronic 
diseases. In this literature review, I reviewed 12 meta-studies, which include a total of 517 
individual studies. Eight of these meta-studies were meta-analyses (66%) and four (33%) 
were evidence reviews (Appendix A). 
The studies included in this review vary, in some cases significantly, amongst each 
other. For example, some studies reported 30-day disease-specific readmission rates (e.g., 
CHF), whereas other studies reported overall readmission rates over a period of 3–6 months. 
This is largely a result of no existing standard or widely utilized approach in evaluating care 
models among populations with varied characteristics and settings. As such, I made attempts 
to extract conclusions from as similar circumstances as possible from both individual and 
pooled results.  
There were six best practices identified through this literature. These best practices 
are defined below: 
1. Risk-stratification of populations into subgroups with defined needs: Risk-
stratification refers to targeting interventions to specific patient populations or 
those most likely to benefit from the intervention (impactable). Risk stratification 
often included characteristics such as diagnostic history, demographics, and 
recent utilization.  
2. Face-to-face patient contact (primarily home-based contact): Face-to-face 
interactions involve in-person interactions between the care team and the patient 
at either a community location, clinic or most frequently, in the home.  
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3. Multidisciplinary teams including two or more health-related professions: 
Multidisciplinary teams (MDTs) may include nonclinical individuals, but 
generally require two or more healthcare professionals. Many of the successful 
interventions included nurse care managers and social workers. 
4. Disease-specific care (e.g., COPD and CHF): Disease-based intervention refers 
to intervention activities that target one specific chronic condition, although more 
underlying chronic conditions could be and often were present 
5. Physician Engagement: Physician engagement is defined as the physician having 
a role in the intervention in any capacity beyond the standard care that a patient 
would receive in the absence of the intervention. This role may be active or 
passive. Passive involvement means the physician (s) are informed about changes 
in their patient health and kept apprised about intervention/patient status and 
involvement. This would be considered “beyond standard care” because in the 
absence of the intervention the physician would not have this information. 
However, this passive involvement does mean the physician is actively 
overseeing or modifying the intervention. An example of passive enrollment is if 
the physician isn't provisioning any extra care, but may have a positive effect on 
intervention results by simply mentioning the intervention to the patient. An 
active role is when the physician is actively participating or contributing to the 
intervention by actively provisioning clinical services above what the patient 
would have received in the absence of the intervention. This may include 
reviewing the care services delivered to the patient and recommending changes, 
or visiting the patient themselves in the patient’s home.  
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6. Transitional care models: Transitional care models referenced in this document 
refer to models which are implemented during the transitional period from 
inpatient acute facility to the home or community.  
The most frequently reported activity that achieved a statistically significant reduction 
in inpatient utilization was risk stratification of patients by disease acuity, which was 
reported as an integral feature in 71% of meta-studies. This was followed by face-to-face 
contact with patients and MDT interventions with two or more professionals, both reported in 
59% of meta-studies reviewed. The next most commonly reported intervention reported in 
association with reduced acute care utilization was disease-specific care focused on CHF 
(COPD) in 53% of meta-studies, followed by physician engagement (e.g., primary care 
provider who was aware of the patient’s care plan in conjunction with other providers or 
interventions) in 41% of meta-studies, and transitional care (care post hospitalization) in 35% 
of meta-studies. For reference, these meta-studies also identified other successful strategies 
such as medication management, training of intervention staff, risk stratification based on 
social factors, intensity of patient (frequency) contact, and the length of an intervention (did 
interventions that lasted longer achieve better outcomes). However, these studies were not 
mentioned in at least 30% of the meta-studies, thus were not the focus of the dissertation.  
These best practices were all reported to help reduce different types of utilization, 
such as ED visits, hospitalizations, or readmissions. It is important to note that readmissions 
were defined in each study for different time periods (usually 30, 60, or 90 days). Specifics 
are outlined below per meta-study review; statistical testing details were provided if available 
within the appendices.  
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Out of the studies that reported using acuity-based risk stratification, the most 
common outcomes achieved were reduced ED visits, and readmissions. Studies that reported 
face-to-face contact with patients as a salient feature of the intervention most often reported 
reduced ED visits and readmissions (a good proxy for quality). The studies that reported 
MDT interventions were more likely to report reduced readmissions, followed equally by 
both reduced ED visits and admissions. Disease-specific care was reported most frequently 
associated with the outcome of readmissions. Out of the studies which specifically mention 
physician engagement as a critical part of the care intervention, the most commonly reported 
outcomes were reduced readmissions and hospitalizations. Lastly, transitional care 
interventions were most correlated with readmissions (summarized in Table 3). Tables 4 and 







activity Most common utilization outcomes 
   
Risk-stratification 71 Reduced ED visits/Readmissions 
Face-to-face contact 59 Reduced ED visits/Readmissions 
Multidisciplinary team 59 Readmissions 
Disease-specific care 53 Readmissions 
Physician engagement 41 Readmissions/hospitalizations 
Transitional care  35 Readmissions 






Summary of Results 
Study Intervention Target population Key findings 
    
Effectiveness of 
Outpatient Case 
Management for Adults 
With Medical Illness 
and Complex Care 
Needs Research (2013)  
Nurse case manager led 
interventions. Details of 
intervention varied by group.  
Frail elderly: Nurse home visits 
One or more chronic disease: 
telephonic and nurse home 
visits 
 
CHF: Provider office and nurse 
home visits 
 
COPD: Clinical home/clinic 
visits and self-management 
training, such as in-person 
education sessions and follow-
up telephone support. 
 
Diabetes: home visits, mostly 
nonclinical (nutrition 
counseling, health literacy 
building, drug management). 
 







Duration of contact with 
patient, type of contact, 
intensity of contact and 
engagement of physician 
may be associated with 
decreased inpatient 
utilization. (Intensity of 
contact was NOT 
correlated with 
improved outcomes in 
the CHF group). The 
COPD group was 
particularly responsive 
to intervention when 
compared to other 
disease states. Pre-
intervention training on 
disease-specific clinical 
education was also noted 
by authors to be an 
important intervention 
component.  
    
Congressional Budget 
Office: Lessons from 
Medicare's 
Demonstration Projects 
on Disease Management 
and Care Coordination 
(2012) 
Measured effect on reduced 
utilization from: intensity of 
patient contact, telephone vs. 
in-person, program integration 
with physicians, effects of 
population stratification. 
Individuals with 
one or more 
chronic 
conditions, high-




were associated with in-
person contact between 
patient and assigned care 
team.  
    
Effectiveness of case 
management for 'at risk' 
patients in primary care: 
A systematic review and 
meta-analysis (2015) 
MDT led case selection and 
assessment, care planning, 
coordination, and monitoring.  
Elderly (mean age 
of 75), with one or 
more chronic 
diseases.  
Use of both nurses and 
social workers were 
associated with reduced 
admissions in this 
population.  
    
Models of Care for 
High-Need, High-Cost 
Patients (2015) 
The interventions varied 
substantial across the studies, 
including multidisciplinary 
disease management, 




defined as those 
contributing to 



















Study Intervention Target population Key findings 
    
Caring for high-need, 
high-cost patients: what 
makes for a successful 
care management 
program? (2014) 
Primarily nurse led 
intervention, often including 
community health and social 
worker on the care team 
providing face-to-face and 
telephone support from 1x a 




Significant cost savings 
(>10%) were achieved 
in 5/7 models that used 
risk stratification. 
Interdisciplinary care 
teams and meetings 
were a primary feature 
in the successful studies.  
    
Case management 
effectiveness in reducing 
hospital use: a 
systematic review 
(2016) 
Transitional care intervention 
aimed at preventing 
readmission using 
multidisciplinary teams. The 
most common activities were 
telephonic management, 
assessment at discharge, 





mean age 61.7 and 
some groups were 
also targeted to 




population had a 
significant reduction in 
ED visits among all of 
the studies. Transitional 
housing services were 
provided to this 
population. The rest of 
the studies did not have 
enough statistical 
reliability to make 
robust conclusions.  
    
A Systematic Meta-
Analysis of the Efficacy 
and Heterogeneity of 
Disease Management 
Programs in Congestive 
Heart Failure (2006) 
Disease management programs 
focusing on education, 
coordination and support post 
discharge.  
Elderly patients 
(mean age of 72) 
with the diagnoses 





that used face-to-face 
visits as their primary 
mode of contact were 
statistically significant 
and 3x as effective as 
telephonic management. 
MDT based 
interventions were also 
noted a key feature 
consistent among studies 
achieving successful 
results.17 





Intensive Primary Care 
Programs (2013) 
The included studies varied, but 
a common thread was that they 
focused on addressing 
functional deficiencies in the 
home and in the clinic setting. 
Some interventions were nurse 
led with social workers. Others 
used a multidisciplinary team 
approach (physicians, 
nutritionists, occupational 
therapists, etc.)  
Patients identified 
as high-risk for 
hospital admission 




One study (the GRACE 
model) successful 
reduced ER visits in 
year 2, but only in the 
high-risk subgroup. And 
another study (PACE) 
decreased acute 
hospitalizations by 48% 
over 2 years.  
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Study Intervention Target population Key findings 
    
Innovative Home Visit 
Models Associated With 




Nurse or health educator led 
home visitation model. This 
included care coordination, 
education, and community-
based referrals.  
Medicare patients 
with one or more 
chronic diseases 
The authors note that 
home-visits were one of 
the most observable 
common trends among 
successful components 
of the models in terms of 
reducing ED visits and 
hospitalizations. 
    
Clinical Service 
Organisation for Heart 
Failure: A Cochrane 
Review (2012) 
Intervention models were 
broken down into post 
discharge case management 
(combination of home visits 
and telephone calls), post 
discharge clinic, and 
multidisciplinary.  
Elderly (mean age 
of 67) with at least 
a diagnosis of 
CHF.  
Case management and 
MDT interventions with 
two or more 
professionals in different 
fields may decrease 
readmissions for patients 
with heart failure.  
    
Transitional Care 
Interventions to Prevent 
Readmissions for 
Persons With Heart 
Failure: A Systematic 
Review and Meta-
analysis (2014) 
The intervention concentrated 
on post discharge care 
differentiated by modality 
including, tele-monitoring, 
telephone support, out-patient 
clinic, education, and home 
visits.  
Elderly (mean age 
of 70) with CHF.  
Home visits evidenced 
the most significant 





support, and pharmacist 
interventions did not 
lead to statistically 
significant reductions in 
readmission 




Services in Patients 
Discharged from the 
Hospital with Heart 
Failure: A Systematic 
Review and Network 
Meta-analysis (2016) 
The intervention focused on 
transitional care activities 
including: education, 
pharmacist interventions, tele-
monitoring, telephone support, 
nurse home visits, nurse case 
management and disease 
management clinics.  




Mean patient age 
per study ranged 
from 53-85.  
Nurse home visits and 
disease management 
clinics were shown to 
reduce all-cause 
readmissions 
specifically in heart 
failure patients.  







Best Practice Key Findings 
Best practices Definition Key findings 
Observations and 
conclusions 
    
Risk 
stratification 
Risk-stratification refers to 
targeting interventions to 
specific patient populations 
or those most likely to 
benefit from the intervention 
(impactable). Risk 
stratification often included 
characteristics such as 
diagnostic history, 
demographics, and recent 
utilization. 
Risk-stratification or 
population targeting, was a 
consistent themes of cost-
savings and/or utilization 
reducing care 
interventions.18 It was 
notably absent from 
interventions that have not 




Significant cost savings 
(>10%) were achieved in 5/7 
models that used risk 
stratification.19 
 
The authors note particular 
importance of including 
acute utilization in the 
stratification methodology to 
help target high-risk 
members. A successful 
feature across studies is risk 
stratification of populations 
that includes a combination 
of risk prediction software, 
chronic disease 
identification and utilization 
in combination with 
clinician selection of at-risk 
patients.19 
 
Risk stratification is the 
most commonly observed 
best-practice among studies 
included in literature review. 
Risk stratification was 
applied using various 
methodology. Using clinical 
data (diagnosis, recent 
hospitalizations) alone to 
risk stratify proved to be 
more effective than using 
social factors (income level, 
race, homelessness) in 
reducing admissions and 
readmissions, while social 
data risk stratification was 
correlated most often with 
reducing emergency 
department visits.  





interactions between the care 
team and the patient at either 
a community location, clinic 
or most frequently, in the 
home. 
Of the 23 programs that did 
not have substantial in-
person contact with patients 
or physicians, none 
experienced a reduction in 









Face-to-face patient contact 
as the primary mode of 
intervention delivery has 
been consistently associated 
with the most successful 
interventions reviewed in 
this literature search. The 
authors found that in-person 
contact evidenced a 
significant effect in reduced 
inpatient utilization, most 
often in the form of 
readmissions and ED visits. 
There has been mixed 
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Best practices Definition Key findings 
Observations and 
conclusions 
    
Home-visits were one of the 
most observable common 
trends among successful 
components of the models in 
terms of reducing ED visits 
and hospitalizations.21 
 
The authors discuss the lack 
of efficacy of remote support 
in high-risk HF patients, 
with evidence pointing to 
face-to-face interactions as 
more effective transitional 
care activities.22 
 
The disease management 
programs that used face-to-
face visits as their primary 
mode of contact were 
statistically significant and 
3x as effective as telephonic 
management.17 
evidence suggesting a 
potential link to duration and 
frequency of the contact and 
better outcomes. 
 
    
MDTs MDTs may include 
nonclinical individuals, but 
generally require two or 
more healthcare 
professionals. Many of the 
successful interventions 
included nurse care 
managers and social 
workers. 
Use of social workers as 
case managers was found to 
be statistically significant in 
subgroup analyses for 
interventions that 
statistically significantly 
reduced inpatient utilization 
in adults with chronic 
disease.23 
 
Interdisciplinary care teams 
and meetings were a primary 
feature in the successful 
studies.19 
 
The subgroup analysis 
showed an effect (statistical 
significance (p<.05) ) for 
studies that measured a 
reduction in hospitalizations 
over 13+ months for case 
management interventions 
that employed a social 
worker as part of the MDTs 
(MDTs).23 
These teams have been 
consistently associated with 
improved outcomes in terms 
of both quality of care 
delivered and reduced 
inpatient utilization. The use 
of this best-practice was 
mostly associated with 
reduction in readmissions, 
followed by reduction in 
emergency department 
visits.  








Best practices Definition Key findings 
Observations and 
conclusions 
    
Disease-
specific care 
Disease-specific care refers 
to interventions that are 
primarily targeted to address 
one predominant medical 
condition as opposed to a 
broad spectrum of 
comorbidities. These type of 
interventions are often 
coupled with advanced 
clinical training and 
practitioners who are well-
versed in that particular 







The authors found evidence 
among the studies which 
reported these data to 
suggest that pre-intervention 
training of clinical and 
nonclinical staff regarding 
disease-specific guidelines 
was correlated with more 
successful outcomes in 
reducing costs.15 
 
Studies showed that case 
management (CM) programs 
targeted at COPD 
populations and separately, 
chronic homeless 
populations, may reduce ED 
visits and hospitalizations.15 
 
Additionally, CHF- 
specialist nurse led 
interventions may be more 
effective than other team 
members in reducing 
readmissions for CHF 
patients.24 
Disease-specific care has 
been associated with reduced 
inpatient utilization. 
Readmissions were the most 
common outcome correlated 
with this best-practice.  
    
Physician 
engagement 
Physician engagement is 
defined as the physician 
having a role in the 
intervention in any capacity 
beyond the standard care 
that a patient would receive 
in the absence of the 
intervention. This role may 
be active or passive. Passive 
involvement means the 
physician (s) are informed 
about changes in their 
patient health and kept 
apprised about 
intervention/patient status 
and involvement. This 
would be considered 
“beyond standard care” 
because in the absence of the 
intervention the physician 
would not have this 
information. However, this 
passive involvement does 
mean the physician is 
actively overseeing or 
modifying the intervention. 
Of the 23 programs that did 
not have substantial in-
person contact with patients 
or physicians, none 
experienced a reduction in 
admissions by more than 
6%.20 
 
CM also appears to be most 
effective when the case 
manager works closely with 
patients’ usual care 
providers (usually primary 
care physicians) and/or 
collaborates with a physician 
(or multidisciplinary team of 
health care providers) with 
expertise in managing the 
targeted medical condition.15 
Out of the studies which 
specifically mention either 
active or passive physician 
engagement as a part of the 
care intervention, the most 
commonly reported 






Best practices Definition Key findings 
Observations and 
conclusions 
    
An example of passive 
enrollment is if the physician 
isn't provisioning any extra 
care, but may have a positive 
effect on intervention results 
by simply mentioning the 
intervention to the patient. 
An active role is when the 
physician is actively 
participating or contributing 
to the intervention by 
actively provisioning clinical 
services above what the 
patient would have received 
in the absence of the 
intervention. This may 
include reviewing the care 
services delivered to the 
patient and recommending 
changes, or visiting the 
patient themselves in the 
patient’s home. 
    
Transitional 
care 
Transitional care refers to 
the effectiveness of care 
interventions in the period 
between post hospitalization 
and pre-stabilization in the 
community or home setting.  
 
The most common 
transitional care services 
were: telephonic 
management, individual 
assessments at discharge, 
referrals to social services 
and supports, and education 
or self-management 
supports.  
Overall, home visits 
combined with the 
aforementioned transitional 
care services appeared to be 
the most impactful activities 
when compared with other 
interventions reviewed in 
this meta-study.25 
 
The only other relevant 
models evidencing positive 
cost savings were 
transitional care and 
interdisciplinary primary 
care for heart failure 
patients.18 
 
Transitional care (not broken 
down into further 
subcategories) showed 
positive outcomes in both 
use and cost (only expenses 
not total spending).18 
This period is often 
associated with significant 
cost savings by reducing 
further/preventable inpatient 
utilization more so than any 
other period in the care 
continuum. As far as 
reduced inpatient utilization, 
readmissions was most 
commonly associated with 
this best-practice.  
 




Outpatient case management for adults with medical illness and complex care 
needs (2013).15 This meta-analysis included 55 studies broken up into several categories 
based on population. I reported results for the categories that were relevant to the inclusion 
criteria of this literature review. These categories are older adults with one or more chronic 
diseases, frail elderly, congestive heart failure (CHF), diabetes and COPD. Conclusions were 
made by the authors in aggregate (each population overall), and also separately through the 
analysis of each population subgroups. Fifteen studies included utilization based outcomes of 
interest. When examining the studies altogether (rather than for specific subgroups), the 
meta-analysis found that case management programs included in this review for patients with 
one or more chronic conditions did not reduce hospitalizations (3 studies, moderate 
evidence), nor overall Medicare expenditures (17 studies, high evidence). Despite the 
findings the authors did not conclude statistically significant results overall, there were 
certain features of the studies, that when analyzed separately, did display significant findings. 
These features, as quoted by the authors of the review, were as follows: 
The results of trials across different clinical conditions suggest that CM effectiveness 
was greater when the intervention was lengthy, high in patient contact, and included 
face-to-face (rather than telephone-only) interactions. . . . CM also appears to be most 
effective when the case manager works closely with patients’ usual care providers 
(usually primary care physicians) and/or collaborates with a physician (or 
multidisciplinary team of health care providers) with expertise in managing the 
targeted medical condition.15   
Studies from this review also showed that CM programs targeted at COPD 
populations and separately, chronic homeless populations, may reduce ED visits and 
hospitalizations. COPD was one of the diseases most significantly affected by care 
management interventions and particularly by self-management and health education. The 
diagnosis of COPD had a high correlation with co-occurring CHF (35% of patients had both 
COPD and CHF).26 The CHF subgroup responded to care management interventions as a 
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whole more readily than other groups. This may be because of the modifiable nature of CHF 
related admissions, and/or specific intervention activities targeted towards specific disease-
related needs. 
Risk stratification using social determinants was not an effective way to identify the 
patients most likely to benefit from CHF interventions, and that held for most all clinical only 
interventions. However, risk stratification using social determinants was effective when 
social issues, as well as clinical issues, were targeted by the intervention. For example, the 
homeless population responded well to interventions that used social determinants to risk 
stratify. These interventions concurrently addressed both clinical and social issues—such as 
securing housing placement.  
Clinically based interventions were effective in reducing CHF related-admissions. 
Additionally, populations with an elevated pre-intervention baseline number of 
admissions/readmissions (as compared to average for like population), showed a larger 
reduction in inpatient utilization overall. Intervening during high-need periods, such as the 
time period post hospitalization in high-need populations, such as the CHF populations, 
appears to be an effective targeting strategy leading to better results with reduced utilization 
or increased return on investment (ROI). 
Congressional Budget Office: Lessons from Medicare’s Demonstration Projects 
on Disease Management and Care Coordination (2012).20 The Congressional Budget 
Office (CBO) prepared a meta-analysis of 34 Medicare demonstrations serving high-need 
Medicare beneficiaries.20 The study populations were divided into several categories 
including high-cost patients, duals (Medicare and Medicaid beneficiaries), or beneficiaries 
with one or more chronic conditions (one of which one had to be CHF, COPD, or diabetes). 
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Most studies (30 of 34) used a randomized design. The intervention measured: intensity of 
patient contact, telephone versus in-person, program integration with physicians and assigned 
nurse case managers, effects of population stratification on outcomes (reduced net savings 
and reduced readmissions), training and experience of staff, and the effect of pharmacist led 
interventions. The authors found that in-person contact evidenced a significant effect in 
reduced inpatient utilization. Of the 23 programs that did not have substantial in-person 
contact with patients or physicians, none experienced a reduction in admissions by more than 
6%. Physician oversight of care programs (also termed physician engagement), risk 
stratification of populations prior to intervention implementation, and training of care 
managers were features noted by the authors to be beneficial in reducing inpatient utilization. 
However, the effectiveness of these features was not statistically validated.  
Effectiveness of case management for “at risk” patients in primary care: A 
systematic review and meta-analysis (2015).23 This meta-analysis included 36 studies 
looking at the effectiveness of interventions on elderly (average age of 75) with chronic 
diseases. The overarching objective of this review was to determine the effectiveness of this 
intervention at the primary care level for at-risk elderly patients, and to evaluate whether this 
effectiveness is modified by a variety of study characteristics including design and 
implementation method. A subgroup analysis was conducted that looked at single nurse 
versus MDT, RCT versus non-RCT, and social worker versus no social worker. For the 
outcomes of interest (cost and hospitalizations), the subgroup analysis only showed a 
significant effect (statistical significance (p<.05)) in reducing hospitalizations for case 
management interventions that employed a social worker as part of the MDT. These findings 
only became significant in interventions that were of longer duration—defined in this study 
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as follow-up over at least 13 months. There were no other significant findings in the 
subgroup analyses. 
Models of Care for High-Need, High-Cost Patients (2015).18 This evidence 
synthesis reviewed 123 studies targeting high-cost patients with complex needs, predicted to 
be high-cost in the future. There were 15 care models within the 123 studies. The major care 
models included interdisciplinary primary care (not divided into further subcategories), 
enhancements to primary care (divided into eight subcategories, including general care 
management, disease management, preventive home visits, geriatric evaluation and 
management, pharmaceutical care, chronic disease self-management, proactive rehabilitation 
and caregiver education and support), and transitional care (not divided into further 
subcategories). The authors found that the enhancements to primary care model showed the 
most promising results overall in regard to reduced ED visits and hospital admissions. Five 
out of eight of these primary care enhancement subcategories (disease management, 
preventative home visits, pharmaceutical care, chronic disease self-management and 
caregiver education and support) showed reduced inpatient utilization metrics. The only other 
relevant models evidencing positive cost savings were transitional care and interdisciplinary 
primary care for heart failure patients. Additionally, risk-stratification or population targeting 
based on patient needs was a consistent theme for studies that evidenced cost-savings and/or 
inpatient utilization reduction. 
Caring for high-need, high-cost patients: what makes for a successful care 
management program? (2014).19 This evidence synthesis included 18 studies, 10 were 
relevant to the target population. These 10 studies targeted Medicare and Medicaid 
populations at high-risk for poor clinical outcomes. Five out of 10 studies targeted Medicaid 
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populations, three out of 10 studies targeted Medicare only populations and two out of 10 
targeted both Medicaid and Medicare populations. Seventy percent of the care programs in 
these 10 studies employed a high-risk stratification strategy to select which populations to 
care manage. Risk scores were used by six out of seven studies that stratified patients by 
high-risk. Diagnosis of chronic conditions was used in five studies. Utilization history was 
used in four, referral by physician in three, and medications in one. The interventions 
analyzed in this review consisted of the following activities including: identifying and 
engaging patients who are at high risk for poor outcomes, performing comprehensive health 
assessments to identify problems that, if addressed through effective interventions, will 
improve care, and working closely with patients and their care team to respond to changes in 
patients’ conditions.19 
Care teams were predominantly led by a nurse case manager, but harder-to-engage 
patients with social/behavioral needs may have included a social worker or lay community 
health worker. Costs savings (at least 10% cost savings) were achieved in five out of seven 
(71%) of the care models that used high-risk stratification.  
Overall the authors identified several successful care intervention strategies from the 
studies that achieved cost-savings: 
• Selecting the right patients for the most appropriate programs. The authors note 
particular importance of including acute utilization in the stratification 
methodology to help target high-risk members 
• MDTs that are able to address complex issues in patients with comorbidities 
• Shared information platforms  
• In-person multidisciplinary meetings  
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• Risk stratification of populations that includes a combination of risk prediction 
software, chronic disease identification and utilization in combination with 
clinical referrals 
Case management effectiveness in reducing hospital use: A systematic review 
(2016).27 This evidence review looked at 10 studies with the objective of evaluating the 
effectiveness of transitional care management programs internationally, including the United 
States. Fifty percent of the studies were US based. The studies in this review targeted 
individuals with chronic disease and/or social issues for the case management interventions. 
Examples of studies that targeted particular groups include low-income African American 
populations with diabetes, elderly individuals with functional impairment and chronic disease 
comorbidities, and homeless populations with uncontrolled chronic disease. All 10 studies 
were based around MDTs including physicians, social workers and nurses. Most of the 
interventions were triggered by a hospitalization and the intervention services were 
conducted right after hospital discharge. The most common transitional care services were: 
telephonic management, individual assessments at discharge, referrals to social services and 
supports, and education or self-management supports.  
Three studies reported a statistically significant reduction in readmissions (studies 
primarily measured 30-, 60-, or 90-day readmissions.). All three studies which reported 
significant reduction in readmissions targeted individuals with chronic illness. Three other 
studies reported reduced readmissions but the change was not statistically significant.  
It is important to mention that a majority of these studies did not have a large enough 
population size to produce the statistical power needed to reliably conclude the reported 
results based on the effect size of similar studies. The studies that had populations size over 
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500, and produced statistically significant results were deemed low quality by the authors. 
The authors of this review did not posit which aspects of the successful studies may have 
contributed to reduced hospital use when compared to other studies. However, one study that 
was of high quality and successful in reducing readmissions showed that the home visit plus 
telephone call intervention group had a lower readmission rate than the telephone only 
intervention group by 5%. It was not reported whether this difference was statistically 
significant. This same study evidenced statistically significant reductions in readmissions 
with a population similar to the target population of this review, however the study only had 
an N of 281 and was conducted in China, which may both limit the power of the conclusions 
and generalizability of the applied methods. Overall, home visits combined with the 
aforementioned transitional care services appeared to be the most impactful activities when 
compared with other interventions reviewed in this meta-study.  
A systematic meta-analysis of the efficacy and heterogeneity of disease 
management programs in congestive heart failure (2006).17 This meta-analysis reviewed 
36 studies with the objective of evaluating the effect of disease management programs 
(DMP) on elderly patients (mean age of 72) with the diagnosis of CHF (usually with the 
accompaniment of additional morbidities). The DMP’s are primarily led by nurses, and may 
also include physicians, social workers, pharmacists and PCPs.  
Ten of the 32 studies utilized home-visits, and all of these studies included at least 
one home visit post hospitalization. Five studies had more than a nurse and a physician on 
the care team delivering the intervention (pharmacist or social worker) and four of these five 
(80%) were interventions that utilized home visits. Thirty-nine percent of the studies used 
transitional care as a component of the disease management program, 28% used telephone 
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calls only, 33% integrated the program with the primary care physician and 25% used 
medication review. Face-to-face contact interventions achieved a statistically significant 
difference in reduced readmissions when compared directly to telephonic contact only. Face-
to-face contact evidenced a -10.5% decrease in readmissions (NNT of 9), while telephone 
contact evidenced a -3.6% (NNT of 27) decrease in all-cause readmissions. NNT is the 
number needed-to-treat to prevent one readmission. In conclusion, disease management 
programs showed a statistically significant difference in all-cause readmissions for patients 
with CHF. Programs that were particularly effective at reducing readmissions were those that 
used face-to-face contact and those that employed MDTs. 
Evidence-based synthesis program evidence brief: Effectiveness of intensive 
primary care programs (2013).28 This meta-analysis included 20 studies. The target 
population consisted of patients at high-risk for future hospitalization and/or death. Two 
studies out of the 20 evidenced statistically significant results in populations of interest for 
this review, GRACE (Geriatric Resources for Assessment and Care of Elders) (N = 951) and 
PACE (program of all-inclusive care for the elderly) (N = 3889) studies.29,30  
The GRACE study was an RCT and the population was selected based on age (>65), 
low income level (<200% of the FPL) and low access to outpatient healthcare services (N = 
951). The GRACE intervention integrated interdisciplinary teams including an advanced 
practice nurse and a social worker into the patient’s regular primary care practice. The 
purpose of this structure was to enhance care continuity for participants. The GRACE model 
delivered services at a free-standing clinic where more intense care was given to a select 
subgroup of patients based on need. A salient characteristic of the GRACE model was 
integration with pharmacy, mental health, home health, inpatient and community-based 
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services. The GRACE model evidenced a significant reduction in ED visits (in Year 2) (p = 
.03) for the full sample of patients including the high-risk group, and a statistically significant 
reduction in hospitalizations in Year 2 (p = .03), but only in the high-risk subgroup. 
PACE targeted nursing-home eligible individuals who were 55 or older. The PACE 
model provided care management through an MDT approach consisting of PCP’s, nurse 
practitioners, social workers, dieticians, pharmacists, and lay community workers. Services 
were delivered inpatient, in the home, and in adult day care centers. There were no 
statistically significant results for Year 1 outcomes in terms of reduced inpatient utilization in 
either group. However, the PACE model did significantly decrease acute hospitalizations by 
48% over two years.  
Innovative home visit models associated with reductions in costs, 
hospitalizations, and emergency department use (2017).21 This evidence review evaluated 
five home-visit based studies, three of which focused on the populations of interest and 
included in this summary. Overall, this review focused on Medicare home visitation models 
for patients with one or more chronic diseases. The primary deliverers of this intervention 
were lay community workers, and in some cases health educators or RN’s. All of the 
programs included home visitation as a component of the intervention. The relevant models 
analyzed were Johns Hopkins’, CAPABLE (Nursing Community Aging in Place, Advancing 
Better Living for Elders; N = 171), DASH (Doctors Assisting Seniors at Home; N = 1,112), 
and Indiana Universities’ ABC (Aging Brain Care; N = 1,244). Of the three relevant models 
analyzed, registered nurses led two (CAPABLE and DASH). DASH offered home-visits “as 
needed” and its purpose was to help older adults avoid ED utilization. CAPABLE delivered 
10 home-visits over a 5-month period with the objective of improving functional home safety 
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to delay nursing home placement and reduce hospitalizations and ED visits. The DASH 
model included care coordination, education, community-based referrals, and advanced care 
planning, but not environmental assessment or home re-design. Statistically significant 
reduction (p < .05) in hospitalizations and ED visits were shown in the DASH model over a 
3-year period. The CAPABLE model included care coordination, education, community-
based referrals and an environmental assessment and re-design. Medicare expenditures (not 
net costs) were reported and were significantly reduced for the CAPABLE model (p<.05) 
over a 2-year period. The authors note that home-visits were one of the most observable 
common trends among successful models in terms of reducing ED visits and hospitalizations 
for these populations. No relevant significant findings to this dissertation were reported for 
the ABC model.  
Clinical Service Organisation for Heart Failure: A Cochrane review (2012).24 
This meta-analysis included 25 randomized controlled studies targeting adult CHF patients 
that had been admitted to the hospital for the condition within the past 12 months. The 
studies were broken up into case management postdischarge interventions (17 studies), 
postdischarge clinic interventions (6 studies), and multidisciplinary interventions (2 studies). 
Case management interventions included a combination of postdischarge home visits and 
follow-up telephone calls. These studies primarily involved telephonic case management 
support with goals such as weight management and health education. A heart failure 
specialist nurse led the intervention in twelve of the studies. These specialist nurse led studies 
primarily used home visits. Of those studies that reported readmissions with specialist nurses 
(6 studies, n = 1,381), five out of the six studies were found to significantly decrease heart 
failure related admission (p = .002). Three studies were led by community pharmacists and 
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one out of three showed an effect on heart failure related readmissions (p = .04). Six studies 
reviewed the efficacy of heart failure clinics, of which there were no significant outcomes. 
There were no other reported significant effects in the subgroup analyses. Overall, the 
authors concluded that case management and MDT interventions with two or more 
professionals in different fields may decrease readmissions for patients with heart failure. 
Additionally, CHF- specialist nurse led interventions may be more effective than other team 
members in reducing readmissions for CHF patients.  
Transitional care interventions to prevent readmissions for persons with heart 
failure: A systematic review and meta-analysis (2014).31 This meta-analysis included 47 
individual studies and focused on the transitional care period post hospitalization from 
facility-to-community settings in adults hospitalized for HF (heart failure). All studies 
included in this meta-study involved some type of transitional postdischarge intervention 
from an acute inpatient facility. The categories of interventions analyzed in this study were 
differentiated by mode of delivery including home-visitation programs, structured telephone 
support (with set clinical goals and number of calls), tele-monitoring, outpatient clinic, 
educational, and other (studies that did not fit into the aforementioned categories). Outcomes 
were reported in terms of risk ratios. The outcomes of interest reported were HF-specific 
readmission over 30 days and over 3–6 months, and all-cause readmissions over 30 days and 
over 3–6 months. The studies did not report all of these outcomes. Nurse case managers 
primarily conducted the home visits. Home visits were shown to prevent all-cause 
readmissions in heart failure patients over 30 days and over 3–6 months in this meta-analysis. 
Home visitation is approximately twice as effective as preventing HF specific readmissions 
over 3–6 months when compared with structured telephonic support. The authors concluded 
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that home visitation programs were effective in reducing 30-day all-cause readmissions. No 
other significant findings were reported.  
Comparative effectiveness of transitional care services in patients discharged 
from the hospital with heart failure: A systematic review and network meta-analysis 
(2016).22 This meta-analysis included 53 individual studies, and at the time it was published 
in 2016 represented the largest collection of RCT’s evaluating comparative effectiveness for 
heart failure (HF) transitional interventions. The transitional care activities were broken 
down into several categories including education alone (4 studies, 3 U.S. based), pharmacist 
interventions (4 studies, 1 U.S. based), tele-monitoring (9 studies, 5 U.S. based), telephone 
support (9 studies, 4 US based), nurse home visits (6 studies, 0 U.S. based), nurse case 
management (which consists of a variety of activities including both telephone support and 
home visits; 10 studies, 5 U.S. based), and DMC or disease management clinics (consisted of 
follow-up visits at a clinic with MDT providers and support staff such as nurses, 
cardiologists, geriatricians, dieticians; 10 studies, 1 U.S. based). Readmissions were 
measured from pooled data across these categories. Overall the authors found that nurse 
home visits and disease management clinics may reduce all-cause readmissions in heart 
failure patients after a heart-failure-related hospitalization. 
Discussion 
This literature review assessed a broad body of literature to more comprehensively 
understand effective care models for elderly Medicare and/or duals patients with chronic 
disease. The findings varied significantly across population types, and setting and by 
intervention activity and disease state (see Table 4).  
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Despite these variations, there were six common best practices that were more often 
associated with positive cost savings, and reductions in readmissions, admissions and ED 
visits: 
• risk stratification;  
• face-to-face visits; 
• MDTs;  
• disease-specific care;  
• physician engagement and;  
• transitional care.  
Within these broader categories there exist a large number of subcategories (often explored 
through post hoc analyses) which are useful to further understanding the complexities and 
nuances of these best practices.  
Overall, this review elucidated the large number of strategies contributing to acute 
care utilization reduction. Authors continually noted the difficulty in controlling for all 
possible confounders. This means that the outcomes may have been mediated or confounded 
by a host of different factors. Nevertheless, pooling large amounts of data in the form of 517 
high-quality studies on elderly patients with chronic diseases, have aided in supporting the 
conclusions put forth in this review. This literature review provided evidence to substantiate 
the following conclusions regarding which populations were deriving the most benefits from 
existing care models implemented over the standard-of-care. Further, the review provided 
additional confirmation that these benefits were simultaneously tied to cost-savings for 
payers through reduced acute utilization.  
Findings from the meta-analysis suggest a collection of best practices that have 
consistently been associated with successful care models, leading to statistically significant 
reductions in ED visits, hospital admissions, and/or readmissions. I limit this discussion of 
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best practices to those strategies that were associated with positive health outcomes in more 
than 30% of the meta-studies.  
Below, each best-practice is discussed as it relates to the results of the literature as 
well as further implications for answering the proposed research questions. 
Risk stratification. Risk-stratification, the process of segmenting populations based 
on targeted characteristics, has consistently been used in successful care models. Stratifying 
populations with like-needs can enhance the ability to provide appropriate services to those 
who can benefit the most. For example, populations who have excellent activities of daily 
living functionality and are not at risk for falls may not benefit from fall-risk mitigation 
efforts. Of the 517 studies included in one or more of the meta-analyses, 252 studies noted 
that risk-stratification was a component of successful initiatives.  
Interventions that do not stratify by risk in effect serve populations with differing 
needs. As with any unsegmented population there is a spectrum of clinical acuity, with some 
groups of individuals requiring more frequent intervention for specific needs, and other 
groups requiring little to no services. By reviewing the outcomes of the meta-studies, it is 
apparent that there is less impact on inpatient utilization in interventions that target broad 
populations with undefined unmet needs. Notably, risk stratification appears to be necessary 
but not sufficient reduce inpatient utilization and cost. Further, it is important to mention that 
the accuracy of the risk stratification measures will dictate the final impact of this best-
practice on outcomes. The efficacy of risk stratification is a factor of how likely these 
measures are to identify the right needs through the proper balance of specificity and 
sensitivity appropriate for the intervention.  
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Two risk-stratification methods have shown to be successful in segmenting 
populations based on need and subsequently achieving the desired outcome of reduced acute 
utilization. The first is identifying and targeting individuals who recently were hospitalized. 
Usually, this means selecting individuals who have been in the hospital recently (defined 
differently by study) has shown to increase the probability that the intervention will achieve 
statistically significant cost-savings or reduction in utilization when compared to a usual care 
group. Further, it is not just the recent timing of hospitalization, but the frequency of 
hospitalizations that have been observed to make a difference in the ability of an outcome to 
achieve a successful endpoint. Hospitalizations function as a proxy for risk and are therefore 
a helpful measure in ascertaining which individuals may benefit from intervention.  
A large meta-study (including 109 individual studies and an N of 18,400) noted that 
one statistically significant characteristic between intervention groups which improved 
outcomes was the number of hospitalizations at baseline, prior to the implementation of the 
intervention.15 Intervention groups that had high baseline readmissions and admissions were 
more likely to show cost-saving positive impacts when compared with groups that had lower 
baseline utilization rates. This means that measuring the baseline utilization rates of 
populations (when compared to similar populations) and selecting populations with high 
baseline rates for interventions may be an important component in evaluating the potential 
impact and cost-effectiveness of an intervention.  
Combined, both recentness and frequency of inpatient utilization appear to be critical 
components of selecting the patients most likely to benefit from interventional care. This 
technique may also be related to the relative effectiveness of transitional care models versus 
nontransitional care models (discussed below).  
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The second effective method of risk stratification is segmentation of populations 
based on severity and number of significant medical conditions. The general assumption 
underlying this method of risk stratification is that populations with specific clinical 
attributes and disease conditions are more appropriate for particular interventional strategies. 
This method is widely used among health organizations to target populations who they 
believe require more frequent contact with the health system to manage their health and 
subsequent healthcare costs. Healthcare organizations determine which individuals are 
appropriate for intervention by using a variety of different data sources including medical 
claims, diagnostic history, medical utilization, age, and provider referrals. But, there seems to 
be a point where simply selecting the most ill patients for care management interventions 
does not return the most benefits for the patient nor the organization. In other words, acuity 
of patient population and benefit received from intervention is not evidenced to be a 
continuous linear relationship.  
There may be some populations and diseases states for which a higher acuity status 
does not translate into additional benefits. For example, in the AHRQ meta-study the two 
defined populations of “one or more chronic disease” and “frail elderly” were very similar 
except that the frail elderly population was generally considered at greater risk because in 
addition to chronic disease states they also had functional deficiencies and other health 
complications and were more likely to be placed into a nursing home. The benefits derived 
from the case management intervention of one or more chronic disease were not seen in the 
frail elderly. Impactability (how likely is a population to benefit from a given intervention) is 
a key feature of successful risk-stratification, and it is based on the premise that there is a 
target level of acuity where the most benefits can be derived for any one population, per 
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intervention. A potential explanation may be that the particular intervention was more suited 
for patients who were sick and high-cost, but not so sick and at-risk that they were eligible 
for the frail elderly category; and therefore perhaps not as receptive to case management 
activities. It is my opinion that finding the balance between populations with unmet needs at 
risk and the intervention’s ability to influence the risk trajectory of the population is key in 
identifying best practices. Some studies targeted populations based on social factors 
(homelessness, race, income). These studies were much more likely to achieve reduced 
utilization for ED visits, with (four) 75% of the studies which used social factors finding a 
reduced number of emergency department visits when compared to a control group. For 
comparison, among the nine meta-studies which only used clinical risk stratification (no 
socially based stratification), only 44% achieved a reduction in ED visits.  
In summary, the overall effectiveness of risk stratification in selecting specific 
populations for care management interventions was the single most consistent component of 
successful care interventions meeting the endpoint of statistically significantly reduced 
inpatient utilization for multimorbid elderly throughout this literature review.  
Face-to-face visits. Face-to-face contact between healthcare professionals and 
patients was one of the most commonly mentioned criteria of best practices across all the 
meta-studies. The number of individual studies that contributed to this conclusion was 240 
out of 517. Studies that incorporated face-to-face contact with patients as part of the 
intervention (most often occurring in the home, but occasionally in a clinic setting) were 
more likely to have reduced ED visits and readmissions—more so than any other acute 
utilization metric. Generally, an ED visit is reported as an emergency department visit if the 
patient is treated and released from the hospital, not requiring a hospital admission. Because 
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of this many ED visits are considered avoidable, as they do not necessitate a hospital 
admission. Additionally, readmissions, in large part, are also considered predominantly 
preventable as well, especially if the readmission is related to the index (original) admission 
diagnosis. Because face-to-face patient interaction was often associated specifically with 
reduced ED visits and readmissions, part of its benefit may lie with preventing ambulatory 
care sensitive admissions, or avoidable readmissions and ED visits. Avoidable ED visits can 
be broken down into several categories, those that can be serviced in an outpatient setting 
(urgent care/clinic), and those that could have been avoided if medical/social needs had been 
met earlier or differently by either the patient themselves or their healthcare team/system. 
Face-to-face contact with patients may help reduce preventable readmissions in both of the 
above areas. Fostering a stronger bond between healthcare professionals and their patients, 
may lead to enhanced trust, opportunity for more comprehensive evaluation, and 
subsequently better adherence and information sharing—effectively reducing the number of 
preventable inpatient episodes.  
Four meta-studies recognized that the face-to-face relationship in terms of duration, 
and frequency may be an important element. But, the evidence reported in this literature 
review did not provide enough conclusive support for this claim to be made with statistical 
confidence. The results were mixed regarding the effect of frequency of visits on intervention 
outcomes. Additionally, there was not a clear difference in inpatient utilization outcomes 
when the duration and intensity of the intervention was adjusted. This may be due to fewer 
studies reporting these features in a way that could be pooled for a meta-analysis. One study 
reported that increased duration was significantly correlated with reduced utilization, and two 
meta-studies reported a correlation between high-intensity and reduced utilization.15,23,31 
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Regardless of these positive outcomes, the evidence for both of these conclusions was rated 
low by the authors due to the relatively low statistical power of the conclusions. Whether 
duration or frequency of face-to-face visits is a modifying factor of reducing inpatient 
utilization remains unclear from the evidence provided in this review. Even so, it is clear that 
presence of any face-to-face contact with patients is conclusively correlated with achieving 
reducing inpatient utilization for the populations targeted in this review.  
Face-to-face contact, particularly when in the home, allows the care management 
team to identify hazards, environmental concerns, medication inconsistencies, living 
arrangements, and clinical or behavioral symptoms which, when combined with other 
environmental or socioeconomic indicators, may indicate specific patient needs. Further, the 
significance of face-to-face interaction has not only been evidenced as a value-add when 
compared to the no-intervention control group, but is also a value-add when directly 
compared to telephonic case management—at roughly double the effectiveness (see Results 
section for details).  
Additionally, combining best practices may enhance effectiveness. Eighty-three 
percent of the meta-studies which utilized risk stratification, also used face-to-face visits with 
patients as an intervention best practice. In addition, 100% of the MDT studies also 
implemented some form of face-to-face interaction. The combination of both face-to-face 
visits and acuity based risk stratification may be an effective pairing of strategies as the 
subsequent application of first risk-stratification and then face-to-face visits has consistently 
been shown to be a concordant strategy in improving outcomes of interest. 
Multidisciplinary teams. MDTs were consistently recognized as a best-practice 
throughout this literature review. MDTs are defined in this review as two or more 
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professionals involved in the care team for a specific intervention. The teams most 
commonly included at least a nurse (disease specific, advanced practice nurse, or general 
case manager), and a physician (PCP or specialist). Other successful models included a 
community health worker (lay healthcare navigator), social worker, pharmacists, nutritionist, 
and/or a behavioral health provider. Seventy percent of the studies using this best-practice of 
MDTs reduced readmissions, while 50% reduced emergency department visits with only 
30% reducing admissions. Of the 517 studies included in the meta-studies, 411 suggested that 
MDTs were an important strategy to improve outcomes. One meta-study suggested that 
teams with social workers may be more likely to achieve reductions in utilization than 
multidisciplinary teams without a social worker.23 This may be especially true when working 
with indigent populations such as dual eligible or other vulnerable groups in which 
socioeconomic conditions are contributing to the development or exacerbation of chronic 
disease states, and subsequent unnecessary acute utilization.32  
MDTs may help meet specific needs of populations so that complex issues (clinical, 
social and behavioral) contributing to declining health can be addressed. In a team-based care 
model, multiple interrelated issues can be addressed simultaneously. Evidence from this 
literature review suggests that MDTs may serve an increasingly integral role as patient 
populations become progressively more complex and diverse. Each member of the MDT 
contributes a unique set of skills, experience and knowledge to address multiple facets of 
care for the patient. For example, primary care physicians and specialists can oversee the care 
given by the MDTs and provide oversight and recommendations to inform the care plan for 
the patient, while disease-state specific needs may be addressed by nurses skilled in looking 
for particular hard to miss symptoms that indicate a worsening of condition. Social workers 
 
47 
or community health workers may be more skilled at addressing the social domain of issues, 
such as homelessness, that may contribute to the ability of the patient to effectively manage 
their disease and pharmacists can manage polypharmacy issues, and ensure that medication 
regimens are optimal.  
Team members can provide one another with cross-disciplinary feedback to manage 
populations more effectively than an individual provider. This effectively contributes to 
improvement in health outcomes which are evidenced by a reduction in inpatient utilization 
when compared to the standard-of-care delivered to control cohorts. It is also true that MDTs 
are expensive, and difficult to scale. Therefore, to achieve an ROI these teams needs to be 
right-staffed (balanced expertise) and used with discretion on populations/conditions 
evidenced to benefit from such interventions.  
Disease-specific care. The meta-analysis conducted by the Agency for Healthcare 
Research and Quality, measured the pooled effectiveness of interventions on specific groups 
including high-cost chronic disease states, and some groups with a defining socioeconomic 
condition (e.g., homelessness). Most of these interventions were nurse-led, with a focus on 
servicing clinical needs, although some targeted those with social needs (e.g., the homeless). 
Some groups were segmented by disease state, such as CHF and COPD, and others by 
functional deficiencies or comorbid conditions that were not disease-specific. The disease-
specific interventions were consistently more likely to achieve successful outcomes than 
when compared with populations defined more broadly (multiple chronic disease) and 
interventions that did not target a specific condition. In this analysis, the authors found that 
the specificity of segmentation was correlated with improved outcomes. Interventions that 
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isolated particular unmet needs for specific chronic diseases were more likely to achieve 
reduce inpatient utilization.  
Disease-specific readmissions (e.g., CHF related readmissions) were more likely to 
be affected at statistically significant levels when compared with all-cause readmissions and 
admissions. Studies with longer-duration follow-ups were more likely to significantly reduce 
admissions and readmissions than short-term follow-ups across the majority of studies. This 
could indicate that disease-specific interventions may take longer to work, or it could mean 
the outcomes take longer to reach statistical significance due to a smaller effect size. If the 
control group was not robust, and participation in the intervention occurred after a medical 
event, this observation may also be a factor of regression to the mean. 
The meta-studies suggested that interventions targeted to people with COPD or CHF 
were most successful in achieving positive health outcomes when compared with other 
disease states such as diabetes. This may be a result of the impact of improved self-
management skills, enhanced coordination processes and clinical intervention on certain 
disease states versus others. Disease-specific care most often led to the outcome of reduced 
readmissions. Additionally, it is possible that the mismanagement of these conditions may 
lead to higher preventable readmissions than other chronic disease states. For example, the 
diabetes management interventions in the AHRQ meta-analysis were shown to have a 
positive impact on glucose levels and HbA1c, but not on utilization, whereas better 
management of COPD and CHF more often led to a key outcome of interest for this study— 
reduced readmissions. Overall, high-risk disease-specific interventions has been identified as 
a best-practice strategy and has been consistently observed to be associated with more 
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significant positive outcomes than groups of patients intervened on for general high-acuity, 
but with no disease-specific inclusion criteria. 
Physician engagement. Across the meta-studies, physicians (primary or specialty) 
engaged in any capacity in the care for intervention populations was associated with reduced 
inpatient utilization. This could mean either passive awareness or active guidance/care. The 
level of physician engagement varied by intervention, and when comparing passive versus 
active across the meta-studies neither form was more likely than the other to result in 
improve outcomes based on the evidence in this review. However, it was clear that some 
level of physician engagement (even passive) was indeed correlated with improved statistical 
outcomes in the form of reduced inpatient utilization. The protocol for physician involvement 
was not standardized across interventions. Regardless, there was a correlation between 
physician involvement in the intervention and reduced inpatient utilization. Although there 
was a significant amount of variety as to how and when physicians were integrated into the 
intervention, I identified several common characteristics, that when present together 
increased the efficacy of the intervention.  
1. The physician (predominantly PCP) was aware the intervention was occurring and 
that their patient was an active participant within the intervention.  
2. The physician was notified when there was any change to their patient’s plan of 
care, such as medication related modifications by pharmacists, or home visits.  
3. The physician was able to give actionable feedback and recommendations to the 
intervention providers.  
I posit several reasons why physician engagement was correlated with reduced 
inpatient utilization. First, if the physician had developed a pre-existing relationship with the 
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patient, the intervention staff may be able to leverage this relationship to facilitate patient 
engagement. The physician then serves as a key linkage between the patient’s current care 
team, and the intervention team, in effect increasing overall participation. Second, if the 
physician knows their patient he/she will be able to provide informed recommendations to 
the intervention team to augment the plan of care for that particular patient and to inform the 
intervention team of underlying issues or concerns that may need to be addressed. Third, the 
physician will be able to provide continuous care to the patient post intervention, as well as 
close care gaps and meet needs that the intervention is not designed to address. This 
continuity may lead to positive outcomes post intervention, but still in the study follow-up 
period improving overall results. Physician engagement in any planned outpatient 
intervention deserves serious consideration, as there are numerous pieces of evidence that 
substantiate the benefits of physician support in care management interventions for elderly 
patients with chronic disease.  
Transitional-Care Models 
Transitional care models refer to interventions that coordinate services and clinical 
interventions post discharge, when individuals transition from acute facility, or hospital-
based setting to the community or home. The clinical interventions varied, but may have 
included activities such as medication reconciliation, coordination of follow-up 
appointments, home health, durable medical equipment delivery, telephone/home visits by 
providers, and disease-specific counseling. This period of time has been identified as a time 
of enhanced vulnerability and risk for patients, as there is a higher probability of admission 
back into the hospital after a recent hospitalization than in the general population. It is 
therefore common that the effectiveness of transitional care models is measured by 
readmission rates. Transitional care models have shown to be one of the most common types 
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of interventions associated with a successful reduction in readmissions. This may simply be 
because in the transitional care population (which is defined as post hospitalization), you 
have more readmissions occurring on average in your intervention group, and therefore more 
chances to target individuals who would have readmitted in the absence of the intervention. It 
may also be because readmissions are predominantly considered preventable and therefore 
interventions have high impact because the nature of the readmissions are more responsive to 
the intervention. For these reasons, transitional care models may be one of the models that is 
most likely to produce positive outcomes (increased quality and reduced costs). Transitional 
care models may also be a good strategy to test the effectiveness of interventions as they 
have a rate of individuals that would readmit anyway, in effect increasing the number of rare 
events (readmissions) one would need to observe to evaluate whether or not there is a 
significant effect. Even though transitional care models appear to be one of the most effective 
paradigms in regards to reducing readmissions for the elderly with chronic diseases, the reach 
of the model is limited to individuals who have already been hospitalized. This approach 
does not address the root causes of initial admissions. Thus, this strategy is may be one well-
suited to be coupled with other, more upstream care management approaches.  
Intervention Combinations 
Some interventions combined several best practices, the most commonly combined 
best practices leading to reduced ED visit, readmissions and admissions, were risk 
stratification, face-to-face visits, and MDTs. While some of these interventions are more 
effective at reducing inpatient and ED use, some are also more expensive. For example, face-
to-face interactions are often more expensive than tele-support, and that MDTs are more 
costly than one provider. Thus one key question is whether combining these best practices 
and achieving improved outcomes, outweighs the increased cost of the intervention over less 
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expensive, but potentially less effective methods. This dimension will be explored in the key 
informant interviews. It is also important to consider in further iterations of this research the 
impact of these best practices on other areas of potential cost-savings such as pharmacy, 
skilled nursing facilities, outpatient specialty costs, and additional quality adjusted life years.  
Ineffective Interventions 
Out of all of the studies reviewed by the way of this literature review, most did not 
achieve statistical significance in reducing inpatient utilization with statistical significance 
when compared to a control group. The successful studies that met inclusion/exclusion 
criteria were included in this review. The features among studies that did not achieve 
statistical significance varied widely. Those that did not have at least one or more best 
practices were less likely to meet outcomes. Notable features among unsuccessful 
interventions were: 
• Telephonic support only in populations that were not risk-stratified by disease, 
were not targeted to address a specific disease, and were not implemented in the 
transitional period post hospitalization.  
• Models that were solely clinic/office based, and did not include another method of 
clinical, coordination or social support outside of this setting (whether telephone 
or home-visit).  
• Models that tried to address inpatient utilization by identifying patients through 
social factors (e.g., socioeconomic status) and not clinical disease state did not 
appear to be effective unless it targeted extreme and specific social conditions 
such as homelessness. 
• Models that broadly addressed multiple chronic diseases without specifying a 
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focus on a predominant disease state, nor a focus on transitional care.  
• Interventions that used general RN’s were less effective than disease-specific 
nurses or advanced practice nurses.  
Conclusion. Major findings across the meta-studies in this review support the 
hypothesis that many of the aforementioned intervention characteristics are more likely to 
yield successful results when paired together. Taken together, these best practices use a broad 
collection of reliable data to conclude that the application of these practices, implemented on 
the appropriate populations, may be more likely to achieve statistically significant reduced 
acute utilization than interventions delivered to similar populations that do not include these 
best practices. The intended audience for these best practices are risk-bearing organizations 
and payers with a strong interest in improving quality and reducing unnecessary utilization. 
Limitations 
The limitations of this literature review include the lack of homogeneity regarding the 
specific characteristics of populations (gender, ethnicity), in addition to variation among 
settings and payer type, which make it hard to extrapolate conclusions to different 
populations and limit the power of evidence for any one group in any one study. International 
studies were included to increase the amount of data and statistical power of the review (by 
limiting the review to only US studies, five of the 12 meta-studies would have been 
excluded)Because of this, meta-study conclusions may not be able as generalizable as they 
would be if the studies were only conducted in the United States.  
Another limitation may be improvement in standard-of-care over time and the 
difference in interpretation of standard-of-care across settings. The earliest meta-study 
included was conducted in 2006, but each meta-study may have individual studies included 
from prior to 2006. Because study comparator groups were “usual care” and this standard 
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improved over time, it limits the generalizability of older studies included in the meta-
studies, and may weaken the conclusions of the meta-studies. 
A further limitation is that some studies only focus on populations with specific 
disease groups. It is not clear if the best practices identified in the disease-specific studies 
would be applicable to other diseases or all chronic diseases in this review. The effectiveness 
of each intervention activity may vary by acuity and permutation of disease states, but to 
assess the impact of each intervention per subpopulation is beyond the scope of this literature 
review.  
An additional limitation is that different meta-studies used different quality criteria to 
assess which studies they included. Overall, studies were deemed to be of “high-quality”, but 
the definition of high-quality differed among meta-studies. This means that some meta-
studies may include certain biases that others have been able to eliminate and may introduce 
inconsistencies in quality among the included studies. Because each meta-study, as a 
consequence of the inclusion criteria, required a peer reviewed quality evaluation 
methodology the overall bias of the included meta-studies should not be significantly 
impacted. 
Measurement limitations. The studies also differed in the way they recorded and 
reported acute care utilization. For example, one study would use risk ratio’s to report the 
reduction in admission rates, while another study would use the NNT (number-need-to-treat) 
to avoid an admission, and others would report absolute numbers or odds ratios. Because of 
this, what is statistically significant in one meta-study may not be statistically significant in 
another. As such, detail on statistical methodology per outcome in each meta-study was 
reported as transparently as possible. Further, the way in which a readmission or admission 
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was counted varied per meta-study and in some instances, per individual study. These 
variations were reported in the results section of the literature review if disclosed by the 
authors. As a results of the large amount of individual studies included (517) in this review, 
the reported outcomes, and interventional characteristics affecting those outcomes, on 
average, should not be largely affected.  
Follow-up duration was a critical factor in reviewing results, as many effects, 
especially outcomes of hospitalizations and readmissions did not show up until later. A 
number of studies did not report significance until Year 2 of a 2-year study. Therefore, the 
studies with only a year follow-up may not have captured statistically significant results due 
not to the intervention itself, but due to a short follow-up duration. This may have to do with 
the effect size and the frequency of the outcome. If the effect size is smaller, the researchers 
needs a higher incidence of the outcome of interest (e.g., hospitalizations, readmissions) to 
show statistical significance.  
Another limitation is the way readmissions were counted. There are different ways of 
reporting a readmission from the index admission. Some are reported on a rolling basis, 
meaning every subsequent admission if within 30 days of the previous admission is counted 
as a new readmission. Other counting methodologies only report one readmission per time 
period after an index admission, even if additional admissions occur within the time period 
(30 days for example). Further, readmissions may reported over different lengths of time post 
index admission. ED visits may be counted differently as well. For example, the traditional 
approach is to only count an ED visit if it does not result in admission. If it results in an 
admission it is no longer an ED visit, but an admission. Other methods may count admissions 
that come through the ED as ED visits. The particular methodology for reporting ED visits 
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and readmissions may vary by institution and by claims systems—this is particularly true for 
international studies. The methodology for counting ED visits and readmissions was not 
reported in every study. Overall though, most studies used the traditional reporting and 
tracking methodology used by CMS, which should ensure relative consistency across a 











CHAPTER 3: RESEARCH DESIGN METHODOLOGY 
Conceptual Model 
The Consolidated Framework for Advancing Implementation Research (CFIR) is a 
framework applicable to the translation of evidenced-based interventions into a feasible 
implementation plan for IPA-based MCOs33 (Figure 2). This framework was selected because 
it was developed for complex, real-world implementation and healthcare service related 
work. Although the CFIR framework is primarily targeted to healthcare services, it is broad 
enough to encompass most large-scale changes taking place within healthcare entities. 
 




Overall, this framework provides a comprehensive list of factors that should be 
considered when implementing new chronic disease management interventions. The 
framework consists of multiple dimensions, termed constructs, from which one can select the 
most relevant and appropriate factors to guide strategy within a particular context. This 
allows for structured evaluation of each intervention feature in its appropriate setting/place 
which allows the implementer to more readily target areas of intervention weakness and/or 
barriers to implementation within a particular organizational environment.  
There are five predominant domains in the CFIR: intervention characteristics, outer 
setting, inner setting, characteristics of individuals, and process. Intervention characteristics 
are the key attributes of the intervention itself, which influence the success of the 
implementation such as how adaptable the intervention is, how flexible, or how complex. 
Outer setting refers to characteristics in the external environment that affect implementation 
such as policy, regulation, and peer organization influences. The inner setting focuses on 
internal organizational forces that may facilitate or impede progress of the implementation 
process. These are generally features that are specific to an individual organization and are 
critical in guiding the implementation strategy of large-scale change initiatives. The fourth 
construct, characteristics of individuals, involves a deeper dive into the traits of individuals 
within the organization who are involved in, or leading the implementation efforts. The fifth 
and final construct, process, refers to any process oriented steps, including planning, 
engagement and execution dimensions.34 Together, the framework features within each of the 
selected constructs facilitate the removal of barriers and augment the chance of 
implementation success. As such, I have selected this framework as a guide to help direct my 
research and my implementation framework as well as the specific plan for change. 
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The features of this framework I have chosen to guide my qualitative research are 
listed in Table 6. Please note, not all constructs in the CFIR were chosen to support the 
development of the interview guide. Selection of each construct will be explained below. 
Table 6 
 
Selected CFIR Constructs 
Construct Description 
  
I. Intervention characteristics  
Adaptability  The degree to which an intervention can be adapted, 
tailored, refined or re-invented to meet local needs. 
  
Evidence Strength & Quality Stakeholder’s perceptions of the quality and validity 
of evidence supporting the belief that the 
intervention will have desired outcomes. 
  
Cost Costs of the intervention and costs associated with 
implementing the intervention including investment, 
supply, and opportunity costs. 
  
Complexity Perceived difficulty of implementation, reflected by 
duration scope, intricacy and number of steps 
required to implement. 
  
II. Inner setting 
 
Goals and Feedback The degree to which goals are clearly communicated, 
acted upon and fed back to the staff, and align of that 
feedback with goals.  
  
Leadership Engagement Commitment, involvement, and accountability of 
leaders and managers with the implementation. 
  
Available Resources The level of resources dedicated for implementation 
and on-going operations, including money, training, 




Executing Carrying out or accomplishing the implementation 




Intervention characteristics. “Intervention Characteristics” were selected to gather 
basic information on the key informants’ views of intervention best practices themselves 
before exploring implementation strategies in the form of barriers and facilitators. I would 
like to understand what the key informant thinks of the intervention’s ability to be (a) 
plausible to implement successfully, (b) adaptable, (c) validated through existing evidence in 
the literature in addition to the key informant’s empirical experience, and (d) cost-effective. 
This construct provides important context through which to view the lens of the proposed 
implementation strategies in the following constructs.  
Inner setting. “Inner Setting” was chosen to help evaluate integral areas of support 
for implementation. Specifically, the selected features are: goals and feedback, leadership 
engagement and available resources. This information will help determine: the intended 
outcomes (e.g., improved quality, reduced utilization and/or costs), how the implementation 
should be evaluated, what type of leadership supports are necessary to champion the 
implementation process, what resources are necessary to carry out a successful 
implementation and whether or not this aligns with the resources available within the 
implementing organization.  
Process. “Process” focuses on the challenges inherent in implementing new care 
management strategies. This feature will allow us to more deeply understand which issues 
are pivotal in driving the implementation process internally. The primary theme within the 
process construct is execution and is intended to unveil which strategies are necessary to 
ensure that the plan is implemented with fidelity. 
The literature review identified six predominant best practices that were associated 
with statistically significant reductions in ED use, admissions or readmissions by at least a 
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third of the meta-studies analyzed. These best practices were implemented in different 
settings, including hospitals, MCOs, clinics, and patient homes. Many of the interventions 
were randomized clinical trials, which tend to have greater control over the intervention 
group. These strategies may work when the organizational leader has control over the staff or 
intervention strategies (e.g., in a group or staff model HMO) or clinical trial setting; but may 
not work equally well for MCOs that contract with a group of practices through an IPA 
model intermediary organization. Thus, the research aims attempt to understand which of 
these best practices can be implemented by MCOs that rely on IPA network models to deliver 
care to a large and diverse membership. 
Dissertation Aims and Research Questions 
The following aims are built upon a comprehensive literature review and are intended 
to aggregate information from high-quality meta-studies with statistically significant cost-
savings and/or reduced acute utilization (in the form of admissions, readmissions, and 
ED)visits) attributed to effectively managing the delivery of care for elderly, multimorbid 
patients in Medicare populations.  
Research question. How can IPA model MCOs most effectively reduce inpatient 
utilization in Medicare beneficiaries with chronic disease, through evidence-based 
intervention? 
Aims. 
1. What are the barriers and facilitators to implementing the best practices identified 
through the literature review in IPA model MCOs for Medicare beneficiaries?  
2. Are there specific adaptations needed to modify implementation of the best 
practices in IPA model MCOs? 
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This research used qualitative methods to explore the facilitators and barriers to 
adopting best care management practices in IPA settings. I chose to utilize semi-structured 
interviews with key informants to understand, in depth, the aforementioned research question 
and aims. Semi-structured interviews offered an opportunity to explore how different 
stakeholders, internal pressures, and external (imposed) requirements contributed to the 
success or failure of implementation procedures. The interviews also allowed the researcher 
to explore why certain implementation strategies were perceived successes, while others 
were failures. The interviews thus allowed the researcher to gain rich information from a 
diverse body of respondents to more fully understand how best practices can be successfully 
applied. 
IPA inclusion and exclusion criteria. IPA’s were identified based on a set of 
inclusion and exclusion criteria. The inclusion and exclusion criteria were chosen to ensure 
that IPAs had sufficient operational experience to be able to successfully implement best 
practices. IPAs could be either full or partial risk. Selected IPAs could not be under the legal 
or financial control of a health plan or health system (although there could be an affiliation 
arrangement between the IPA and the health plan or health system). In addition, the 
researcher initially attempted to identify IPAs with broad geographic diversity, but for 
reasons discussed later, ended up focusing my research on IPAs based primarily in California.  
Inclusion criteria.  
• Mature IPA > 10 years of operations. Mature IPA’s were selected so that the 
organization would have substantial experience in both medical group operations, 
and in implementing the selected best practices. 
 
63 
• Represents one of three areas in the United States which have the longest 
experience operating IPA networks (West Coast, Northeast and Midwest).  
• Full or partial risk. Full risk IPA’s refer to organizations that are responsible for 
both institutional (facility/hospital) and professional (provider) costs, which 
therefore renders the organization financially “at-risk” for health care expenses 
incurred by their affiliated membership population across both outpatient and 
inpatient settings (with the exception of certain carve-outs which are specific to 
the organization’s contract with the health plan). Partial risk refers to 
organizations that only assume professional risk. In general this means that a large 
majority of the expenses incurred (inpatient costs) by members in a partial risk 
IPA are generally paid by for the health plan or another payer such as CMS 
(Center for Medicaid and Medicare Services).  
• The IPA may be connected to a health system or hospital, but cannot be legally or 
financially controlled by the health system/or hospital. This is so that the key 
informants represent organizations that are truly independent, rather than 
controlled by a larger health system, or hospital.  
Exclusion criteria.  
• Exclusively staff or group model HMO’s, or IPA’s that contract with only one 
managed care organization/health plan. This exclusion criterion was intended to 
eliminate organizations that employ physicians, or IPA’s that are only associated 
with a single payer, as these network models may not have the same challenges as 
the traditional IPA’s that contract with many different entities.  
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After inclusion and exclusion criteria were met, a series of additional screening 
questions determined whether or not the selected IPA currently engages in, or has in the past 
tried to implement, one or both of the selected best practices (either face-to-face contact or 
MDTs).  
Key informants. Three types of key informants were chosen to represent a variety of 
different perspectives from varying levels of the organization. The perspectives ranged from 
those in leadership and decision-making roles (executives), to those implementing and 
providing clinical oversight of the best practices (medical directors), to those on the front line 
working with patients (nurses and nursing leadership). The researcher’s original goal was to 
interview at least one individual representing each of the three groups from each organization 
to observe if perspectives varied by role within each organization. However, the researcher 
was unable to get three respondents from each organization to agree to be interviewed 
(despite reaching out to them). Seven out of eight organizations had at least one 
representative from at least two groups, and two IPA organizations out of eight had all three 
groups represented.  
• Health plan/medical group executives: Traditionally, this group is nonclinical and 
primarily focused on the financial health and sustainability of the organization. 
This group of stakeholders is generally the group responsible for deciding 
whether or not to invest in additional staffing, infrastructure changes and 
resources—all critical for intervention implementation. It is therefore important to 
understand this group’s reflections on barriers and facilitators related to the 
implementation process. This group of professionals provide information on 
considerations from a feasibility and high-level cost-perspective which would 
 
65 
significantly affect key senior leadership buy-in of any proposed implementation 
plan and continued investment. It is intended that this group will help explain how 
care management relates to the larger operational landscape of IPA delegated 
responsibilities.  
• Medical directors: Generally, medical directors oversee the clinical operations of 
a population under the purview of the group or plan. Oversight may include 
activities such as peer-to-peer consults with physicians, utilization management 
supervision such as final approval of high-cost authorizations, and the design of 
outpatient or inpatient clinical protocols. Medical directors have an integral role in 
MCOs, as they ultimately serve as the lead for a network of primary care and 
specialty physicians in IPA environments. Therefore, they serve as critical key 
informants in identifying barriers and facilitators for any implementation 
processes that specifically involve physician operations. Since medical directors 
also have a comprehensive understanding of managed care organization processes 
they can provide perspective to the feasibility of the proposed best practices. This 
group of key informants may foresee obstacles in implementing certain processes 
in specific types of environments and help identify strategies to proactively avoid 
roadblocks in implementing new care management strategies. Additionally, 
medical directors may be able to identify strategic peer-to-peer implementation 
approaches.  
• Care managers/nursing leadership: Care managers provide an on-the-ground 
perspective into barriers and facilitators of best-practice implementation, 
including which best practices will be most easily or most challenging to execute. 
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This group can provide experiential insight into how to circumvent barriers. Care 
managers lead the nurse team, help select care management program strategies 
and are well-aware of the issues these teams regularly face. This perspective is 
likely to be distinct from that of the higher level medical directors or healthcare 
executives who are often less exposed to the granular details of patient care at the 
level of the nurse case manager.  
Outreach to potential key informants. Key informants were assessed for fit for this 
study through their employment at an independent physician’s association (IPA) with 
enrolled Medicare beneficiaries (as described above). Key informants were recruited from a 
list of IPAs affiliated with a large national IPA association. A subset of the IPAs from that list 
that serve Medicare beneficiaries and met initial inclusion criteria were then contacted by 
email by a dissertation committee member who is also a member of the association to gauge 
interest in voluntary participation in this study. If they were interested in participating; they 
were sent the screening questions. The committee member who sent out the initial email had 
no knowledge of who the researcher ultimately included in the study, ensuring that all 
respondents remained anonymous. All efforts were made to ensure that any identified 
potential key informants remained anonymous to everyone but the researcher (contact 
protocol for key informants identified in Appendix D and Appendix E).  
Initially, the researcher’s goal was to interview representatives from IPAs in the West 
(California), Midwest (e.g., Minnesota, Michigan), and Northeast (e.g., Massachusetts, 
Connecticut), with equal representation from the different parts of the country. However, the 
researcher did not have specific contacts with IPA organizations in the Midwest or Northeast. 
The researcher attempted to “cold-call” IPA organizations identified through public lists of 
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IPA associations, as well as through internet research. The researcher attempted to contact 
five additional organizations (located through an internet search of IPA’s) from the Midwest 
and Northeast region of the United States, which met the inclusion/exclusion criteria listed 
above. After three attempts to contact prospective key informants in these organizations 
(initial email, follow-up phone call, and a second follow-up email) (Appendices D and E), it 
was assumed that these organizations were not interested. One organization from the 
Midwest responded to an email outreach, but was not included because it did not meet 
eligibility criteria. Due to the low response rate of Northeast and Midwest IPAs, a decision 
was made to focus only on West Coast IPAs.  
Initially, 17 IPAs indicated a willingness to participate in the study. Additional 
screening questions were sent to these organizations to ensure that the IPAs had or were 
currently implementing face-to-face care management or multidisciplinary teams. Five 
organizations did not respond to follow-up e-mails from the researcher after screening 
questions were sent. A total of four IPA organizations were excluded due to not meeting the 
screening criteria (the screening questions can be found in Appendix B: Screening 
Questions). A total of eight IPA organizations were included in the study.  
Key respondents from the IPAs who met the criteria of the initial screening and who were 
interested in participating were sent a notice of informed consent/fact sheet (Appendix D), 
and a list of IRB approved interview questions in advance of the interview (Appendix C).  
Interview questions. The study was approved by the UNC IRB. Interview questions 
were intended to elicit information on the barriers and facilitators of best-practice 
implementation in IPA environments. The interview included the following topics: strategy 
for one or both of the best practices, associated barriers and effective strategies for mitigating 
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barriers, integration of the providers into the IPA’s implementation strategy, resource 
allocation decisions, details regarding each individual best-practice, and other best practices 
used by the organization. The full list of questions is included in Appendix C.  
Interviews 
There were a total of 20 interviews conducted between May 2018 and August 2018, 
representing eight IPAs. Seven out of eight of the IPAs were located within California, with 
one organization based on the east coast.  
The 20 key informants were categorized into three separate groupings based on their 
role in the organization: executives, medical directors and case managers/nursing leadership. 
Out of the 20 interviews, five (25%) were executives, six (30%) were medical directors and 
nine were nursing leadership/case managers (45%; Table 7).  
The average interview length was approximately 60 minutes (range: 35 to 70 
minutes). All interviews were conducted over the telephone in English. The subjects were 





Role  IPA1 IPA2 IPA3 IPA4 IPA5 IPA6 IPA7 IPA8 Total 
          
Executive × × × × × 5 
  
         
Nursing  
 
× × × × × × ×(3) 9 
  















Detailed interview impression notes were taken during and after every interview. The 
interview recordings were transcribed and stored on a password protected computer for 
further analysis in Nvivo version 12.  
The transcriptions were verified against the recordings, and subsequently uploaded 
into Nvivo12 Plus for categorization, coding and analysis. An initial codebook was 
developed using the constructs from the adapted Damschroder CFIR conceptual model. The 
codes were then modified as themes emerge from the respondents.  
Four interviews were coded by the second coder, with at least one interview 
representing each of the three groups of participants. Intercoder reliability was assessed by 
the Kappa statistic. As a result of comparing across coders, the codebook was adjusted to 
clarify and update codes to achieve a higher level of agreement between the coders. With the 
final codebook, the kappa statistic overall was .66 with the score from each group listed in 
Table 8. Published research states that a Kappa statistic between .4 and .8 is considered 
substantial agreement between raters.35 The results of this analysis are described in chapter 4. 
Table 8 
 
Kappa Statistics by Participant Group 





Medical directors .69 






Protections against Conflicts 
I did not contact or interview anyone that works at my organization (a large IPA in 
Southern California) or that is affiliated with my organization, nor did I share information 
from my dissertation with anyone from my organization.  
Limitations 
There were several limitations to this portion of this study. First, the researcher was 
unable to recruit an equal number of participants from each category: nursing, medical 
director and executive. However, there are enough respondents in each category to reach 
saturation across each role category.  
Second, all but one IPA was on the west coast, primarily in California. This may limit 
the generalizability of the results. However, qualitative studies are often not generalizable. 
This study is a good start to explore the facilitators and barriers to implement best-care 
management practices in IPA settings, however further studies are needed to determine if the 
barriers and facilitators found in West Coast IPAs are similar to those found in other parts of 
the country. There may be portions of the recommendations that are more applicable to 
California IPAs. For example, there may be attributes of IPAs in California (such as 
physician contract status) that differ from that of IPAs in other states making some 
recommendations—such as those that concentrate on provider volume per IPA—more 
relevant.  
Third, this study only focused on two of the six best practices (face-to-face care 
management, and interdisciplinary teams) identified in the literature review. Future studies 
should explore the barriers and facilitators of the other four best practices: risk stratification, 
physician engagement, transitional care, and disease-specific care.  
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Finally, we did not interview IPA primary care physicians as doing so was beyond the 
scope of this study due to difficulty in recruitment and limitations on number of interviews to 
be conducted. Several respondents noted that IPA primary care physicians could be either a 
major facilitator or a barrier to implementing best practices discussed. Therefore, it would be 








CHAPTER 4: RESULTS  
Respondents identified a number of barriers and facilitators which were pertinent to 
the implementation of all best care management practices. In addition, respondents also 
discussed barriers and facilitators that were specific to each of the best practices explored in 
the key informant interviews, face-to-face visits and MDT care. Respondents also discussed 
which factors influenced the selection of best practices within their organization.  
This chapter first discusses the findings generic to all respondents’ efforts to 
implement evidence-based care management strategies, then focuses more specifically on 
common themes identified by respondents specific to implementation of either face-to-face 
care management or MDTs. This is followed by a discussion on which factors influenced 
organizations to choose certain care strategies over others and then the chapter concludes 
with a brief overview of how the other four best practices (identified in the literature review) 
were incorporated by the respondent’s organizations.  
Major Barriers to Implementation of Best Practices Overall 
The key informants reported two cross-cutting barriers that made it difficult to 
implement any type of evidence-based care management strategy: the ability to exchange 
electronic medical records across providers and settings, and physician engagement and 





Barriers to Implementation: Overall 
Barrier Issue 
  
a. Electronic Medical Records • Lack of interoperability  
• Lack of timely access to medical 
records 
  
b. Physician Engagement and Behavior • Lack of communication to and from 
providers 
• Volume of patients per IPA/contract 
status of physicians  
• Perceived interference in 
patient/provider relationship 
• Lack of financial incentive to 
encourage use of best practices 
c.  •  
 
Electronic medical records. Participants explained that interoperability issues were a 
major threat to optimal implementation of best practices. When EMRs lack interoperability, 
providers and care teams are forced to gather information on the patient’s medical history 
from a variety of different sources. This often fragments transitions in care and may also 
results in delays in receiving the entirety of information necessary to provide high quality 
care. Without an interconnected EMR system, it becomes difficult for one single provider to 
understand all of the patient history including interventions and treatments provisioned 
through different entities (e.g., specialists, medical group, skilled nursing facilities, inpatient 
facilities). More specifically, this may adversely affect best practice implementation as the 
participants in the multidisciplinary team may be operating with an incomplete medical 
history which may renders their treatment plans less effective. Further, follow-up care post 
discharge will be less coordinated as all of the providers, vendors and other members of the 
care team may not be aware of all of the patient’s medical needs and/or pre-exiting 
conditions when transitioning care settings (e.g., inpatient to home).  
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A vast majority of the participants explained that many of their independent physician 
offices (both PCP and specialty) have a large number of different EMR systems. These EMR 
systems not only differ from each other, but they differ from the IPA central administration 
system where case management is delivered, and from the EMRs used by inpatient and 
subacute facilities (such as skilled nursing facilities or ambulatory surgery centers). One 
participant noted that the lack of an interoperable EMR is a major barrier to effective 
implementation of these best practices: 
I think it all comes down to EMR and everybody being able to see as real time as 
possible what's happening, and who's doing what, and where somebody is in their 
care. I think that's the biggest challenge is that communication piece. It's a barrier 
when they [physicians] are on a different one. (Nursing Director) 
Another participant discussed medication safety issues, and the drain on resources in 
accumulating information from a variety of sources to understand the current status of a 
patient’s health:  
Each of these specialties may not be communicating with each other [because of 
different EMRs], so they're all writing a medication. And they don't know that there's 
a drug interaction because they don't know what the other doctor is writing. (Medical 
Director) 
Additionally, although acknowledging the persistent challenge, one participant 
discussed that some IPA physicians may be hesitant to take next steps to integrate EMR’s for 
fear of alienating the other IPA’s they are contracted with:  
Our IPA PCPs who are contracted with multiple IPAs are perhaps less interested in 
zeroing in on a single EMR that favors one IPA over the others. That can create 
fragmentation in terms of information. The challenge is: how do you communicate 
with EMRs that don't talk to each other? (Executive) 
Another participant laments the challenges regarding timely access to medical records: “We 
have 250 PCPs and not any of them are on the same EMR so on our end, their EMRs are 
totally different and we don't have access” (Nursing Director). 
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Another participant discusses how a single EMR system would add value and 
enhance integrated care in an IPA environment by interconnecting all of the providers caring 
for one IPA’s member population. A single EMR that all providers are on would enhance 
communication among the different providers caring for one patient including also 
connecting any interventional teams employed by the IPA administration:  
It (one EMR system) is just incredibly expensive to get in place. But that would be a 
gold mine, I think, for the IPA environment. That would be a gold mine in many 
ways. It would help us financially, but it would really enable us to be able to provide 
more integrative care. (Executive) 
Despite a vast majority of the participants citing EMR access and interoperability as a 
challenge, a few participants mentioned that their organizations were actively attempting to 
convince primary care providers to join one central system used by whole the IPA—despite 
the fact that these physicians were contracted with other medical groups and health plans as 
well. One participant stated that they have been successful moving 60% of their PCP’s onto 
the IPA’s preferred EMR platform, and that the strategy has proven to be fruitful.  
We have some of our providers, on our electronic health records. That makes it a lot 
simpler because we can communicate with them via the electronic health record and 
send them emails, we call them tasks, to their offices with “this is what I talked to the 
patient about”. (Care manager) 
Overall, these findings illustrate that almost all participants felt strongly that an 
integrated and accessible electronic medical system which spans various points of care and 
connects providers within the IPA network is an integral component in operating optimally. 
Participants expressed that timely communication and open information exchange with 
providers is a critical element in successfully executing best-practice strategies.  
Physician engagement and behavior. This theme relates to the role of the physician, 
as well as the operations of the physician practice office and how their engagement, operating 
patterns, and beliefs may create barriers to successful implementation of best practices within 
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an IPA environment. The answers were arranged into four categories: lack of communication 
to and from providers, physician contracts and volume of patients per IPA, perceived 
interference with provider/patient relationship and alignment of incentives. Communication 
issues with physicians, and physician contract and volume of patients per IPA were the two 
most oft cited themes within the physician engagement and behavior theme. Communication 
refers to bidirectional information exchange between provider and IPA central administration, 
while engagement refers to the provider’s involvement in care management practices and 
willingness to participate in best practice related activities.  
Lack of communication to and from providers. A number of respondents noted that 
the lack of physician communication was a barrier that made it difficult to implement best 
practices. In part, this was due to the fact that physicians contracted with many different 
medical groups and health plans, and were therefore unaware of the IPA’s 
programs/interventions and available services and resources for higher risk members with 
chronic diseases. This was generally a result of a lack of communication between the central 
IPA administration and the network providers regarding care management program 
opportunities for patients. One respondent stated:  
I think it's getting all of our providers aware of these programs and the benefit that 
they are for their patients. Sometimes we're so busy being creative and thinking of 
new programs that we may struggle to convey to our PCPs, hey, here's what's 
happening and here are these programs. 
So the challenges, really, I think it's around the communication. The biggest one is 
the communication, because . . . in IPA, the I is independent, and they are not all 
connected. And so the communication's really poor. I think that's a big challenge. 
(Nursing Director) 
Communication by involving the physician’s team and input was seen as critical for 
identifying patients for intervention programs by one respondent: 
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A good portion of the population that we serve are identified by data, but nothing can 
take the place of the physicians identifying patients for the services. Sometimes if you 
have a really good, solid team within the practice, they know how to connect the 
patients back to the programs, they know the type of patients who could benefit from 
the programs. Those are the kind of things that you aspire to do smoothly and 
methodically, but they don't always quite flow that easy in an IPA. (Executive)  
Another respondent states that communication is challenging because of the large amount of 
data each individual physician office is being inundated with:  
They [IPA providers] have multiple inputs for information and data and a lot of 
demands are being placed on IPAs, and so I think sometimes they become almost 
immune to any type of new input. (Nursing Director) 
Various participants described how important it is to leverage the physician’s office 
staff to improve communication. When one participant was asked whether or not the office 
staff make a big difference they emphatically replied, “Oh my gosh! Absolutely! 
Absolutely!” (Care manager). Another respondent states the office staff is critical as they 
function as a gatekeeper for the physician: “I think sometimes it's that they don't know who 
we are. They're unsure of our role and they are a gatekeeper for their physicians” (Care 
manager). And another respondent explained how the office staff have come to be the 
primary focus of their communication efforts:  
Our organization frankly concentrates more on the office staff than we do the 
physicians. We figure we let the office staff know that this is the goal and we provide 
things like Starbucks cards if they get 25 diabetics to get their A1C they get a $25 
Starbucks card, because they seem to be more easily motivated. (Executive) 
Many of the respondents spoke about the need for ongoing education and communication 
with providers and their office staff, because of rapid turnover rates. This is particularly true 
for office staff:  
What we're finding out is that because of changes in employees and staff within the 
practices that we would educate them, and then in six months they're gone and we 
have a new group coming in who's not aware of our programs. (Executive) 
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Another respondent mentioned how the variability in office staffing creates a vast 
difference in the workforce skill-set and ability to perform some of the IPA intervention 
functions necessary to successfully implement the best practices in the office setting.  
The challenge is the inconsistent levels of preparation of the people they hire into 
their practices because you could have a high school grad who has not had training on 
Excel spreadsheets and you're teaching them about how to manage their population 
health report. (Executive) 
Overall, respondents noted that physician engagement and behavior is a critical 
consideration when implementing best practices in an IPA environment. Consistent education 
regarding available services and programs, and leveraging office staff were some of the most 
oft cited strategies mentioned by participants as a way to enhance communication amongst 
the providers. Additional strategies on successful provider communication is discussed later 
in the facilitator section of this chapter.  
Physician contracts and volume of patients per IPA. Respondents discussed the 
difficulty in obtaining cooperation of contracted physicians to participate fully in the IPA’s 
care management strategies, because of the nonexclusive nature of their contract. This may 
be due to the large number of care management interventions and programs for physicians 
who contract with several IPA’s/health plans. The preponderance of IPA respondents had 
nonexclusive contracts with the IPA, meaning they were free to also care for patients from a 
variety of different sources including different health plans, other IPA’s or through straight 
Medicare (FFS), or cash patients. Respondents noted that there was increased engagement 
and willingness to participate in IPA-dictated best practices when the physician was either 
exclusive with the group or had a high volume of that IPA’s patients. Several participants 
discussed the issue of multiple contracts: 
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We’re a small piece of everybody's pie. From the physician's point of view: our 
members make up 8% of my patients, how am I going to remember that there's a case 
manager available for these at-risk patients? I won't. (Medical Director) 
The specialist indeed can have different contracts but if they get 50 or 60 or 70% of 
their patients through us, it makes it [cooperation/engagement] easier. (Medical 
Director) 
Another participant expressed a similar sentiment in that the contractual relationship with 
other IPAs made it challenging for providers to know what is available for patients from each 
individual IPA.  
These doctors have multiple contracts, and so they're not fully aware of who has 
what. And they're busy taking care of the patient in front of them, they don't 
necessarily look at a patient and go, “Oh, you're a [X IPA] patient, or you're a [Y 
IPA] patient.” They just have the patient in front of them. And they say, “Well, you 
have heart failure. Okay. Well, I'll treat your heart failure.” They're not going to think, 
“Oh, you belong in the [IPA X] Heart Failure Program.” (Medical Director) 
Various respondents made the point that physician buy-in is important to encourage patient 
participation in the IPA’s care management program(s). This is especially true when the 
patient is only familiar with the provider and not the IPA:  
Patients know that they have Dr. Jones. They don't know that they're part of a 
particular medical group. That physician really gives credence and validity to the 
medical group’s relationship with a patient. They're totally critical. 
Without their engagement, sure we can do some good work, but their simple 
reinforcement is very impactful to the buy-in from the patient. Particularly it relates to 
offices that we're not exclusive with. (Executive) 
Both primary care and specialty physicians stated that high-volume IPA providers 
tended to be more engaged in care management programs than low volume providers. 
Another respondent expressed that employed physicians were more likely to refer to 
available programs. The same respondent expressed that employed physicians are easier to 
communicate with from a logistics perspective because the physicians are generally clustered 
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in just a few locations which makes it easier to disseminate information when compared with 
a geographically diverse, widespread IPA network with many offices. 
This discussion topic revealed that a physician’s contractual relationship with the 
IPA, and the volume of patients that the physician has within a particular IPA, influenced 
both their capacity and willingness to engage in best practices being deployed by the IPA.  
Perceived interference in provider/patient relationship. Several participants 
mentioned that physicians may fear that by enrolling their patients in an IPA’s program, 
service or intervention, the IPA would provide care that was counter to that the physician was 
providing. “My experience is that the physicians do not trust that you are teaching the patient 
to be compliant with their treatment plan, they think like you're [the IPA] a renegade.” 
(Nursing Director). Respondents expressed that when physicians have a positive relationship 
with the IPA they were less likely to feel threatened and more like to refer the patient to the 
program/intervention or resources.  
Incentive alignment. Several participants mentioned the importance of aligning 
incentives for providers. This theme overlapped some with the contractual relationship 
discussion in that practices that have a high-volume of attributed members have more of a 
financial incentive to engage in an IPA’s best-practice interventions. However, aligning 
incentives was generally discussed in the form of financial rewards. One participant stated 
the importance of financial returns: “There's just so much work you demand from them. I 
think that, that's a barrier when they're not being what they feel is financially rewarded” 
(Medical Director). Another participant mentioned the importance of having a contract with 
IPA providers that incentivizes a variety of performance metrics important to the IPA (many 
of which align with the care management programs discussed): “It [the physician/IPA 
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contract] has to contain other bonuses, so that if we hit certain quality gates or we hit 
readmission rate gates, those things are also rewarded.”  
Barriers to Implementation: Best-Practice Specific  
In addition to barriers to implementing any type of evidence-based care management 
strategy, respondents also noted barriers to two specific best practices studied as part of this 
dissertation: face-to-face visits and MDTs (see Table 10).  
Table 10 
 
Barriers to Implementation: Best-Practice Specific 
Best practice Barriers 
  
Face-to-face visits • Large IPA Geographic Area 
• Lack of Resources/Funding 
  
MDTs • Lack of Resources/Funding  
 •  
 
Face-to-face visits. Respondents identified two major barriers to effective 
implementation of face-to-face care management visits: large IPA geography (resulting in 
difficulties reaching patients) and a lack of organizational resources to support face-to-face 
strategies. Some of these barriers were specific to face-to-face visits that occurred in the 
home setting. The home was the most common setting discussed by respondents for a face-
to-face visit to occur.  
Large IPA geography. Many IPAs have their membership spread out over a large 
geographic areas. This was true for most participants. Therefore, driving to a patient’s home 
from the central administrative office can be challenging as well as time consuming. This 
was expressed by a vast majority of respondents currently engaged in or having previously 
implemented face-to-face visits:  
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There's no way we could even begin to do face-to-face on all of our members. We're 
located in one place and our members and our PCPs and specialists are at the closest, 
45 minutes away. They’re (nurses) not in the office. It takes 45 minutes to drive and 
they get paid mileage. If our patients were like 10 minutes away, then I think maybe 
my answer would be different but it takes them just truly, an hour and a half, driving 
out there. 45 minutes to drive out there and 45 minutes to come back. They miss an 
entire day of emails and other things, of transitions of care calls that they need to be 
doing because they're out. (Nursing Director) 
Some organizations split large areas into smaller, more accessible pockets, but still found 
access challenging.  
What we tried to do is identify the highest risk populations by territories and we 
created four pods. But even with the four pods, having one nurse, one social worker 
and one APN (advanced practice nurse) to be able to see enough patients in a day was 
a challenge, just based on the fact that they had to drive so far. (Nursing Director) 
Several respondents stated their organization discontinued face-to-face home visits altogether 
due to the issues with driving time to the patient’s home. “We used to do home visits, but we 
stopped that because we found that windshield time was preventing us from reaching more 
patients” (Care Manager). 
One respondent expressed that although the driving time is extremely challenging, the 
organization still supports the face-to-face program because they believe in its efficacy—as 
long they are able to target to the right population.  
If you're close to your physicians, geographically, I think that that is most important. 
Two is if you're in a clinic, it's much easier. You can probably do an assessment and 
see the patient and perhaps do one after another after another after another, which 
would be more efficient. I just think that we do have some barriers but it's still a 
program that we truly believe in and we still get support from our leaders to continue 
to do it. (Care Manager) 
Overall, this discussion illustrated that geographical spread of the IPA can be a critical factor 
in successful implementation from both a logistical and financial perspective.  
Lack of resources. In response to why two organizations stopped their face-to-face 
programs, they expressed that face-to-face visits simply took too much manpower and were 
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too expensive to staff, even though one respondent simultaneously acknowledged the 
efficacy of the program: “It is a resource issue. I think everybody knows that home visits and 
face-to-face is much better than telephonic” (Nursing Director). 
One respondent discussed that their participation in an ACO based shared-savings 
models made it difficult to allocate funds to the face-to-face programs upfront and that is why 
they had to discontinue this best-practice. The benchmark methodology for the ACO shared 
savings calculation would not allow them to realize the eventual ROI of the face-to-face 
visits.  
MDTs (lack of resources). Respondents noted that a lack of resources was the major 
impediment to MDTs: “It would be nice to have an onsite social worker. We've talked about 
it but we don't have the financial ability to actually hire a social worker or a pharmacist” 
(Nursing Director). Another respondent discussed that it was really a financial barrier, not a 
lack of confidence in the value of the best-practice as the reason why they weren’t 
implementing the strategy. So it's not that they’re [leadership] not convinced of the value of 
the social worker and the pharmacist, it's just really comes down to dollars” (Case Manager). 
These responses illustrate that there is overlap in terms of barriers of with MDTs and face-to-
face visits, both of which may be considered resource intensive strategies by IPA’s. However, 
as later discussed in the result, the revenue model of the IPA has a large influence on how 
resources are selectively spent. 
Facilitators and Supports  
This section reviews facilitators and supports for implementing best-practice 
strategies. The first two sections review major themes specific to the two best practices 
discussed, and the third section reviews strategies related to facilitating physician 
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engagement and communication which was identified as a major barrier to implementation in 
IPA environments (see Table 11).  
Table 11 
 
Facilitators and Supports 
Best practice Facilitator/Supports 
  
a. Face-to-face visits • Identifying barriers to patient 
engagement in treatment 
recommendations 
• Targeting the “right” patients for in-home 
visits 
• Components of in-home visits 
• Part of a larger care management strategy 
  
b. MDTs  • Team composition: nurse care managers, 
social workers, pharmacists, and 
behavioral health professionals 
• Communication back to the PCP (if not 
part of the MDT) 
  
c. Physician Engagement and 
Communication  
• Education and communication 
• Providing resources  
• Working around the provider 
(implementing best practices regardless 
of physician engagement) 
d.  •  
 
Face-to-face visits. Key informants who implemented face-to-face visits, particularly 
in the home, noted the improved health outcomes and financial cost-effectiveness t) of this 
best-practice. In addition, respondents noted that the face-to-face visits helped build trust 
between the care manager and patient.  
Respondent comments regarding the efficacy of face-to-face visits included:  
Some of them [patients] have social issues and multiple chronic conditions and [you 
need to] orchestrate between specialists and primary care doctors, etc., some really 
complex clinical pieces and interweave them—I think none of that really could be 




So one of the things we had noticed very early is that a lot of our Spanish speaking 
members in particular could not follow heart failure guidelines or COPD. They didn't 
know how to use their inhalers. A lot of them weren't even going to get their basic 
labs done. [We had a Spanish speaker] start going into the home. And I think that 
made a tremendous difference because we got people to actually get labs who never 
got labs, we actually were able to change alignment to a PCP who spoke their 
language so that there was better connection there. So it was very effective doing that 
face to face. When you go to someone's home, I think it's easier to establish trust, 
especially when you're talking about same language and culture matching. (Nursing 
Director) 
Identifying barriers. Respondents also noted that care managers gained a better 
understanding of the problems patients faced in following treatment regimens when they 
visited patients in the home, especially as they relate to socially based issues such as abuse in 
the home, dementia or mental health problems that may not be not as evident in the clinic 
setting: 
I think we all know that these program that are telephonically administered have 
some limitations. They are limited because you're on the phone and you don't really 
know a lot of the social determinants of health even though maybe we assess them in 
a questionnaire, it's different than going into someone's house and seeing pizza boxes 
all over the house. You don't really observe things quite the same way on a telephone. 
So we do face to face. (Nursing Director)  
I think by having the face-to-face visits, which is the most important thing you can 
do. You need to be out there because patients can tell you anything but when you 
walk into their house or their trailer or wherever, or their beautiful house on the hill. 
You can tell so much by one look versus calling somebody on a telephone because 
you can tell socially, what they're dealing with. Many people that have dementia can 
pull it off on the phone but once you get there face-to-face, they start to stumble, and 
you can see it—and then you can help them if you have the resources. (Nursing 
Director) 
Those respondents that have conducted face-to-face visits themselves expressed confidence 
in the efficacy of the strategy.  
All the nurse case managers were really worried that we weren't going to be able to 
continue our home visits [as program cuts were enacted]. But we fought hard for that 
because we saw the results for our patients. (Care Manager) 
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The respondents who were in IPAs that engaged in home-visits thought that home 
visits were more effective than office visits and much more effective than telephonic care 
management. One respondent commented,  
So you you're able to see a lot more when you're able to go into the home than even 
an office visit because depending upon how guarded that person is, they always hold 
back a little bit of information. So I think there's a gradual advantage [to going into 
the home]. I would say the phone is probably the most difficult, and then an office 
visit would be better. But the best would be home visit, if of course, if the system 
could afford it. (Nursing Director) 
Several respondents commented that home visits were effective, but only if there 
existed a strong clinical reason for the home visit. For example, one respondent noted that 
care managers needed to go into the home with a good assessment tool and clear guidelines 
that would help them gather the information needed for ongoing care management: 
They’d have to have a really good assessment tool. They'd have to know what they 
were going to be assessing the patient for. And what the expectation or the outcome 
of the meeting would generate. So it wouldn't be just a visit to see how the patient's 
doing. It would be some very clear guidelines on, “This is what I anticipate being able 
to achieve in this visit.” And then going back to the physician and say, “This is what I 
found, this is our next step.” (Care Manager) 
Targeting patients for face-to-face visits. Other respondents noted that for face-to-
face care management visits to be cost effective, they need to be focused on the right 
patients. However, respondents’ views of which populations to provide face-to-face visits for 
varied widely. Some respondents spoke about targeting the elderly and frail for home visits, 
while others honed in on those with recent ER visits and/or hospitalizations; a few 
respondents said it just depended upon the individual patients’ needs. Others explained that 
the nurse care manager would make the determination as to whether or not a home visit was 
necessary.  
Other respondents were more precise with their face-to-face visits criteria. A care 
manager explained that their organization requires: “Two or more admissions, multiple 
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comorbidities, people who we feel are having a difficult time managing both their medical 
problems as well as some social issues” (Care Manager). Additionally, one respondent 
explained that their face-to-face visit selection process had to do with the capacity of the 
patient to follow-up with providers and manage their own care post discharge. Those with 
less capacity would receive a visit.  
Components of in-home visits. The respondents differed less in terms of what they 
evaluated during the face-to-face visit. A vast majority of participants said that in the face-to-
face visits they evaluated both medical (e.g., disease related), and social issues (e.g., housing 
insecurity, elder abuse, poverty) but how they responded to those issues ultimately depended 
on individual need. A large majority of participants also mentioned the incorporation of a 
behavioral health assessment component.  
They (nurses) go over all of their medical history, their social history, their 
medications, their physicians, their functional ability, their PHQ9 [depression 
screening]. All of that is included in there and so they get a really good baseline of 
what is going on with the patient. (Nursing Director) 
Respondents did not discuss whether the individuals visiting the patients were employed or 
contracted.  
In conclusion, the formula by which organizations selected patients for face-to-face 
visits varied significantly and depended on the patient’s underlying need for care 
management services. For example, many face-to-face visits were focused on transitions of 
care, while other programs targeted social issues, and still other programs focused on long-
term chronic disease management. Many respondents thought that the programs which 
utilized face-to-face visits as part of a transitions of care strategy (e.g., from the hospital to 
the community setting), were able to produce the most notable reduction in inpatient 
utilization as well as the largest return on investment.  
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Part of a Larger Care Management Strategy  
In-home face-to-face visits were generally not considered a care management strategy 
in itself. Most respondents referenced how in-person care management was one component 
of many used in helping the patient manage their care. For example, face-to-face visits were 
coupled with follow-up physician appointments, telephone support by a care manager, 
medication reconciliation by a pharmacist, disease management education, patient centered 
goal-setting, and communication of findings from the home visit back to the patient’s care 
team. In addition, face-to-face visits were almost always part of a larger care management 
program. As mentioned above, the most common program associated with face-to-face visits 
was related to a transition of care model—primarily from inpatient hospital setting to home.  
MDTs. A vast majority of respondents whose organizations use MDTs agreed that the 
function of the MDTs is to contribute a variety of perspectives to the care delivered to an 
individual or population, therefore increasing the quality of care. This is because different 
disciplines can pool resources, and collectively problem-solve with experts in a specific 
health related area (e.g., medication issues by pharmacist, social issues by social worker): “I 
think that when you have support from the multidisciplinary team to the patient, that different 
people know different resources and different ways of approaching the problem. So, that's 
why it's been successful” (Care Manager). 
Team composition. The composition of MDTs is critical, as it dictates the function 
and clinical capacity of the team. In addition to the nurse care managers, respondents were 
most likely to note the need for social workers and pharmacists in MDTs. Respondents also 
noted the need for behavioral health therapists, but this type of professional was not 
mentioned as often as the others. In the vast majority of interviews, the nurse was identified 
as the leader of the team. However, in a few interviews, in which programs were 
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predominantly socially focused, the social worker was the leader of the team. A few 
respondents expressed their opinion on the value that the social worker adds to the MDT.  
A lot of times our social worker will be the one to make follow-up visits, and the 
reason for that is because most of these patients in the Medicare population have 
social determinants that are driving the admissions or lack of chronic care 
management so that they aren't able to self-manage because of the lack of money, 
housing, whatever the case may be. (Nursing Director) 
Many of the respondents felt the pharmacist as part of the MDT was equally as valuable as 
the social worker. For example, a nursing director explained a pharmacist is valuable for 
many reasons:  
Not only the medication reconciliation, and education for the patient. They 
[pharmacist] help with the disease management program and can interact with the 
specialist to help with medications. So when we got more specialized we realized a 
pharmacist was a great tool to help us more effectively manage disease. And they also 
have another understanding beyond what a case manager does about medication. 
(Nursing Director) 
Another respondent commented on the partnership that can develop between provider and 
pharmacist: 
What we found was providers weren't updating the medication profile. When we 
added the pharmacist, and the pharmacist was able to go into the EMR and reconcile 
everything, and the provider knew that they had a pharmacist that they could talk to 
when they were struggling, or that there was a high-cost med that the patient wasn't 
filling because they couldn't afford it, they were able to partner together to come up 
with a plan for that patient. That became successful. (Medical Director) 
Another respondent commented on the importance of the collaboration between the 
pharmacist and the primary care provider:  
The pharmacist in this [MDT] program was able to send a recommendation to the 
physician and we were able to actually change prescribing patterns. I think that's the 
piece that's missing when programs just teach families and patients because you can't 
change the medication that's being given to the member without engaging the 
physician. (Nursing Director) 
As noted above, trained behavioral health professionals were also considered by some 
to be essential members of MDTs. Respondents noted that these professionals could have 
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different types of training, including nurses with behavioral health training, licensed clinical 
social workers, or psychologists or psychiatrists depending on the needs of the population. 
For example:  
We have behavioral health social worker now because the analysis of the data showed 
we have increasing number of patients who are visiting the emergency room because 
of behavioral health issues but presenting with a medical signs and symptoms. For 
those patients who are strictly really behavioral health, she [the behavioral health 
social worker] gets to the point that she's able to establish the care with a behavioral 
health provider and make sure the patient is handed off appropriately. Then she 
monitors them by ensuring that that patient has not returned to the emergency room. 
(Executive)  
Communication Back to PCP 
A majority of respondents commented that the most important element for success in 
an MDT was communication among team members and specifically to the PCP (who may or 
may not be on the MDT). Communication strategies mentioned by interview participants are 
discussed later in the results.  
In conclusion, both MDTs and face-to-face strategies were applied differently by each 
organization. Nonetheless, an overwhelming majority of respondents believed that these 
strategies were effective, even though they were being implemented in unique ways by each 
IPA.  
Physician engagement and communication strategies. Many respondents discussed 
strategies to increase physician engagement and communication and noted that these 
strategies served as facilitators in implementing best practices. Three strategies were most 
commonly mentioned by key informants: education and communication, providing the 
primary care physicians with additional resources, and—as a last resort—delivering the 
intervention regardless of full physician engagement.  
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Education and communication. Many of the respondent’s organizations have teams 
and processes in place to regularly educate the physicians on the IPA’s programs, practices 
and protocols.  
We currently have three full-time people. Their whole job is to visit physician offices 
and engage both the physician and their staff so that they are listening to our message 
about what our projects are. (Executive) 
I think that we need a solid educational commitment program for the practices to 
maintain the gains that we've had because one of the things that we've picked up in 
the many years that we've been doing programs is that you'll only be good for about 
so long a time and then as people changes in the practice, you lose traction. You kind 
of continuously repeat yourself in re-educating. (Executive) 
Really, it's talking to them, physician to physician. So I hired a CMO out there who's 
living in the market. It's becoming an asset to the physician rather than an annoyance. 
(Executive) 
Other respondent’s organizations used a multifaceted approach to educate providers on the 
role of the IPA and to communicate with providers regarding available resources:  
We send out messages. We send out faxes. We have meetings. We have membership 
meetings where the providers in the community come to listen to our talks, and we 
have some of our specialists go out to the offices, to our high volume offices to talk 
about our program. Recently, we look at our doctors who have a high volume of 
patients who are not doing as well. These are doctors that have patients that end up in 
the hospital a lot, or end up in the ER a lot. That's when we go and have a face to face 
meeting with these doctors to go over our different programs. (Medical Director) 
We've gone to great lengths to make sure that they [IPA physicians] do understand 
and do learn who we [IPA] are, we made sure that they get their documentation, we 
share risk stratification models with them so that they see how we stratify them for 
risk. We tell them what we can do. We have handouts. We meet with them 
periodically. (Care Manager) 
When a provider signs onto the IPA, they have a manual that they're given. They have 
assigned a liaison who basically hand-holds them and is their point of reference if 
they struggle with anything. (Medical Director) 
Providing resources. Some respondents discussed giving the PCP additional tools 
and resources that allow them to better manage their patients and plug into the IPA’s existing 
resources. For example, some IPAs hired pharmacists so that PCPs could consult on 
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medication questions. Another respondent noted that the IPA provided their PCPs with 
population health management systems to help them identify and manage patients with 
uncontrolled chronic conditions.  
One medical director explained that his organization prepares the physician with all 
the relevant information regarding the patient before the appointment so that the provider is 
well-informed on the patient’s medical and social history before the patient even steps into 
the office. He also noted that the goal was to have the physicians understand that the IPA is a 
resource. “We're here to be a resource for them so that they know they can just call us and 
say, “Alright, I have a difficult case. I'm not sure what to do with it,” and we take it from 
there” (Medical Director). 
Working around the provider (delivering intervention regardless of provider 
engagement). As a last resort, some respondents mentioned the need to work around the 
provider to close gaps in care that were not being addressed.  
In some cases, you can't depend on the PCP to take care of whatever needs to be 
taken care of, could be because they're too busy, to umpteen different other reasons. 
And in those cases, we have to make sure that whatever care we're providing, the 
managing gets taken care of independent of a PCP. (Executive) 
Working around the provider was a strategy mentioned by a small minority of 
participants, and as a last attempt in the case where the IPA was severely challenged in 
achieving provider cooperation in managing high-risk patients. It was the least popular 
strategy, but one that some respondents expressed would be used in the event that the other 
engagement strategies failed to reach their objectives. 
In conclusion, there are a variety of different strategies for enhancing provider 
engagement and communication. Each organization interviewed used unique strategies but 
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all respondents agreed on the importance of having an effective plan in place to consistently 
communicate with and educate the providers in their IPA network.  
Program Selection and Resource Allocation 
Respondents noted a variety factors that affected their decisions regarding the 
selection of a care management program or the best practice strategy to implement. These 
factors included: cost or return-on-investment (ROI), external requirements/influences such 
as health plan mandates and risk contracts, evidence-based guidelines, and local population 
needs to address gaps in care.  
Cost/ROI. A vast majority of the respondents mentioned cost and ROI as key factors 
in determining whether to implement a program or strategy, or whether to continue to support 
a program/strategy that was ongoing. When a respondent was asked what criteria his 
organization used to determine whether or not to support a particular initiative, he replied, 
“The potential trade off in terms of the cost of a program versus the perceived cost savings 
that the organization would receive” (Executive). Others responded similarly,  
We use ROI, unfortunately, probably far too much. (Nursing Director)  
Financial implications, generally, because it costs money to do these programs. So 
there has to be an ROI based upon it. (Executive) 
One respondent reported that his/her organization shut down its face-to-face home visitation 
program because of its revenue model and how much risk the organization was taking on as 
an IPA: 
We had a very, very expensive program. We had 40 employees and it just wasn't 
sustainable. We knew that moving forward in order to continue to generate an ROI 




And another respondent cited cost as the reason they had not been able to hire additional staff 
onto the MDT. “It’s not that they're not convinced of the value of the social worker and the 
pharmacist, it just really comes down to dollars” (Care Manager). 
Several respondents stated that it was a lack of upfront funds to support the program 
that provided the largest barrier, even if further savings were promised further down the line. 
From the executives to the care managers, the respondents expressed that cost and financial 
considerations are the primary reasons for not implementing programs that have been proven 
to contribute added value for patients. This held true even if the program had demonstrated 
over time to return savings greater than the initial program expenditures.  
External requirements/influences. Many of the executive respondents explained 
that the financial model of care, revenue model and value-based contract arrangement 
heavily influenced which programs were adopted. Some organizations are in the Medicare 
Shared Savings Program, others participate in ACO’s and others are shared risk or full-risk. 
The contractual status with health plans, and how the money is paid to the organization (later 
or upfront) has an enormous influence on which programs and strategies such as the best 
practices outlined in study, can be implemented. Depending on the revenue model, more 
funds may be allocated to the IPA to care for the population upfront, which can support more 
comprehensive programs and best practices. One respondent explained, 
The financial models surrounding the interventions is determining whether or not 
certain interventions are cost-effective or not. So even though they're shown to work 
statistically if implemented with fidelity, they are not necessarily cost-effective for 
everyone because of the risk environment. (Executive) 
Several others reported that it was much easier to implement best-practice strategies with a 
capitation-based payment model.  
We're in a capitated environment. We're given a certain number of dollars to manage 
these patients, and to pay for the nurses, and the social workers, and my salary. We're 
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still able to make some money, so we're not losing money. I guess in that sense, it’s 
[face-to-face and MDTs] cost effective. We're keeping them [members] out of the 
hospital. (Medical Director) 
Another respondent with similar sentiments stated that the organization is only able to 
support the programs because of their ability to take on risk and receive the funds upfront to 
care for the population:  
We need the infrastructure money. The way we get that is to enter into the risk 
contracting world and we'll be able to afford to employ the staff that can continue to 
support that program. (Nursing Director) 
A majority of respondents also expressed that in large part they are beholden to apply 
whatever care management strategies are included as part of the health plan’s contractual 
arrangement:  
We're actually delegated by the health plans certain responsibilities. Depending on 
that, we will tailor what programs we need to implement in order to satisfy the 
delegation requirements. (Nursing Director) 
Most respondents reported choosing the programs they implemented based upon the 
type of performance measurement required. This implies that the IPAs may base their 
resource investment decisions on what they are being measured on and reimbursed for rather 
than evidenced-based best practice such as face-to-face visits or multidisciplinary care teams. 
For example, health plans who receive financial rewards for increasing preventative 
screenings (e.g., colonoscopies) may incentivize or contractually require the medical group to 
concentrate their limited resources on improving this metric. As a result, this may leave less 
funding for investing in chronic care programs such as an MDT—which would focus on 
different measures such as reducing acute inpatient utilization. 
We are being measured either in Medicare or 5 Star or Pay for Performance or HEDIS. So, 
we're being measured on those metrics. (Nursing Director)  
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When building programs, one respondent stated they work backwards by starting with 
metrics for which they are being are paid. Another respondent explained that the IPA selects 
their interventions and programs based on what the health plan contracts dictates—which 
may not be based on best practices or the needs of the specific population. “In all honesty we 
do certain things because the contract directs us to do it that way” (Executive). One CEO 
explained that they are sometimes forced to implement particular quality strategies, even 
when these strategies are not supported by the evidence:  
[Health Plan] requires PCMH (primary care medical homes). PCMH was in vogue 
five years ago. Everyone was talking about it as the coolest thing. But the data is out 
now, and a lot of the data does not show a material impact for the patient and the care. 
And they're still implementing it. It doesn't necessarily mean it's the right thing to do, 
to be honest, just because some of the plans require it. (Executive)  
These responses in aggregate illustrate the point that health plans, state and federal 
policy, and contractual arrangements have a predominant influence on what programs the 
IPA’s choose to adopt—whether or not that strategy meets the specific needs of a given 
population or is currently considered a best-practice. Ultimately, this highlights the 
opportunity to align funding models and financial incentives to support the adoption of 
robust best practices by multiple stakeholders including IPA’s, health plans and government 
payers.  
Evidenced-based. A minority of those interviewed stated that they used existing 
evidence-based guidelines or established programs which were effective in other settings to 
decide how to select interventions and care management strategies for their own 
organizations. 
We definitely rely on literature review, use Up-to-Date a lot and US Preventive 
Services Task Force and Choosing Wisely campaign. (Medical Director) 
[We ask] is there any evidence of other best practices out in the community or with 
other medical groups that we could adopt? (Medical Director)  
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One respondent stated that their organization uses internal implementation research to 
develop and evolve existing programs. “We use implementation research early on to find out 
what our program needs or if it needs to be tweaked” (Nursing Director). 
Population-based needs. A small handful of respondents reported assessing the 
disease burden, gaps in care and specific needs of their local population and then using those 
results to dictate which programs and strategies to prioritize within the IPA.  
We see a problem, and then, we think, “Well, okay, well, how do we address this? 
Let's design a program around it. (Medical Director)  
We have an overall assessment based on our registries. We put together how many 
patients have chronic conditions, what are the key chronic conditions and what are the 
resources around that area for those members. Then that way we see where our gaps 
are. We do this annually and then we readjust the program or start a new program. 
(Executive)  
In summary, there were several influences that dictated which best-practice strategies 
were supported and ultimately implemented in IPA environments. The interviews suggested 
IPA’s gave the highest priority to measures of ROI, followed by evidence-based methods and 
population specific needs.  
Other Areas of Interest 
Results from respondent best-practice programs. Several of the respondents 
discussed the results of the two best-practice strategies discussed—multidisciplinary teams 





Care Management Selection Criteria 
Face-to-face visits Multidisciplinary teams Combined effort 
   
• We decreased readmissions 
from 15% to 11.5%. 
• We've been very diligent 
about making sure that 
especially the more 
complex cases get a visit, 
we have reduced our 
recidivism rate of the 
emergency room by 30%. 
• Admits have gone down 
from 200 to 185 in terms of 
the whole team-based 
approach. 
• Not specifically the 
home visit 
component, as I 
evaluate the 
program overall, but 
last year the 
program did reduce 
readmission rates 
by 56%. 
•  •  •  
 
Discussion on potential reasons for these results will be discussed in the following 
chapter. Overall, the respondents reported positive results associated with the best-practice 
strategies. However, as mentioned earlier, it is challenging to attribute the results to a 
particular strategy as there are usually several other activities co-occurring simultaneously.  
Remaining best practices. Participants were also questioned about their 
implementation of the other remaining best practices including disease-specific care, 
transitional care, physician engagement, and risk stratification. As discussed throughout the 
results section, all participants engaged in some form of physician engagement strategy. Most 
participants had an ongoing transitional care program at their organization and all 
participants had some form of disease-specific care. The most common disease targets were 
CHF, COPD and Diabetes, followed by hypertension and renal disease programs.  
One participant stated, “We have results from our postacute program that we ran for our 
Medicare population, and we had a 3% readmission rate.” 
Risk stratification. All participants utilized some form of risk stratification, although 
only two respondents claimed to incorporate social determinants. In both cases, the IPA 
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included homelessness as the one social determinant incorporated into their risk stratification 
model. The most common risk stratification tool used among participants was the LACE 
index scoring tool, which is a measure of readmission risk after an inpatient stay. In all cases, 
the LACE score was used to determine placement into specific care management programs. 
Other methods included proprietary algorithms which were often based upon factors such as 
disease diagnosis, utilization history, age, and other information from disease registries.  
Response variation by respondent role. Analysis of the responses by role illustrated 
that those in executive roles were more likely to be able to answer interview questions 
regarding executive decision making, program selection and IPA resource allocation, whereas 
case managers and nursing leaders were more likely to expound on granular programmatic 
details, and care management operation processes. They often expressed their points using 
patient-facing stories. Medical directors were generally able to answer questions in both 
domains (business and care program operations), but this depended upon the organization 
and the role of the medical director within that organizations. There was the most variation in 
response in this role. For example, some medical directors were well versed on case 
management program details, while others were a central part of executive level decision-
making and had less knowledge of the on-the-ground program procedures. Aside from these 
points of emphasis, there was little variability among substantive points made by the different 
types of respondents. There was also little variability among responses from direct care 








CHAPTER 5: CONCLUSION  
The purpose of this study was to identify barriers and facilitators to 
implementing/adopting best care management practices in IPAs that did not have exclusive 
relationships with MCOs. The goal was to develop a plan that may be used by IPAs 
nationally to increase the quality and value of the care management services they deliver to 
Medicare and dual beneficiaries.  
The results of this study indicate that the major barriers related to the implementation 
of best practices in IPA settings include fragmented EMR systems, geographical challenges 
in reaching patient homes, IPA physician engagement, communication between the IPA and 
providers, challenges relating to physician practice contracts with multiple organizations, and 
incentive misalignment for both IPA providers and the IPA central administration. The key 
informant interviews in conjunction with the literature review provided a set of 
complementary insights to address these barriers and augment facilitators. These insights and 
the subsequent discussion will culminate in a set of recommendations intended to be adopted 
and adapted by IPA’s interested in transitioning to value-based care through the effective 
utilization of evidenced-based best practices.  
Insights 
Electronic medical records. Several challenges to adopting and adapting best 
practices in IPA environments relate to the structure of the network itself which is often 
spread over a large geographic area and includes many independent physician offices. The 




technology, often resulting in the use of varied EMRs across an IPA network and different 
work flows and patient care procedures in each office.  
Changing EMR systems may be too high an administrative and financial burden for 
an independent physician practice, particularly smaller practices. Many of the key informants 
mentioned some physicians in their IPA network were still utilizing paper records as their 
primary record keeping system. This illustrates the challenges to obtaining a uniform EMR 
for a large group of independent provider offices. By selecting one EMR over another, the 
office may believe they are disregarding the preferences of their other contractual partners 
through which they receive their patients (e.g., medical groups, health plans). 
Obtaining consensus on a universal EMR for a large network of providers (and 
facilities) is both expensive and time-consuming, making achieving interoperability a 
prodigious task for any single entity. Several IPA’s have adapted strategies intended to 
circumvent this barrier by enhancing communication between the IPA central administration 
care team and the provider offices. A small minority of IPAs reported addressing the 
challenge of separate EMR’s by convincing a percentage of the providers contracted with 
their IPA to join the EMR system of choice. All participants using this strategy felt that it 
helped to mitigate problems cause by receiving information from disparate sources; however, 
they also felt that convincing providers was often a challenge and that full network 
cooperation without provider employment or exclusivity was unlikely.  
Rather than force IPAs to use a common EMR, the most common strategies to 
address interoperability were those that worked to mitigate the fragmentation for practices on 
separate EMRs. The strategies used by the organizations participating in this study were 




from other physicians and facilities to the PCP’s office, face-to-face visits with physicians to 
deliver medical records and discuss high-risk patients, and regular in-person meetings with 
providers to discuss concerns as it relates to information exchange.  
None of these strategies are cure-alls, and some are even inconsistent or unreliable 
(for example providers may not receive or view faxes). It is important that these strategies are 
augmented by strong communication processes (discussed later), and mitigated by diligent 
implementation planning. The results of this study supports the notion that unless the medical 
group invests in a single EMR system for its IPA network and then requires its use by all of 
its medical groups, issues related to interoperability across separate EMR systems will likely 
continue to be a challenge for the foreseeable future. This means that this constitutes a barrier 
that should be kept at the forefront of implementation planning and design for best practices.  
Geography. The vast majority of respondents were in agreement with the studies in 
the literature review which recommended face-to-face visits as an effective strategy for 
reducing preventable inpatient utilization. However, the IPAs participating in this study were 
often spread out over large geographic areas. This is a particular challenge in implementing 
face-to-face visits which often occur within the patient’s home. If the beneficiaries are both 
far away from each other and far away from the central administrative office of the medical 
group where the nursing staff is based, this creates a logistical challenge in terms of reaching 
the patient. Moreover, participants reported that network geography affects productivity, 
efficiency and ultimately increases the cost of at-home face-to-face visits. Many of the 
participants felt that the driving time to patient’s homes made the best practice more costly to 




The organizations that were successful in implementing this best practice believed 
that a precise and effective risk stratification could target patients who could most benefit 
from face-to-face visits. Thus, appropriately identifying and targeting patients who would 
benefit the most from each face-to-face visit appeared to increase the perception of overall 
efficiency of this best-practice. It also important to note that the geographical challenges may 
also apply to MDTs, as several members of the team may drive to see patients, such as social 
workers or nonclinical community health workers. Therefore, this strategy may also increase 
productivity of the function of MDTs in addition to that of face-to-face visits.  
Physician engagement. Physician engagement has been identified as a best practice, 
as well as a facilitator of other best practices, making this strategy particularly important in 
the implementation planning stages. The results of this study, in conjunction with the 
literature review, strongly support direct physician involvement in program implementation 
and care for complex populations as a way to reduce inpatient and ED utilization. Physician 
engagement, though, can be difficult to achieve as IPA network physician practices are often 
independently run and operated, spread out geographically, and may have contractual 
obligations with several medical groups simultaneously.  
Our participants repeatedly noted the importance of the physician’s role in guiding 
medical group care management programs. Many participants stated that the patients’ 
ongoing relationship with their provider was much stronger than with the IPA or IPA care 
team. The physician can act as a conduit between the patient and the IPA while lending 
credence to the programs being introduced by the IPA care team. Further, the provider can 
also support the IPA by contributing valuable information on the patients’ medical history, 




time. The physicians can also refer the right type of patients into IPA based programs and 
continuing relevant follow-up care upon program completion.  
The goal of early engagement is for the provider and the provider’s office to view the 
IPA as a resource and a partner as opposed to a burden. Early engagement of physicians by 
the IPA is critical to ensuring a physicians’ strategy aligns with that of the IPA. It is necessary 
to establish the role of the IPA in the providers care paradigm as early as possible. Early 
engagement refers to a concerted effort to inform the provider of the IPA’s programs using 
preferred communication and expectations upfront—ideally before a contract/agreement is 
signed between the provider and IPA.  
If the IPA requires fidelity of implementation of specific practices that necessitate 
provider engagement, that should be clearly outlined as well as incentivized financially and 
equally among all contracted clinicians. The research in the study supports the idea that 
financial incentives may act as motivators for physicians. This responses from key 
informants support the idea that IPA providers with a high-volume (generally defined as a 
majority) of patients from one IPA organization are much more likely to be engaged when 
compared with providers with a smaller patient population attributed to that IPA.  
For IPAs with an already-established IPA provider network, setting expectations may 
have to be implemented when the physician/medical group contracts are renewed; they may 
be more challenging as the physicians have become used to the status quo regarding 
expectations. 
In summation, early engagement is a critical component of setting the precedent for a 
long-term effective collaboration between provider and medical group, and essential in 




Establishing a communication strategy. We found that communicating with the 
physician bi-directionally (to and from the central IPA office) was a major factor in the 
programmatic success of the implementation of best practices. Communication with the 
physician and with the physician’s office, which is mutually beneficial for provider and 
patient, appears to enhance the success of best practice led programs (e.g., face-to-face visit-
based programs, multidisciplinary teams), as well to align the interests of the central IPA and 
individual physician practices. This is particularly important as IPA providers that contract 
with many different IPAs and health plans may have an overload of information and may 
simply not remember which member is affiliated with which IPA and subsequently which 
programs are available for them. The frequency, consistency and quality of communication 
are key considerations when devising and preparing an engagement plan. Respondents 
expressed that providers themselves as well as the office staff may experience high levels of 
turnover, highlighting the need to apply a communication strategy consistently over-time, 
with regular frequency, and high quality information exchange.  
It is also important to note that the IPA administration should be responsible for 
controlling information from the IPA so that is not overwhelming for the practices. Because 
of the large amount of information physician’s deal with on a daily basis, it is critical to keep 
communications to those that are useful to the provider and impactful for the practice and the 
patient.  
Although it is a powerful facilitator, an effective communication strategy was not 
adequate, on its own, to achieve sustainable implementation of best practices. While 
education of available IPA services and programs enhance awareness, it may not be enough 




alignment of incentives, and an understanding of the revenue environment in which IPA’s 
operate.  
Revenue model. Respondents noted that revenue models have a large influence on 
the type and scope of programs that IPA administrative offices implement. Understanding 
this association will help elucidate which IPA’s are more or less likely to succeed in 
implementing a particular set of best practices and may help guide the development of value-
based healthcare models.  
Respondents reported that a common barrier to implementing both multidisciplinary 
care models and face-to-face visits was the lack of financial support to operate the programs 
and/or employ the necessary staff. Since IPAs receive their revenue from health plans, the 
health plan’s revenue model seems to be a strong predictor of whether IPAs will adopt 
programs that require up-front financial capital. The IPAs that receive funding upfront 
through global payments or full-risk (fully delegated for inpatient and outpatient) capitated 
models appear more likely to implement or continue to support programs with significant 
upfront costs; they may see a subsequent return on investment in these programs (e.g., 
MDTs, face-to-face member visit) over time. This differs from shared or partial risk models 
(only at risk for outpatient costs) where full risk models have more flexible upfront funding 
to invest in strategies that make take longer to see cost savings. Our findings support the 
concept that IPAs that participate in revenue models with limited upfront revenue and/or 
partial risk models are less likely to adopt and sustain best practices that require substantial 
upfront investment costs.  
Incentives. This research provides evidence that aligning revenue models and 




a facilitator to the adoption of the discussed best practices. Financial incentives have shown 
to be particularly impactful in shaping the behavior of both the IPA administration and the 
IPA provider network. Understanding how financial incentives (e.g., bonuses, reward-based 
compensation structures) affect physician behavior may help facilitate a more effective 
strategy for adopting best practices as the healthcare landscapes transitions from a volume-
based to a value-based care environment. The alignment of interests across stakeholders can 
be shaped to promote best practices shown to be successful in both reducing expensive 
inpatient utilization and promoting a higher quality of patient care. The network composition 
and associated payment structure, including: how rewards are distributed per individual 
contract, setting clear expectations on how to successfully achieve the rewards (e.g., what 
does this IPA expect from me), and the type of reward (often financial, such as bonuses), are 
all integral pieces in streamlining diverse interests across a fragmented environment. 
Rewards should be consistently delivered, with clear expectations as to how to achieve high 
performance to earn the rewards. These rewards should be aligned with the interests of the 
IPA and should be distributed regularly (quarterly) to provide timely feedback on 
performance and give the provider a chance to correct performance. Incentives should 
balance encouraging providers to engage in best practices, while also considering the need to 
break even with savings achieved through reduced utilization. At least a portion of the 
rewards should include financial incentives, and the opportunities to achieve the rewards 
should be offered to providers equitably across the network.  
Recommendations 
The below recommendations are based on our findings and literature review. These 
are aimed at domestic IPA organizations—particularly those located in California, although 




Altogether, I have nine recommendations on how IPAs can more effectively adopt and adapt 
best care management strategies—particularly face-to-face care management, and MDTs. 
These recommendations fall into two groupings: preparation and readiness, and 
implementation.  
Preparation and readiness (recommendations 1 through 3). All of the 
recommendations in the preparation and readiness phase are intended to occur prior to the 
implementation of best practices. They serve as a general framework to allow organizations 
to assess their readiness to successfully adopt and adapt the discussed best practices, face-to-
face visits and MDTs, within IPA environments. There may be organizations that do not have 
the data or underlying infrastructure to successfully perform several of the recommendations. 
It is therefore suggested that organizations realistically assess their ability to perform the 
below recommendations by profiling their assets (access to data for example) and 
weaknesses (claims are not shared with the IPA by the health plan) prior to implementation 
efforts.  
Recommendation 1: IPAs should develop a reliable and effective communication 
strategy prior to and during implementation of best-practice strategies. Having a reliable 
method for readily communicating with a network of IPA providers is one of the first steps in 
making the adoption of the discussed best practices as effective as possible. The ability to 
communicate with providers on a timely basis and to share information on developing 
programs, programmatic changes and/or patient information is the cornerstone of successful 
implementation. Providers should also be able to provide feedback on care plans and shape 




It is important for organizations to evaluate the strength and reliability of their current 
communication strategy in the initial stage of implementation planning. Enhanced 
communication between IPA and provider may facilitate provider engagement and mitigate 
against physician withdrawal from best practice programs implemented by the central IPA.  
The primary strategy discussed by our key informants to augment communication 
with providers was automated communication via IT systems and/or in-person meetings. An 
ongoing plan for communication and educating providers should be in place prior to 
implementation of best practices to increase the probability of programmatic success and 
particularly of physician engagement. It is recommended that the plan include the below set 
of action items mentioned by respondents as key areas of communication facilitation:  
1. Limit information exchanged to that which is useful and valuable to both the IPA, 
and provider/provider office. This prevents the provider’s office from being 
inundated with unnecessary information and therefore ignoring certain 
communications. This also means that information exchange should be targeted 
per office, personalized, and specifically relevant to a particular physician’s 
membership panel or practice.  
2. The provider should understand which communications channels are going to be 
used, when, and for which type of information. For example, all recommendations 
for medication reconciliations are faxed to the office within 24 hours of hospital 
discharge, while all other communication regarding patients on an outpatient basis 
is recorded in an EMR and is accessible by both the IPA and provider office. The 
provider should be aware of which type of communication the IPA will provide 




reports, quality measure updates, and notice of acute care utilization. In addition, 
the IPA should be consistent in providing this information. In this way the 
provider knows what patient level information will be provided by the IPA.  
3. Some form of face-to-face meeting/interaction between provider, office and IPA 
should occur at regular intervals to set clear expectations and resolve any issues. 
Respondents recommended both group (peer-to-peer) gatherings with other 
physicians and the IPA, and one-to-one meetings with provider/office and IPA 
staff. Because each type of face-to-face meeting contributes unique value, the 
recommendation put forth here is that they should be used in combination and 
supplemented by electronic and telephonic communication. This will require 
substantial staffing by the IPA to meet with all the providers in a network 
regularly, but this research suggests that regular, effective communication with a 
provider is the linchpin to provider engagement and participation in best practice 
initiatives and will produce significant value.  
4. The provider should be made aware of how to contact the IPA quickly and 
effectively if any questions, needs for support, problems or inconsistencies with 
information are received.  
Recommendation 2: IPAs should include an assessment of its revenue model when 
determining readiness for best practice implementation. Understanding the IPA 
administration’s revenue model will help the IPA determine which types of care management 
strategies can be best implemented. This research supports the hypothesis that IPA’s with 
revenue models that provide upfront funds to care for their members are more likely to 




capitated models, global capitation and other value-based models that reward on healthcare 
outcomes while providing the revenue to care for the patient prior to spending on services. If 
an organization lacks this type of funding model, it may be more difficult to finance these 
care management best practices. This is because the adoptions of the recommended best 
practices requires an investment upfront to hire appropriate staff to ensure the best practices 
are effective. Respondents suggested that IPAs which do not manage all of the risk for a 
population often struggle in sustaining care management programs which take a longer time 
to show returns/results. IPAs which are not full risk generally have less flexibility as to how 
to spend their limited funds. This limits the opportunity to spend funds on programs that 
typically require a longer period of time before they are able to show returns. It is therefore 
recommended that IPAs evaluate the revenue model and the sustainability of funding for such 
programs prior to implementation. The IPA should also explore the longevity of the funding 
sources to ensure sufficient time to assess program effectiveness.  
Recommendation 3: IPAs should evaluate the number of high volume providers to 
help assess readiness for adoption of best care management practices. Generally 
respondents noted that it is easier to educate, train, and facilitate provider involvement in 
best-practice based care management initiatives with providers who have a higher volume of 
IPA patients from one IPA or exclusivity arrangements with the IPA. Therefore, it is 
recommended that this feature is evaluated prior to implementation of new programs to 
assess the fitness of the network to absorb a series of best practices that requires physician 




1. Provider networks without a significant number of high-volume providers should 
assess the number of providers willing to actively participate in IPA central 
administration care management programs.  
2. IPA networks with a low number of high-volume providers or providers willing to 
actively participate may need to consider, according to respondents, offering 
additional financial incentives for active participation and engagement in care 
management programs. Incentives may include restructured bonuses, performance 
based rewards, and/or value based capitation payments in which capitation is 
adjusted quarterly based upon meeting quarterly metrics (this is also an example 
of the provider assuming some risk). Each IPA will need to determine, based on 
individual circumstances, what percentage of high volume providers is the 
appropriate threshold for their particular organizations. However, one respondent 
mentioned 50% and above of as the proportion of high volume providers 
recommended in an IPA network to obtain sufficient implementation of best 
practices.  
Adoption and adaption (recommendations 4 through 9). This next set of 
recommendations is intended to guide the organization throughout the adoption phase by 
highlighting factors found to be integral to the overall success of the best practices.  
Recommendation 4: IPAs should employ a robust targeting/risk stratification 
system to determine eligibility of populations for face-to-face visitation programs. As noted 
earlier, respondents mentioned the high cost of implementing face-to-face care management 
programs, especially if patients are geographically dispersed. The IPAs that were able to 




from the intervention (using a risk-stratification system). Focusing in-person care 
management to those most likely to benefit helped IPAs demonstrate a positive return on 
investment. Therefore, IPAs should use an evidenced-based risk stratification system to 
identify patients that will benefit from home visit interventions. This recommendation will 
also apply to face-to-face visits not located in the home, but because other settings for face-
to-face visits, such as clinics and provider office, are often more centrally located this 
strategy will be most useful in terms of increasing productivity when applied to home 
visitation models. 
Respondents suggested that patients who benefit the most are usually those with some 
level of social distress (e.g., isolation, food insecurity, housing instability) that is contributing 
to medical utilization, as well as those patients with underlying behavioral health issues. 
Therefore, the risk stratification method utilized by the organization should include at least 
some measures in the social domain to most accurately determine which patients are most 
appropriate for this interventional strategy.  
Specific methodologies and stratification strategies mentioned varied widely, but one 
of the most popular sets of criteria across the participating organizations was a combination 
of a measure of future (short-term 30-day) inpatient admission risk (e.g., LACE score), and 
an evaluation of social/behavioral issues (e.g., social worker assessment). It is recommended 
that the patient selection methodology incorporate both of these domains. Some IPAs may 
not have the requisite data or resources to implement these risk stratification procedures. In 
this scenario, it is recommendation the IPA central administration partner with a more 
equipped entity to obtain the needed data. Such entities may include the health plan, provider 




include claim records, notifications of inpatient utilization, and information related to risk 
stratification algorithms.  
Recommendation 5: IPAs should include a social worker and a pharmacist on the 
multidisciplinary team. Participants in this study expressed strong views regarding the value 
of including both a pharmacist and a social work on the multidisciplinary care team. The 
literature review also support pharmacists and social workers being important disciplines on 
the care team as they complement the lead nurse care manager. Pharmacists are able to 
contribute specialized knowledge regarding complex medication recommendations and may 
help to supplement the expertise of both PCP’s and specialists caring for a complex 
population. Social workers address underlying social and behavioral issues that may 
contribute to preventable utilization. Both of these disciplines (pharmacy and social work) 
were cited by respondents as the most valuable contributions to care. It is therefore 
recommended that they are essential (in addition to the nurse care manager) to develop a 
minimally effective care team that emulates the type of care teams used by the organizations 
researched in the literature review as well as the type of care teams developed by the 
participants in the key informant interviews.  
Recommendation 6: IPAs implementing face-to-face visits should require care 
managers to visit the homes of high-risk patients. A majority of participants engaging in 
face-to-face visits agreed that the home was the most valuable setting to conduct the visits. 
This is generally because of the rich information that can be gathered by observing the 
environmental living conditions affecting the health of the patient. This increases the value of 
the interaction between care team and patient, and expands the care beyond just a clinical 




visits significantly enhance the quality of care provided. For example, some key informants 
expressed that seeing the patient face-to-face, particularly in the home environment could 
reveal further diagnosable conditions not readily apparent over the phone, such as dementia, 
which may be initially masked by patients. It is therefore recommended that at least one face-
to-face visit is conducted in the home environment for high-risk or complex patients. This 
recommendation holds true even when the face-to-face visits are wrapped into a larger 
program (e.g., transitional care).  
Recommendation 7: IPAs should incorporate a transitional care program into 
either or both of the best practices (face-to-face visits and multidisciplinary teams). 
Transitional care programs, when combined with multidisciplinary team models and/or face-
to-face visits, were viewed by participants as a particularly important to reducing inpatient 
utilization (a primary focus of this study). Transitional care programs are those which focus 
on effectively (and sustainably) transitioning the patient from the inpatient to outpatient 
setting. MDTs and face-to-face visits may help facilitate this transition. Key respondents 
suggested that the ability to prevent readmissions after an inpatient stay is enhanced when 
paired with the two programmatic based best practices (MDTs and/or face-to-face visits). 
Several factors may explain the increase in positive results when the best practices included a 
transitional care component. First, the transition from an inpatient to an outpatient setting 
marks an especially vulnerable period for patients. This may increase the probability of a 
potential readmission when compared with other period of times that are lower risk. Focusing 
on transitional care may reduce the number of preventable readmissions. Combining 
transitional care with home visits may be particularly effective, as it affords the IPA the 




often include input from many health-related domains including social work and pharmacy. 
The expertise of the team members may address unique problems contributing to 
readmissions, such as medication complexity for patients with polypharmacy and/or social 
issues. Therefore, combining these best practices (face-to-face visits and MDTs) may create a 
synergy with transitional care programs that are particularly effective at reducing inpatient 
utilization. Overall, directing concentrated care resources towards this transitional period 
(especially in the form of best practices) appeared to improve the results of both of the best 
practices in terms of lowering inpatient utilization.  
Recommendation 8: IPAs should encourage consistent provider engagement. The 
provider is instrumental in facilitating program cooperation with the patient, providing long-
term care after program completion/graduation, and following through on care plan activities 
that require physician oversight and execution (e.g., medication changes). The involvement 
of the physician in best practices has been associated with successful program 
implementation when compared with program/best practices that do not include the patient’s 
physicians. The provider engagement strategy should ideally be prepared in the preparation 
phase and continue on throughout the implementation of the best-practice. Specific 
recommendations for a provider engagement strategy include:  
1. Incorporating incentives (preferably at least one form of financial incentive (e.g., 
bonus for achieving certain metrics) 
2. Clearly defining engagement/participation expectations as early as possible in the 
best practice implementation process (preferable at the contract signing stage).  
3. Clear and consistent communication with provider and provider office per the 




4. Regularly discussing feedback, both to and from the provider on 
performance/patient status, as well as updating the communication strategy as 
needed.  
It is of note that because the research for this study was primarily conducted among 
California IPAs, some of the recommendations may be more applicable to California or like 
areas, than other states. Of the nine recommendations, Recommendations 2 and 3 are most 
likely more specific to California than the other six. For example, Recommendation 3 
concentrates on provider volume, and was developed in response to the key informant’s view 
that it is important to assess patient volume for a particular IPA because it can influence 
physician engagement in the IPA’s care management initiatives. However, because the 
majority of IPAs included in the study were from California, this insight might be more 
applicable to those IPAs located in the state. Recommendation 2 focuses on revenue models, 
which may be more or less of a consideration depending on location. California has a large 
percentage of capitated models (26% of physicians visits in 2013 used capitation in CA vs. 
2% on average in other states) and therefore understanding the impact of receiving upfront 
revenue (capitation payments) on best practices is more clearly understood.36 In summary, 
geographic variation will play a part in how these recommendations are adapted to a 
particular environment and should be taken into account when considering which 
recommendations an individual organization should select to adopt.  
Recommendation 9: Organizations should robustly evaluate their ability to achieve 
outcomes of interest. It is recommended that intervention implementers develop robust and 
standardized methods of measurement to observe outcomes of interest. This is especially 




satisfaction, and return on investment for the organization. This will increase transparency, 
allow for easier identification of effective methods, and facilitate the adoption of successful 
interventions and best practices by similar organizations. 
The Shifting Healthcare Landscape 
There are new factors within the healthcare environment that may make the 
implementation of these recommendations more or less challenging. Advances in technology 
and medicine in addition to political, and regulatory influences all serve as potential 
mediators to successful implementation of these recommendations. Specifically, new 
advances in technology including the wide adoption of EHRs borne from the meaningful use 
requirements (the federal EHR incentive program), telemedicine, and patient centered disease 
management devices (such as wearables)—have and will continue to fundamentally change 
how best practices are received and implemented within a particular context. Regulatory 
influences such as fluctuating reimbursement models in managed care, changing enrollment 
algorithms and public program uncertainties may also result in differences in how 
organizations (IPAs) function and are paid, and subsequently may affect the type and number 
of services they are able to provide patients.  
For example, modern technology may help increase access to patients in hard to reach 
areas such as in rural settings, but may simultaneously reduce face-to-face interactions with 
patients in more accessible areas and become a substitute for face-to-face visits 
(Recommendation 6). This may make the implementation of this recommendation more 
challenging. Changes to the reimbursement models for MCOs may limit the amount of funds 
available for patients. Similarly, federal, state or health plan requirements regarding how 
these funds are allocated may leave little room for IPAs to fund and therefore to implement 




from agreeing to full-risk arrangements—which key informants agree is the revenue model 
where best practices tend to be most sustainable and effective.  
While challenges exists, there are also new changes which work to facilitate the 
adoption of best practices. As the industry shifts from volume based reimbursement to value 
based purchasing, providers are incentivized to engage in activities which increase quality 
and improve patient outcomes—such as the best practices highlighted in this dissertation. 
Further, technology such as interconnected EHRs work to improve information sharing, and 
increase the availability of information among different health disciplines (such as that of the 
MDT). Other facilitators may include an increased national focus on social determinants 
which may work to more regularly incorporate social workers into care protocol 
(Recommendation 5).  
In conclusion, it will be critical to assess the environment in which these 
recommendations are implemented to understand how dynamic shifts may influence the 
success of implementation and adoption of these strategies.  
Based on these aforementioned recommendations, Chapter 6 discusses a plan for 
change using Kotter’s Change Model as it applies to IPA organizations as an industry, as well 









CHAPTER 6: PLAN FOR CHANGE 
This plan for change is informed by the information collected in this study. It is 
guided by eight steps in Kotter’s change framework which includes: establish a sense of 
urgency, create a guiding coalition, develop a vision and strategy, communicate the change 
vision, empower broad-based action, generate short-term wins, consolidate gains to produce 
more change and anchor the change in culture.37 Kotter’s 8-step change model offers 
specific, prescriptive steps and was therefore selected as the framework of choice to guide 
this plan for change.  
This plan for change encompasses two sections. The first section broadly applies 
Kotter’s model to IPA organizations as an industry. Also applicable to the first section of the 
plan for change is the Diffusion of Innovation Theory, established by Everett Rogers, which 
generally states that the time to adoption of an innovation (such as a best practice) follows an 
S-curve, with different stages of the curve representing different phases of adoption (see 
Figure 3).36 As depicted in Figure 3, the adopters of an innovation are split into five 
categories: innovators, early adopters, early majority, late majority and laggards. The plan for 
change using Kotter’s model is intended to first engage early adopters and then to help 





Figure 3. Adoption of innovation.36  
Everett, in his book Diffusion of Innovations, explains that there are certain attributes 
of innovations which make them more or less likely to spread, which includes relative 
advantage, compatibility with existing values and practices, simplicity and ease of use, 
trialability, and observable results, which are further detailed below.38 In Part 1 of the plan 
for change, I will describe how the steps in the plan for change model enhances the 
effectiveness of these attributes.  
The second section of the plan for change applies relevant recommendations to my 
specific IPA organization, where I plan to implement the recommended changes outlined 
below. This latter example is used to illustrate how I will make changes within my own 





Figure 4. Kotter’s 8-step plan for change.37 
Part 1: Kotter’s Framework for Instituting Best Practices across the IPA Industry 
Create a sense of urgency. Creating a sense of urgency to implement best practices 
on the part of both the providers and the IPA provides an impetus for this change. This step in 
Kotter’s change model functions to establish a rationale for swift action, which otherwise 
might be delayed. This might be the most important step in catalyzing a large scale or 
paradigm shift within an organization or more broadly, across an industry.  
An urgent need for change is important to ensure that the required recommendations 
for best practices are put near the top of a, likely competitive, priority list. It is important to 
establish a sense of urgency in all relevant stakeholders including both the IPA central 
administration and the affiliated providers.  
1. Create a 
Sense of 
Urgency
2. Build a 
Coalition





















As such, the best practices selected for this study were inherently selected due to their 
ability to produce value for patients, providers, and payers alike. This means they are based 
on activities that produce improve health outcomes while simultaneously decreasing costs. 
Thus, the sense of urgency to move to value based best practices for both providers and IPAs 
should be supported by healthcare’s continued efforts to move from volume-to-value based 
care. Additionally, the move to a value-based healthcare system has exerted pressure on IPAs 
and their respective provider networks to move away from fee-for-service for delivering and 
reimbursing care. The sense of urgency that exists for providers and IPAs as a function of this 
movement will help to facilitate the adoption of best practices. 
When organizations take on financial risk based on performance (this means 
organizations are at risk for expenses but also share in profits if money is saved), they are 
incentivized to operate as efficiently as possible. Interests are aligned with improving health 
outcomes and reducing unnecessary expenditures (e.g., shifting from inpatient to outpatient 
care when appropriate). These motivations fit nicely with implementing best practices that 
seek to improve health outcomes and reduce costs. With the adoption of increased risk 
models, providers, payers organizations, and IPAs may feel an increased sense of urgency to 
embrace best practices.  
To further promote the idea of value-based care, I will author a series of three articles 
for America’s Physician Groups (APG), an association of physician groups and IPAs. The 
articles will be published in a newsletter which is distributed 3 times a year to approximately 
9000, to 12,000 readers. The article will focus on why value-based care models contribute to 
better outcomes for patients (particularly for patients with complex diseases such as those 




utilize both evidence from this research study as well as highlight case studies of 
organizations that have successfully transitioned to a value-based environment.  
The articles will also include content on best practice strategies with an email address 
that interested parties can reach out to be placed on a listserv. The listserv will be used to 
send out information to engaged participants regarding successful best-practice strategies in-
between newsletters distributions, as well as to encourage them to submit their own 
experiences which will be shared with others on the listserv.  
In regards to further dissemination of the results in this study, I plan to share pertinent 
information with interested organization such as the Learning Action Network as well as 
attempt to publish the findings in relevant peer reviewed journals. 
Build a coalition. The coalition is intended to be the guiding body executing the 
recommendations and may serve one of the most influential roles in driving industry-wide 
change. The coalition will include representatives from senior leadership (e.g., Chief 
Executive Officers and Chief Medical Officers,) as well as individuals that are patient-facing 
(e.g., Directors of Case Management.) My goal in forming the coalition is to serve as a 
resource for other IPA organizations that are currently not engaging in best practices. I will 
attempt to recruit coalition members who have experience implementing best practices, and 
who are willing to share success and failures with other organizations.  
I will also leverage existing coalitions, such as provider associations. One such 
organization is the aforementioned APG, which is composed of a variety of physician led 
medical groups that have a large concentration of IPAs. I will work with the associations to 




continue to be a guiding force for implementing the changes in their respective organizations 
and among the IPA community.  
To promote the formation and sustainment of these coalitions, I will be giving 
lectures at APG’s general member meetings across the United States. The lectures will focus 
on the benefits of adopting best practices. The lectures will also describe the enormous value 
of learning from one another as IPA organizations to share experiences. At the end of each 
lecture, a list of interested participants may be collected. There are approximately 20-30 
member meetings per year, therefore the opportunity to speak to potential members of this 
forming coalition is high.  
Once a list of interested APG members is formed, it will be provided to APG 
regionally with a designated APG volunteer leader selected for each region. It will be 
suggested to APG that they integrate best practice discussions as outlined in this dissertation 
into their existing regular meetings. Members of the coalition are encouraged to use the APG 
platform to share experiences and espouse the benefits of evidenced-based practices. This 
approach will lead to APG-supported learning collaboratives, which are groups of individuals 
that get together to enhance their understanding of a particular subject, skill, or task. A 
learning collaborative, supported by APG, will help to increase understanding of how to 
implement best practices and serve as a support system for those with less experience in 
adopting best practice. Learning collaboratives are often used as a means to bring together 
different teams or organizations who will work together towards a common goal. Similarly, a 
learning collaborative can be used to integrate best practices into the existing health care 
system, particularly among IPA organizations. IPA organizations will be encouraged to 




these learning opportunities will be presented through the coalition leaders at regular 
intervals.  
Form a strategic vision and initiatives. This step entails ensuring that all members 
of the coalition can disseminate a clear and consistent vision of the changes to the IPA 
community. Kotter mentions the importance of linking vision to practical and concrete 
strategic actions as a critical component of this step.  
I will encourage the coalition and the appropriate APG members to have 
booths/displays at relevant events where additional information will be passed out regarding 
successful implementation strategies for best practices. I would also suggest that APGs 
arrange dinners with industry thought leaders, as well as expert panels discussing strategies 
to adopt best practices and working to communicate and disseminate the vision.  
To link vision to concrete strategic steps, members of the coalitions implementing the 
recommendations in their respective organizations should be prepared to share their vision 
and path to success within the learning collaborative, as well as to discuss failures and 
specific actions leading to those outcomes. I will help support APG to encourage the 
dissemination of these experiences among IPAs implementing the best practices through the 
learning collaborative and newsletters, as well as through a series of lectures.  
Although the ultimate process may differ among individual IPAs, the overall vision 
should be shared among IPAs as a community and espoused through the work of the driving 
coalition. The coalition will form learning collaboratives with the specific goal of sharing 
strategies that have led to success. IPAs that are willing to try new implementation methods 
and share their short-term and long-term results with the wider community should lead the 




well as broader strategic insight and support. I would also support APG in connecting with 
those who have been pioneers in these areas to gauge their interest in becoming leaders for 
the learning collaborative. This will help make the vision a reality by applying concrete steps 
to support organizations in practice.  
Enlist a volunteer army. Any large-scale change requires a large number of 
individuals to execute it. The volunteer army represents the manpower necessary to carry 
through the needed changes and consists of individuals who have demonstrated the 
willingness to implement the recommendations. The volunteer army will include IPAs that 
believe in implementation of best practices and are willing to advocate for the changes. The 
volunteer army differs from the coalition in that they help support and execute the decisions 
made by the coalition. Generally, the coalition will be composed by best practice experts, 
while the volunteer army could be any number of individuals (not necessarily experts or with 
prior experiences) interested in implementing best practices.  
I have reached out to several participants in the key informant interviews who have 
been instrumental in implementing best practices at their respective organizations to see if 
they would be willing to share their experiences with the IPA community. The individuals 
who agree will act as the first members of the volunteer army (potentially also joining the 
leading coalition). I will encourage these individuals to share their experiences with the wider 
IPA community. For example, I will invite them to participate in an expert panel at the APG 
general membership meetings to discuss their path to success in implementing best practices 





This volunteer army (and guiding coalition) will also be responsible for such tasks as 
arranging gatherings for the IPA community to learn from one another’s implementation 
attempts, enlisting additional IPAs to adopt best practices, and documenting and 
disseminating further information regarding the application of these best practices nationally. 
The goal of the volunteer army is to create momentum required to start and sustain a 
movement that allows other IPAs to more easily adopt the successes and avoid the failures of 
organizations that attempted best practice implementation.  
Enable action by removing barriers. Every large-scale change effort will face 
barriers; this step in Kotter’s framework refers to removing these barriers to be as effective as 
possible in driving change. One barrier to implementation of best practices in the IPA 
industry includes policy changes. For example, if value-based care does not continue to be 
supported by the primary payers (CMS), the lack of revenue may influence the ability of 
organizations to implement best practices. Another barrier is the lack of knowledge regarding 
how to successfully implement best practices in an IPA environment. The strategies to 
remove such barriers will be supported by the first three recommendations (outlined in 
Chapter: 5 Discussion) which are tailored towards to mitigating against major barriers IPAs 
have come across in the implementation process.  
Per the Readiness Recommendations (1 through 3), several characteristics of IPAs 
may make organizations more or less prepared to implement the best practices discussed in 
this study (e.g., IPA-to-provider communication strategy, number of high volume providers 
in a network, and the IPA revenue model by which payments to the IPA are processed). If any 
of these features is not optimal in a particular organization, it might constitute a barrier. 




practices in their own environment to share strategies they have used to overcome these 
barriers within their learning collaborative. Engaging a coalition that has members from IPAs 
that have successfully implemented these best practices, and who are willing to share those 
experiences within a collaborative, will help to remove barriers to implementation.  
Generate short-term wins. Short-term wins let the team know they are .making 
progress; it is both motiving and rewarding. Dr. Kotter believes this step highlights the 
importance of tracking progress both early and often. 
The IPA community should celebrate and share small wins. An example is an initial 
decrease in readmission rates and improved health outcomes (such as HbA1C) resulting from 
applying best practices. Teams should be rewarded for achieving these short-term goals; 
doing so can create momentum and motivation in achieving longer term goals, such as 
sustained reduction in inpatient utilization across populations. The APG magazine which is 
distributed to a variety of stakeholders (including a large number of IPA organizations) can 
be used to share which best practices being implemented among willing IPAs and the results 
from those implementation efforts—including short-term successes (e.g., public recognition 
from large associations, such as APG.) These organizations may profiled in the newsletter 
and/or recognized at annual APG conference awards ceremonies. Some organizations may be 
reluctant to share their progress and how they achieved their wins with the wider IPA 
community; however, a coalition of IPA leaders willing to share successes will help to 
establish a culture of intercommunity trust and cross-pollination of ideas. The IPA 
community as a whole should celebrate the adoption of value-based care, and specifically of 




Sustain acceleration. Quick changes and early successes can slow progress over the 
long-term. The seventh step in Kotter’s change model promotes sustaining change to stay the 
course and achieve the overarching vision. The goal of this step is to ensure that the 
excitement for change and sense of urgency in the beginning do not fade.  
Consistent momentum will need to be cultivated by requiring intra-community 
support from other IPAs. The coalition and volunteer army will work to set up regular (at 
least annual) learning collaborative gatherings for IPAs applying the best practices and 
incorporate measures to gauge progress and assess continual performance improvement. The 
gatherings will also aim to include IPAs wanting to learn more about best practices. The 
coalition (and volunteer army) will be charged with sustaining this initiative over time. As I 
deliver lectures to the APG community, I plan to (with permission) share the collective of 
experience of IPAs that have implemented best practices within their organization. This will 
help organizations recognize that other IPAs are moving towards an evidenced-based care 
approach in managing their complex populations.  
The IPA community that forms should retain responsibility for policing their own 
progress, ensure accountability among the organizations, and consistently encourage 
engagement over time. It is strongly suggested that those IPAs implementing best practices 
share their progress via publications, conferences, seminars, webinars, and social media with 
the goal of illustrating the value of implementing the best practices to other IPAs. As 
discussed previously, APG will be a major resource to catalyze the dissemination of these 
materials—using the coalition as the driving force for accomplishing these goals. 
Institute change (also referred to as anchoring change in the culture). The eighth 




in the organization. For this to happen, organizations will need continuing to be positive 
reinforcement for employing these practices successfully over time. Positive reinforcement 
may including: publicity, monetary rewards, or peer recognitions; organizations may even be 
rewarded by health plans and government payers through additional perks such as improved 
contract deals, or membership to a preferred IPA. I will continue to work regularly with best 
practice champions, and the coalition and volunteer army to publicize the work of the IPA 
community implementing best practices through published articles, lectures, expert forums 
and involvement in associations such as APG. This will help to perpetuate the momentum 
established from the sense of urgency and quick wins. Once best practices are rooted in 
organizational operations, external rewards may be less necessary as the value from the best 
practices will begin to reap benefits within each organization –such as lowered costs from a 
reduction in inpatient utilization.  
Diffusion of Innovation Theory 
As discussed previously, Diffusion of Innovation Theory describes attributes 
associated with the dissemination of innovation over time, and these attributes are thought to 
facilitate adoption. These attributes are: relative advantage, compatibility with existing values 
and practices, simplicity and ease of use, trialability and observable results. Below I will 
describe how these attributes are enhanced by the plan for change presented above.  
Relative advantage. Refers to the degree to which an innovation is perceived as 
better than the status quo. The best practices described have been developed specifically to 
confer relative advantages for patients (improved health outcomes) and/or payers (lower 
costs) compared to existing practices. These relative advantages will be communicated to 




lectures, newsletters, and experts and learning collaboratives to espouse these benefits to 
others in the IPA community.  
Compatibility with existing values and practices. This step relates to how well the 
innovation fits within in the existing environment. Noting the volume-to-value movement in 
healthcare, best practices that are intended to increase total value delivered to the system will 
align very nicely with the recent shifts in the healthcare ecosystem to move towards 
performance-based metrics. The level of compatibility of best practices with existing values 
and practices may differ from organization to organization depending upon that IPAs’ 
willingness to move to a value-based system; however, as an industry, compatibility should 
be high.  
Simplicity and ease of use. This refers to the simplicity of the innovation and how 
easy it is to apply in practice. This perception of this attribute, like the prior attribute, will 
tend to vary across organizations due to differences in available resources and prior 
experience. The steps outlined above using Kotter’s change model are intended to 
communicate helpful strategies, and to develop learning collaboratives, which should 
enhance simplicity and ease of use.  
Trialability. Trialablilty is the extent to which an innovation can be tested. This is the 
purpose of the learning collaborative sharing early results (and wins) amongst the IPA 
community. The best practices are highly trialable, and this attribute will work to establish an 
increased measure of credibility and ideally confidence in those contemplating best practice 
implementation in their respective organizations.  
Observable results. This is the extent to which results from the innovation are visible 




observed when organizations improve health outcomes and reduce inpatient utilization. This 
can be accomplished through lectures, forums, panels, and learning collaboratives in which 
the results are shared consistently across organizations. The five attributes of the Diffusion of 
Innovation theory are readily enhanced by using Kotter’s 8-steps in the plan for change and 
will work to increase the rate of adoption of best practices among IPAs.  
With long-term application of best practices using the nine recommendations, as well 
as the plan for change action steps, I believe that these strategies will eventually become part 
of the standard-of-care. To anchor this change in the culture, best-practice champions like me 
will need to continually advocate for organizations to participate in the move to value-based 
care and will for successful organizations to share their formula for best practices with other 
IPAs. 
Part 2: Recommendations and Change Model Applied to a Specific IPA 
Kotter’s model is a guide to help identify some of the salient action items in 
instituting change; however, it will likely need to be adapted to the current context and 
environment of individual IPA organizations. Readers are therefore encouraged to adapt each 
of the steps to their respective organizations. Below is a plan for how I will propose to adapt 
the recommendations to my specific organization. IPA organizations may need not apply all 
nine recommendations, as some may have already been implemented, as is the case with my 
organization. Additionally, some recommendations may not apply to all environments. 
Therefore, not every recommendation will apply to every IPA.  
My organization has already implemented the face-to-face care management and 
MDT’s best practices. Yet, this IPA has not developed robust physician engagement or 
communication strategies. Therefore, I recommend that the organization would need to 




efficacy of the best practices already implemented as well as Recommendation 8, which 
focuses on improving provider engagement. These two recommendations will be outlined in 
the following section.  
Recommendation 1: IPAs should develop a reliable and effective communication 
strategy prior to and during implementation of best-practice strategies. To understand 
how best to implement the recommendations, a baseline assessment of the current status of 
the organization is necessary. In my current organization there are approximately 36,000 
providers who use a multitude of EMR systems. Five percent of the providers are employed 
by the IPA, and these are the only providers on the same EMR. For purposes of this example, 
I will exclude the employed providers and only include the 95% of the network which is IPA 
based. The vast majority of providers contract with multiple payers, including IPAs, health 
plans, and directly through CMS (Center for Medicare and Medicaid Services). The primary 
communication strategies from the IPA to the provider includes a proprietary case 
management system in which case management notes and authorizations are recorded, faxes 
to office staff, phone calls, and occasional face-to-face meetings when major issues arise. The 
majority of the providers are not aware that the best practices are occurring at the IPA 
administration level and are often surprised to hear that their patients are enrolled in these 
programs.  
The first step of Recommendation 1 for which I plan to work with my organization to 
implement is to limit information exchange to that which is useful and valuable to both the 
IPA and the provider/office. This means avoiding inundating the provider’s office with 
unnecessary notifications. My organization should intentionally select which messages are 




provider office receives a communication from the IPA, it is confident that it is important and 
useful in managing their patients or practice. I would also recommend leaders in my 
organization sit down with a sample of providers (especially those with complex patient 
panels) to elicit feedback to more accurately determine which type of communication is most 
valuable for providers to receive. This will help streamline the incoming communication 
from the IPA central administrative office and also work to help the providers pay attention to 
new and urgent information.  
This first step lends itself well to the second, which is to help the provider understand 
which communication channels are going to be used and for which type of information. 
Establishing an internal strategy for consistent communication will help guide provider 
expectations for receiving information from that particular IPA. A strategy for my 
organization to achieve these objective is outlined below: 
• When patients on the provider’s panel are admitted to an inpatient facility or 
skilled nursing facility, an automatic alert will be sent via secure email. These 
emails will be sent within 12 hours of an admission.  
• When a provider’s patient is discharged from the hospital, an alert will be sent via 
secure email notifying the provider of the discharge and all discharge paper work 
including scheduled follow-up physician visits. Medication reconciliations will be 
sent to the provider’s office within 24 hours of discharge. If the provider has any 
questions, he/she should contact the IPAs pharmacy team or case manager who 
will be able to provide any additional information the provider may need 




• When one of the provider’s patients goes to the ER, the IPA will notify that 
provider via secure email.  
• When the patient is due for a preventive visit (including screening), the IPA will 
send a notification to the provider’s office via regular mail reminding the provider 
to schedule the patient’s next appointment.  
In this example, only urgent information is sent via secure e-mail. This functions to separate 
the urgent from the nonurgent and get the provider in the habit of relying on the secure email 
for important and time sensitive information that must be checked regularly. The secure e-
mail can of course be replaced by any system that the provider has access to which is able to 
relay the type of information explained above.  
The third component of Recommendation 1 is that some form of face-to-face/meeting 
between the IPA central administration and the IPA should occur quarterly. Ideally, these 
face-to-face meetings will take two forms, both small one-on-ones with provider and/or 
office, and larger gatherings with multiple physicians who contract with the IPA. The former 
will be used as a tool to solve potential issues before they become major concerns, 
understand what type of resources are most valuable for providers, and to ascertain what 
measures and processes work well for providers. The latter gathering will be instrumental in 
gathering feedback from providers in a group setting and allowing the providers to form a 
community amongst themselves to share effective patient management strategies.  
Because of the size of the network associated with my organization, to meet face-to-
face with such large number of providers it will be necessary to prioritize by the number of 
patients each provider has from the IPA. For example, high-volume and medium-volume 




annually. My IPA may also consider using technology such as Skype to connect with 
providers that are low-volume or more challenging to reach. This will allow the IPA to obtain 
access to the providers with the most influence over their member populations. This will 
require adequate staff to meet with the providers in such a large network regularly, but is 
posited to facilitate provider satisfaction and more effective patient panel management. It is 
recommended that this IPA build a team whose primary purpose is to liaison with their 
physician network to communicate information regarding their patient panels (this should be 
distinct from the traditional network team which focuses mainly on business processes and 
contracting issues). It is also recommend that this team involve individuals with some level 
of clinical background or patient care experience, such as a nurse case manager.  
The fourth and final step of this recommendation is to ensure the provider has a 
familiar contact at the IPA central administrative office so that they can reach out to them 
quickly and reliably should any questions or concerns arise outside of the regular meeting 
schedule. This will help to foster trust between my IPA and the provider and to work to 
ensure the provider has the resources and support necessary to be successful in managing the 
organization’s member population.  
Recommendation 8: Encourage consistent provider engagement. All of the below 
steps in aggregate are intended to increase provider engagement with the program. The 
provider will be incentivized to participate in the best practice programs, given instruction on 
how and when to participate, and be encouraged to add value to the development of the 
program, with the shared goal of ultimately improving patient outcomes.  
As the best practices are underway it is critical to maintain and encourage consistent 




speak to, the patients who are eligible for the program about enrollment, to actively 
contributing to the care plan and communicating with those conducting face-to-face visits or 
those on the multidisciplinary team. This plan for change adapted for my organization will 
aim for high-level provider engagement, which means contributing regularly to the patients’ 
care plan and building a working relationship with the IPA central administrative team 
delivering the intervention.  
Referencing the recommendations, the first step for my organization will be to 
incorporate at least one financial incentive to encourage active provider participation. For an 
already established network, it will be necessary to add any bonus to an active contract as it 
will be difficult to renegotiate payment terms in an existing contract. Therefore, 
incorporating an additional bonus based on performance of members enrolled in best practice 
care management is recommended for ease and simplicity. Please note, each IPA will have to 
decide the appropriate bonus amount based on their environment. In this specific plan for 
change for my organization, I will recommend incorporating a performance-based bonus (up 
to 5% of annual salary per year) that is determined by: number of patients enrolled in best 
practice programs, inpatient utilization compared to pre-program baseline measures, patient 
satisfaction, clinical indicators (e.g., HbA1C score decreases) if appropriate, as well as 
provider participation with the IPA administrative care team meetings (explained below). Up 
to five percent of salary was selected for the incentive because that is the same percentage 
used by CMS when incorporating incentives for several current value-based programs 
including the Merit Based Incentive Payment Systems.39 However, individual IPAs will have 
unique parameters (network composition, payment model, bonuses already in place, contract 




select which levels of bonus are most effective for their provider network. This bonus will 
encourage providers to remain active stewards of the patient’s care while enrolled in best 
practice based programs at the IPA central administration level.  
The second step in provider engagement as it relates to best practices is clearly 
defining what is expected of them by my organization. My organization has monthly 
interdisciplinary care team meetings (ICT) led by the IPA central administration care 
management team, where several medical disciplines (e.g., nurse case manager, social 
worker, pharmacist) meet to discuss complex patients. The primary care provider (PCP) is 
strongly encouraged to join the portions of the meeting discussing their patients. With the 
PCP’s participation, the meeting can focus on patients enrolled in best practice programs and 
work to further encourage provider participation with the ICT (and IPA central 
administration.) My organization should set expectations for providers to attend meetings and 
be prepared to review the care plan both monthly (prior to ICT meetings), and when any 
significant changes have been made by the IPA central administration care team. Further, as 
with any inpatient utilization, the provider is expected to communicate to the care team any 
changes in the management of the patient (including medications) after the postdischarge 
visit and any follow-up visits pursuant to the inpatient stay. This level of participation will be 
rewarded by the bonus in the aforementioned bonus category of “provider participation”.  
The third step is clear and consistent communication. This concept spanned the 
majority of key respondent interviews and subsequent discussions. The plan should be 
detailed enough to specifically incorporate how communication is exchanged for individual 
programs and specific best practices. In my organization, scheduled communication will be 




receive weekly updates regarding the patients enrolled in the program should be provided 
weekly to the provider. The provider should be expected to notify the IPA if he/she has any 
updates or there is pertinent information missing. To encourage updates, the IPA can 
incorporate physician-initiated updates into the participation score in determining the 
quarterly bonus.  
The fourth step is discussing feedback and updating the communication strategy as 
needed. The feedback should be bi-directional between the IPA central administration and the 
provider. The feedback is intended to help ensure that the care for the patient is streamlined 
and coordinated; feedback will also help improve the program over time so that it is 
responsive to patients’ and providers’ needs. Formal bi-directional feedback will involve 
participating providers quarterly to initiate a dialogue on what was done well and how to 
continue to improve performance moving forward.  
Evaluation of Implementation of Recommendations 
I will develop an internal evaluation plan to determine whether the recommendations 
have been successfully implemented. This plan will include both process, outcome, and 
patient/providers satisfaction measures. Process measures will include metrics such as 
number of times providers participate in ICT meetings, number of times provider or provider 
offices responded timely to urgent communications. In addition, I will augment the process 
measures with patient and provider satisfaction surveys. These process measures will be used 
to assess the effectiveness of the provider communication and engagement implementation 
efforts. If these measures are returning suboptimal results, I will plan to use the feedback 
from the peer-to-peer and provider to IPA central administration meetings to explore jointly 
with the provider alternative strategies of increasing engagement and improving 




utilization metrics, such as ED use, admissions, readmissions, and length of hospital stay. I 
am expecting to see a subsequent improvement in outcome measures after process measures 
are optimized.  
Conclusion  
The plan for change is intended to be used nationally, as it relates to the IPA industry 
as a whole adopting best practice strategies in managing complex patients, and locally as it is 
adapted to the IPAs’ environment, resources, network, and population. I will plan to impact 
change at both levels—through national IPA associations, as well as by providing and 
implementing recommendations within my own organization. Over time, as more evidence is 
collected and additional research is conducted—especially as it pertains to varying 
organizational environments, these best practices can be further adapted so that they achieve 




APPENDIX A: STUDY RESULT DETAILS 
Outpatient Case Management for Adults with Medical Illness and Complex Care Needs 
(2013)15 
 
Type of Study: Meta-Analysis 
 
Number of Studies: 55 
 
Population: Within this meta-analysis there were 20 studies on older adults with one or more 
chronic diseases, eight studies on the frail elderly, 12 studies on patients congestive heart 
failure (CHF), 12 studies on patients with diabetes and three studies on patients with COPD, 
for a total of 55 studies.  
It is important to note that 12 of the 15 Medicare Demonstrations were reviewed in this 
report, so there exists some overlap in results between the AHRQ review and the CBO 
report, and to prevent redundancy these studies were excluded when reviewing this report.13   
Intervention: This meta-analysis predominantly focused on interventions in which the nurse 
case manager occupied a dominant role in the intervention. The studies were broken up into 
several categories based on population. I will be reporting results on the categories which are 
relevant to the inclusion criteria of this literature review, which includes older adults with 
one or more chronic disease, frail elderly, congestive heart failure (CHF), diabetes and 
COPD. 
Quality: The authors of this AHRQ analysis reviewed each study for quality and 
susceptibility to bias. The studies in this review were categorized into fair, moderate and poor 
buckets. The factors that define a good quality study include 
clear descriptions of the population, setting, interventions, and comparison groups; a 
valid method for allocation of patients to treatment; low dropout rates and clear 
reporting of dropouts; appropriate means for preventing bias; and appropriate 
measurement of outcomes.15 
The synthesized findings and subsequent conclusions were further categorized into evidence 
levels: low, medium and high.  
Overall Outcomes: Fifteen studies included utilization based outcomes of interest. Overall, 
the meta-analysis found that case management programs included in this review for patients 
with one or more chronic conditions did not reduce hospitalizations (3 studies, moderate 
evidence), nor overall Medicare expenditures (17 studies, high evidence). Yet, although that 
the one or more chronic disease category overall evidenced statistically nonsignificant 
results, there were certain features of the studies that displayed findings noted by the authors 
to be significant when analyzed individually. These findings included including duration of 
contact with patient, type of contact and intensity of contact with patient, and the level of 
engagement between intervention staff and primary care physicians (discussed below). 




separately, chronic homeless populations, may reduce ED visits and hospitalizations. The 
authors cited low evidence for these findings on COPD and homeless due to the low number 
of studies supporting these conclusions, even though the findings were statistically 
significant. Other findings of interest from this review were that CM programs included in 
this review, in aggregate, did not lower hospitalization admissions for patients with diabetes 
(low evidence), but do improve glucose control and management (12 studies, moderate 
evidence).  
Overall Findings: This review states that,  
The results of trials across different clinical conditions suggest that CM effectiveness 
was greater when the intervention was lengthy, high in patient contact, and included 
face-to-face (rather than telephone-only) interactions. . . . CM also appears to be most 
effective when the case manager works closely with patients’ usual care providers 
(usually primary care physicians) and/or collaborates with a physician (or 
multidisciplinary team of health care providers) with expertise in managing the 
targeted medical condition.15  
These findings align with the conclusions in the Congressional Budget Office analysis (also 
included within this literature review).20  
The authors of this AHRQ review reported inconsistent study duration, nonstandardized risk 
stratification measures, and lack of documentation for the training and intensity of 
intervention (e.g., how many face-to-face contacts in what time period) as limitations of the 
meta-analysis. This prevented the authors from analyzing these features across all relevant 
studies to gain higher powered conclusions. Regardless of the fact that not all studies in this 
review reported the data for these metrics the authors did find evidence among the studies 
which did report this data to suggest that pre-intervention training of clinical and nonclinical 
staff regarding disease-specific guidelines was correlated with more successful outcomes in 
reducing costs.15 Additionally, longer duration of intervention, more intense contact (face-to-
face visits), and longer contact time was correlated with reductions in hospitalizations.  
The following subcategories in the report are further reviewed below. 
One or more chronic diseases15 
 
Number of Studies: 20 
 
Population: Fifteen trials targeted patients with one or more chronic diseases; seven of these 
were randomized controlled trials (RCT)’s. The most frequent chronic disease diagnoses 
among study participants were COPD and CHF. I excluded the Medicare Coordinated Care 
Demonstration (MCCD trials) from this summary to eliminate redundancy as they were 
already reviewed in the CBO meta-study discussed previously.  
Intervention: Nurses served as the case managers in all of the studies included in this 
category. Out of four good to fair quality trials that examined ED visits, two RCT’s found no 




found a significant decrease in ED rates.15 No studies found overall reductions in costs for 
this population. One of the studies reviewed by the AHRQ evidenced a decrease in 
hospitalizations.40 The rest of the studies in this category that were deemed above poor 
quality evidenced no change in hospitalizations. The study with decreased hospitalization had 
more face-to-face contacts than other like-studies, and this therefore may be a factor of 
interest for improving case management models.  
Outcomes/Findings: Interventions without disease-specific care that generally target patients 
with more than one chronic diseases did not show significant results and may not be targeted 
enough to specific needs to statistically affect overall inpatient utilization or cost patterns. 
However, the authors did find that those interventions which included face-to-face patient 
contact (even with variability in how this was administered per study) were more likely to 
have improved inpatient utilization outcomes when compared to studies that did not integrate 
face-to-face to contact. 
Frail Elderly 
 
Number of Studies: 8 
Population: The frail elderly population subgroup is defined as patients who have a higher 
prevalence of functional deficits than the one or more chronic disease group. This means this 
population is at higher risk for being moved from their home to a supervised nurse or group 
setting due to a lack of functional independence. To be eligible to enroll in the studies, 
individuals had to demonstrate certain functional limitations (as demonstrated by difficulties 
with activities of daily living). The frail elderly population had a mean age of 74 to 85 years 
old.  
Intervention: The average caseload per nurse case manager ranged from 10 to 100. The 
duration of follow-up ranged from 3 to 24 months. Six out of the eight studies involved a 
home visitation component. There were eight RCT’s for this category, and four of them were 
rated good quality. 
Outcomes: The primary outcome of interest was whether the intervention helped maintain 
functioning, thereby delaying nursing home placement. Seven studies used hospitalizations 
as a study outcome. Overall, the frail elderly studies showed no difference in hospitalizations 
between intervention group with case management and the comparator group without case 
management. Two studies showed decreases in hospitalizations, but one was conducted in 
Hong Kong, and another had an N of less than 50 limiting both generalizability and power. 
None of the studies deemed fair to good quality showed statistically significant reduction in 
hospitalizations between study and control group. Two US trials looked at ED visits, with 
none showing a decrease in ED rates between the CM (study group) and comparator group. 
Studies produced mixed results on the effect of CM on overall costs, all of the studies rated 
good quality showed no difference in costs between the two groups. The one or more chronic 
disease group showed evidence (albeit low) of reduced hospitalizations associated with 
certain programmatic characteristics such as face-to-face visits, duration of contact, and 




Findings: The studies included in this category failed to produce statistically significant cost 
savings or evidence of reduced utilization in aggregate. The population selection criteria may 
be too broad (not disease or social issue specific) and/or the population may be too sick to 
affect the trajectory of health through intervention activities. Additionally, the intervention 
activities including in this set of studies may have been too varied to measure the effective 
components. 
Congestive Heart Failure (CHF) 
 
Number of studies: 12 
Population: Individuals with a CHF diagnosis. The mean age of participants across these 
studies varied from 60 to 80 years old. Participant enrollment was triggered by an acute 
hospitalization in most of the studies.  
Intervention: Six interventions employed home-visits and four used face-to-face clinics, the 
remaining intervention used only telephonic contact. Duration of follow-up ranged from 3 to 
18 months.  
Outcomes: Nine of the CHF studies used hospitalization admission rates as outcomes. Four 
of these studies showed lower hospitalization rates, with three also showing lower total costs 
of care, while five showed no difference. In selecting out only the studies rated as high-
quality by AHRQ (4), two showed reduced hospitalization rates and two showed no 
difference. Six total studies (of varying quality) in the CHF category analyzed the impact on 
total cost of care with three studies reporting reductions. Three studies selected patients for 
the CHF intervention who were at high-risk for readmission (all three studies included recent 
prior hospitalization as a criteria). Two out of three of these studies showed lower 
hospitalization rates and reduction in costs, while three of four studies that enrolled patients 
that were identified as low risk or general population showed no change in hospitalization. It 
is also of note that the acuity of the patient’s CHF condition (moderate to severe) did not 
affect the impact of CM on any outcomes. The reduction in all-cause hospitalizations were 
primarily driven by reduction in CHF related admissions. Two of the studies that showed a 
positive difference in readmissions used clinical indicators to select patients, while the study 
that only used social and behavioral factors showed no impact on readmissions. The authors 
examined the hospitalization rates of the control group, and noted that the studies that 
evidenced a reduction in inpatient acute utilization selected populations with higher 
admission rates to begin with. Studies which reported the duration of contact made with 
patients in the home were not correlated with reduced utilization in the CHF population. 
Most CHF interventions were based on clinical-only activities (ex., medication review) as 
opposed to coordination related activities (transportation/appointment scheduling/follow-up 
on durable medical equipment arrival). Of the two studies where nurses managed 
medications, only one showed positive outcomes.  
Findings: The CHF subgroup responded to care management interventions as a whole more 
readily than other groups. This may be because of the modifiable nature of CHF related 
admissions, and/or specific intervention activities targeted towards specific disease-related 




identifying the patients who would benefit the most from CHF specific interventions. 
Further, clinically based interventions were effective in reducing CHF related-admissions. 
Intervening during high-need periods, such as the time period post hospitalization in CHF 
populations with increased baseline risk of admissions/readmissions appears to be an 
effective targeting strategy leading to better results with reduced utilization or increased 
return on investment (ROI).  
Chronic Obstructive Pulmonary Disorder (COPD) 
 
Number of Studies: 3 
Population: Individuals with a COPD diagnosis.  
Intervention: The COPD studies focused on disease self-management as well as self-
administration of medications conducted through in-person education sessions (all studies) 
and follow-up telephone support (two studies).  
Outcomes: Out of the three good quality COPD studies included in the AHRQ review, all 
three showed a reduction in hospitalizations. Two of these three reported statistically 
significant differences. One observational COPD study reported reduced ED visits, while in 
another clinical trial, the group with CM had half as many ED visits over one year. The 
severity of COPD did not appear to affect the outcomes as there was no difference in 
admission rates across COPD acuity rated subgroups.  
Findings: According to AHRQ report, COPD was one of the diseases most significantly 
affected by care management interventions and particularly by self-management and health 
education. COPD also has a high correlation with co-occurring CHF, in 35% of the 
individuals in the studies. This suggests that disease management interventions for COPD 




Number of Studies: 12 
Population: Five trials examined only individuals with Type II diabetes. Five clinical trials 
focused on populations with lower socioeconomic status, while four targeted low health 
literacy and diabetes. The mean age ranged from 48 to 71. 
Intervention: The duration of these studies ranged from one to five years, but only one study 
followed patients for five years. In seven of the 12 trials, face-to-face case management was 
the primary mode of intervention delivery. The interventions used a combination of health 
literacy building, nutrition counseling, and drug management.  
Outcomes: Out of two trials that examined ED visits, one showed a slight decrease between 
study and comparator group and another showed no difference, producing conflicting 
evidence. Neither of the two trials that examined hospital admission rates showed a 
difference. Because only three trials examined utilization criteria, the strength of evidence to 




studies was large, this introduces additional confounders in assessing the efficacy of diabetes 
based interventions on elderly populations. 
Findings: The diabetes interventions were effective in controlling specific clinical factors 
such as blood glucose, but did not translate into statistically significant acute utilization 
reductions or cost savings.  
Patients with Other Medical Problems 
 
# of Studies: 15 
Population: This category included studies that did not fall neatly into any of the other 
aforementioned categories. This includes populations that are low income with limited access 
to clinical services, and those who need housing placement transition services post 
hospitalization—such as the homeless.  
Intervention: Intervention activities varied widely, but included housing placement, and 
dedicated coordination personnel to ensure clinical access.  
Outcomes: There were nine trials and six observational studies. Only one observational trial 
targeting high ED and hospital utilizers showed reduction in ED visits, as did the study 
targeting transitional care for the homeless. The study targeting the homeless utilized case 
management for 18 months which included housing placement services. The study focused 
on high-utilizers employed a social worker as the central point of care coordination. Neither 
of these trials showed a difference in hospitalizations. 
Findings: Populations with social needs, such as high ER utilizers and/or homeless individual 







Congressional Budget Office: Lessons from Medicare’s Demonstration Projects on 
Disease Management and Care Coordination (2012)20 
 
Type of Study: Meta-Analysis 
Number of Studies: 34 
Population: The Congressional Budget Office (CBO) prepared a report of 34 Medicare 
demonstrations serving high-need Medicare beneficiaries.20 These demonstrations were 
conducted on FFS Medicare populations in varied states, and in varied locations (rural versus 
urban). The study populations were divided into several categories including high-cost, duals 
(Medicare and Medicaid beneficiaries), or beneficiaries with one or more chronic 
conditions—one of which one had to be CHF, COPD, or diabetes.  
Quality: All Center of Medicare and Medicaid services (CMS) demonstrations as part of the 
(Center for Medicare and Medicaid Innovation) CMMI initiative were included in this report. 
To reduce bias, randomized controlled trial designs were employed in 30 out of the 34 
demonstrations. All demonstrations utilized a controlled group which was matched to the 
intervention based on demographics and disease acuity.  
Intervention: A randomized design was used in 30 out of the 34 demonstrations. Intervention 
activities for this population varied, but the below characteristics were specifically explored 
through pooled analysis:  
 
1. Intensity of patient contact, telephone versus in-person 
2. Program integration with physicians and assigned nurse case managers 
3. Effects of population targeting and selection on outcomes (reduced net savings and 
reduced readmissions).  
4. Training, experience of staff 
5. Pharmacist led interventions 
 
Outcomes: The authors examined reductions in net costs, admissions, readmissions, and/or 
emergency department (ED) visits as the outcomes of interest.  
Care managers and physicians had substantial contact with each other in seven of the 34 
demonstrations. Out of these seven, four demonstrations decreased hospital admissions by at 
least 10%. Out of the four that decreased hospital admissions by at least 10%, three of these 
programs (75%), also employed high-intensity face-to-face contact with patients. All three of 
these programs used a randomized study design. These programs were Massachusetts 
General Hospital (MGH) (N = 6800 | 3400 = treatment 3400 = control), Mercy Medical 
Center (Mercy) (N = 1392, 696 = treatment, 696 = control), and Healthy Quality Partners 
(HQP) (N = 1016 treatment, 2,219 = treatment + control).41-43 Eight of 34 programs had high-
intensity, face-to-face contact with patients and three of these eight decreased hospital 
admissions by at least 10%. None of the 23 programs that did not have either substantial 
contact with patients or physicians experienced a reduction in admissions by more than 6%. 




Findings: Face-to-face contact with patients showed a significantly greater impact in the form 
of reduced inpatient utilization, and may be a required but not sufficient key characteristic of 




Effectiveness of Case Management for “At Risk” Patients in Primary Care: A 
Systematic Review and Meta-Analysis (2015)23 
 
Type of Study: Meta-analysis 
Number of Studies: 36 
Population: Eighty-three percent of the 36 studies specifically targeted elderly populations. It 
was not clear if the studies varied in the age-cut off for the definition of elderly. The mean 
age across all studies was 75 years old. The follow-up duration ranged from six to 60 months. 
The studies were all targeted to adults with one or more chronic diseases. The authors of this 
meta-review excluded studies that focused solely on mental health conditions (unless they 
were present alongside with chronic comorbidities), transitional care, or studies from only 
grey literature. 
Quality: Seventy-eight percent of the studies were RCT’s. Sixty-four percent of the studies 
were deemed high-quality through the EPOC (Cochrane Effective Practice and Organization 
of Care) risk of bias tool.44 Studies deemed high-risk of bias were excluded from the author’s 
analysis. 
Intervention: The overarching objective of this review was to synthesize outcomes for 
interventions to determine the effectiveness at the primary care level for at-risk patients, as 
well as to evaluate whether this effectiveness is impacted by a variety of study characteristics 
including design and implementation method. In this review, case management was defined 
as all of the following activities: case selection and assessment, care planning, coordination, 
and monitoring. The comparison group was usual or standard care. Eight-nine percent of the 
studies utilized some form of risk tool to select patients for the case management 
intervention, while 11% utilized clinical judgement. Fifty-eight percent (21) of the studies 
employed an MDT approach. Thirty-three percent (12) of the studies used a social worker as 
part of the MDT. Only three studies or 8% were targeted to disease-specific groups (e.g., 
COPD/CHF).  
Outcomes: The authors conducted a subgroup analysis for the studies in which 10 or more 
individual studies contributed to the effect size.  
The primary outcomes of interest to this review were long and short term effects on ED 
visits, admissions, readmissions and hospital days. Overall, no significant differences in 
expenses were found between comparator and study groups. A subgroup analysis was 
conducted that looked at single nurse versus MDT (MDT), RCT versus non-RCT, and social 
worker versus no social worker. For the outcomes of interest (cost and hospitalizations), the 
subgroup analysis showed an effect (statistical significance (p<.05) ) for studies that 
measured a reduction in hospitalizations over 13+ months for case management interventions 
that employed a social worker as part of the MDTs (MDT). There were no other significant 
findings in the subgroup analyses. 
Findings: Overall, the studies showed no significant effect for cost-savings or utilization, but 




managers was found to be statistically significant in subgroup analyses for interventions that 
statistically significantly reduced inpatient utilization in adults with chronic disease. The 
authors also mention MDTs as a beneficial feature of successful interventions, but the pooled 




Models of Care for High-Need, High-Cost Patients (2015)18 
 
Type of study: Evidence Synthesis 
Number of studies: 123 
Population: Patients with complex needs that are high cost (contributing to a disproportionate 
share of costs) or predicted to be high-cost in the future. Mean age was not reported. 
Quality: Quality was determined by strong design, adequate sample, valid measures, reliable 
data collection and rigorous data analysis as reported by the authors.  
Intervention: The review conducted through the Commonwealth Fund by McCarthy et al., in 
2015 summarized the results of 15 care models in 123 studies. Many of these studies were 
larger evidence syntheses. This made it challenging to isolate key factors across individual 
studies.  
The authors grouped the 123 studies into four relevant care models which were further 
broken down into subcategories based on intervention activities. The major care models 
included interdisciplinary primary care (not divided into further subcategories), 
enhancements to primary care (divided into eight subcategories), and transitional care (not 
divided into further subcategories).  
Outcomes: The enhancements to primary care showed the most promising results overall in 
regards to reduced ED visits and admissions. This category was further divided into general 
care management, disease management, preventive home visits, geriatric evaluation and 
management, pharmaceutical care, chronic disease self-management, proactive rehabilitation 
and caregiver education and support. Five out of eight subcategories (disease management, 
preventative home visits, pharmaceutical care, chronic disease self-management and 
caregiver education and support), showed reduced acute care utilization metrics, two 
produced mixed results (care and case management, geriatric evaluation and management), 
the remaining category, proactive rehabilitation, did not show any reductions in ED use or 
hospitalizations.  
Transitional care (not broken down into further subcategories) showed positive outcomes in 
both use and cost (only expenses not total spending). 
The interdisciplinary care model studies included Guided Care, GRACE, IMPACT and 
PACE and showed mixed results on cost, but positive results on reduced utilization. The only 
other relevant cost saving categories were transitional care and interdisciplinary primary care, 
however this was only for heart failure patients.  
Findings: McCarthy et al., synthesized common attributes from studies they found to be 
successful. Success was defined as meeting expected endpoints of reduced cost and reduced 






• Targeting/Risk stratifying individuals; 
• Interdisciplinary team work; 
• Evidenced based medication management; 
• Reliable IT platforms. 
 
The categories which showed positive results in the form of decreased utilization were: 
interdisciplinary primary care, disease management, preventive home visits, pharmaceutical 
care, chronic disease self-management, caregiver education and support, and hospital-to-
home transitional care. Mixed results were seen for utilization in care and case management, 
and geriatric evaluation and management. It was not well-defined what care and case 
management included in this study, and how it overlapped or was differentiated from 
interdisciplinary primary care and disease management.  
Risk-stratification or population targeting, interdisciplinary team integration, and patient-
centered care were consistent themes of cost-savings and/or utilization reducing care 
interventions. Yet, it was challenging in this review to isolate the results to a particular 





Caring for High-Need, High-Cost Patients: What Makes for a Successful Care 
Management Program? (2014)19 
 
Type of study: Evidence Synthesis 
Number of studies: 18  
Population: 10 studies out of 18 targeted Medicare/Medicaid populations at high-risk 
(defined below) for poor outcomes. Five out of 10 targeted Medicaid populations, three out 
of 10 targeted Medicare only populations and two out 10 targeted both Medicaid and 
Medicare populations. The mean patient age was not reported.  
Quality: US Preventive Services Task Force Methodology was used to evaluate the quality of 
the evidence level of each included study.  
Intervention: Seventy percent of the care programs employed a high-risk stratification 
strategy to select which populations to intervene on. Risk scores were used by six out of 
seven studies that stratified patients by high-risk. Diagnosis of chronic conditions was used in 
five studies. Utilization history was used in four, referral by physician in three, and 
medications in one. It is important to note that several of these factors may also have been 
incorporated into the risk score category. 
High-risk was defined differently for each study, with all combining some form of the 
following criteria: 
1. Risk scores predicted by proprietary and commercially available algorithms2 
2. Recent utilization patterns 
3. High cost  
4. Diagnoses of chronic conditions, number of and type of chronic disease 
5. Physician Referrals  
6. High-risk medications 
 
The specifics of each individual case management programs were not discussed in this 
review. Instead, the authors defined complex care management programs as those that 
perform four essential activities:  
1. Identifying and engaging patients who are at high risk for poor outcomes and 
unnecessary utilization. 
2. Performing comprehensive health assessments to identify problems that, if 
addressed through effective interventions, will improve care and reduce the need 
for expensive services. 
3. Working closely with patients and their caregivers as well primary care, specialty, 
behavioral health, and social service providers. 
4. Rapidly and effectively responding to changes in patients’ conditions to avoid use 
of unnecessary services, particularly emergency department visits or 
hospitalizations.19 
                                                 




Care teams were predominantly led by a nurse case manager, but harder-to-engage patients 
with social/behavioral needs may also have included a social worker or lay community health 
worker. Caseloads throughout the review varied from 25 to 500 patients per case 
management team, though not all patients were active or sick when assigned to a care team, 
therefore total caseload may not be an accurate indicator of total capacity. In this review, 
case managers were connecting with patients (both face-to-face and over the phone) from 
once weekly to once monthly.  
Outcomes: Nine out of 10 studies reported a decrease in admissions, one did not report 
admission data. Eight out of 10 studies reported a decrease in ED visits, and eight out of 10 
reported a decrease in cost of care with one study only reporting a decrease in costs of care in 
Year 2.19 Costs savings were achieved in five out of seven of the care models that used high-
risk stratification at levels of at least 10% cost savings each. Two studies did not have 
sufficient information to calculate cost savings. In the three programs not using high-risk 
stratification as a strategy, two reported cost data. One showed a 3% decrease in costs, the 
other showed a 5% decrease in Year 2. (The other study did not report cost data.) 
Findings: The authors identified several successful care intervention strategies from the 
successful studies:  
• Selecting the right patients for the most appropriate programs. The authors note 
particular importance of including acute utilization in the stratification 
methodology to help target high-risk members. 
• MDTs that are able to address complex issues in patients with comorbidities 
• Shared information platforms  
• In-person multidisciplinary meetings.  
• Risk stratification of populations that includes a combination of risk prediction 
software, chronic disease identification and utilization in combination with 





Case Management Effectiveness in Reducing Hospital Use: A Systematic Review 
(2016)27 
 
Type of Study: Evidence Review 
Number of studies: 10 
Population: The purpose of this review is to evaluate the effectiveness of transitional care 
management programs internationally, including the United States. Fifty percent of the 
studies were US based. The mean age of participants was 61.7. The studies in this review 
targeted individuals with chronic disease and/or social issues for the case management 
interventions. Examples of studies that targeted particular groups include low-income 
African American populations with diabetes, elderly individuals with functional impairment 
and chronic disease comorbidities, and homeless populations with uncontrolled chronic 
disease. Control groups for all studies were usual care, which varied by location and 
population. The authors did not measure heterogeneity, but reported substantial variations in 
intervention deployment making the studies challenging to directly compare to one another. 
The mean follow-up period was 1.75 years.  
Quality: The quality of studies was assessed using the Jadad scale which assesses the risk of 
bias in RCT’s using three primary components: randomization, double blinding and 
withdrawal of patients from the study (lost to follow-up).  
Intervention: All 10 studies were based around MDTs which included a combination of 
physicians, social workers and nurses. Most of the interventions were triggered by a 
hospitalization and services conducted right after hospital discharge. The most common 
transitional care services were: telephonic management, individual assessments at discharge, 
referrals to social services and supports, and education or self-management supports. The 
individual study activities varied and will be reported under outcomes.  
Outcomes: The authors reported outcomes including ED visits, healthcare costs, admissions, 
readmissions, and hospital days. No study reported on all five outcomes. The only outcome 
every study reported on was readmissions. 
Three studies reported a statistically significant reduction in re-admissions (studies primarily 
measured 30-, 60-, or 90-day readmissions.). All three studies which reported significant 
reduction in readmissions targeted individuals with chronic illness. Melton et al. (2012) (N = 
3988), targeted individuals with diabetes, asthma or coronary heart disease (p = <.05 for 30 
day readmissions, p = .01 for 60 day readmissions). Chow and Wong (2014) (N = 281), 
selected older adults with chronic conditions (p = 0.0005) and Sadowski (2009) et al. (N = 
405) targeted homeless adults with chronic illness (p = .018). It is of note that Chow and 
Wong, and Sadowski et al., received the highest quality scores out of the 10 studies on the 
Jadad quality scale. Melton et al, received the lowest score when compared with the 10 other 
studies on the Jadad scale. Three other studies reported reduced readmissions but the change 




Chow and Wong (rated high-quality) targeted older adults (mean age = 76.5) with chronic 
illness. The follow-up period was 2 years. The intervention offered a nurse-led home visit 
post discharge, followed by a supplemental call. The nurses used motivational and 
empowerment approaches. Readmissions were reduced significantly at 90 days (this effect 
was not shown for 30 days). The home visit plus telephone call intervention group had a 
lower readmission rate than the telephone only intervention group by 5%. It was not reported 
whether this difference was statistically significant.  
Sadowski et al., (N = 405) targeted homeless adults with chronic illness. Case management 
was offered (at a community site), as well as at transitional housing services for all study 
participants. The results evidenced a statistically significant reduction in ED visits (24%, p = 
0.03) and readmissions at (29%, p = .0005) at 18 months of follow-up.  
Two studies reported hospitalization rates, and both showed a statistically significant 
reduction, but each study had an N less than 200, rendering the results in the absence of a 
pooled analysis statistically unreliable (Reinius et al., 2013 and Sandberg et al., 2014). Two 
studies reported healthcare costs, and one of the two reported a significant reduction in costs 
(Reinius et al., 2013). 
Only two out of 10 studies had an N over 500. One of these studies showed no difference 
found in any outcome measures (N = 945, intervention = 611, control = 309) (Farris et al.), 
the other showed a statistically significant reduction in readmission rates (N = 3988, 
intervention = 1994, control = 1994; Melton et al.) by employing telephonic case 
management to connect heart failure commercial patients to physicians.45 The latter study 
was conducted on commercial patients, and possessed a low quality score. Therefore, it may 
not have applicability to Medicaid or Medicare populations. The remaining four studies that 
targeted the populations of interest did not show any statistically significant results.  
Findings: A majority of these studies did not have a large enough population size to produce 
the statistical power needed to reliably conclude the reported results based on the effect size 
of similar studies. The studies that had populations size over 500, and produced statistically 
significant results were deemed low quality on the Jadad scale. One study evidenced 
statistically significant reductions in readmissions with a population similar to the target 
population of this review, but the study only had an N of 281, and was conducted in China 






A Systematic Meta-Analysis of the Efficacy and Heterogeneity of Disease Management 
Programs in Congestive Heart Failure (2006)17 
 
Type of Study: Meta-analysis 
Number of Studies: 36 
Population: This meta-analysis analyzed the effect of disease management programs (DMP) 
on elderly patients (mean age of 72) with the diagnosis of CHF (usually with the 
accompaniment of additional morbidities). 
Quality: The statistical analysis of the included studies controlled for heterogeneity and other 
biases. Begg’s funnel plot and the rank correlation test was used to assess publication bias. 
The I2 statistic (a heterogeneity measure) for studies, utilized as a measure of quality for 
pooled analyses, reported readmission I , 51.9%, which was statistically significant and 
indicates a large amount of variation among studies in the pooled analysis. The factors most 
responsible for heterogeneity were team composition (60%), followed by intervention mode 
(17%). When two outlier studies (based on nonoverlapping confidence intervals) were 
removed, the I statistic fell to a nonsignificant 23.6%, with only a minor change in the 
readmission absolute risk difference between control and intervention arm to a still 
statistically significant 7% (95% CI of 5-10%). 
 
Intervention: Disease management programs were defined by the authors as programs that 
focus on education, coordination and continuing support after discharge from the hospital. 
The DMP’s are primarily led by nurses, and may also include physicians, social workers, 
pharmacists and PCPs.  
Ten of the 32 studies utilized home-visits, all of these studies included at least one home visit 
post hospitalization. Five studies had more than a nurse and a physician on the care team 
delivering the intervention (pharmacist or social worker) and four of these five (80%) were 
interventions that utilized home visits. Thirty-nine percent of the studies used transitional 
care as a component of the disease management program, 28% used telephone calls only, 
33% integrated the program with the primary care physician and 25% used medication 
review. Follow-up duration varied from three to 18 months, with a median duration of 9 
months.  
Outcomes: The statistic of risk difference (RD) was used to measure hospitalization rates. 
Thirty-two of the 36 (89%) studies reported all-cause readmissions. Six of these 32 (19%) 
reported statistically significant reductions. Gohler et al conducted a pooled meta-analysis of 
the studies reporting all-cause readmissions and found a significant reduction in the DMP 
intervention arm with an absolute risk reduction of 8% (with an NNT of 13). For subsequent 
readmissions (second and third readmissions) the adjusted effect rises to an absolute 
reduction of 19% (NNT of 5). This means the intervention was more effective at reducing 
subsequent readmissions. 
Of note in subgroup analyses was the difference in intervention mode (face-to-face contact 




significant difference in reduced readmissions over telephonic contact only. Face-to-face 
contact evidenced a -10.5% decrease in readmissions (NNT of 9), while telephone evidenced 
a -3.6% (NNT of 27) decrease in all-cause readmissions. This provides evidence that face-to-
face interaction may be increasingly more effective as patient risk increases during the 
postdischarge transitional period.  
Readmission risk reductions were -8.6% for programs with a transitional care component, 
and -6.1% for programs without a transitional care components. This was not a statistically 
significant difference. There was an also an effect found for MDTs; teams with more than 
three professionals evidenced a statistically significant risk difference for all-cause 
readmissions of -18.1%, compared with teams that had less than three disciplines included in 
the team. This finding is consistent throughout the literature. Outcomes for US programs 
versus non-US programs showed no effect, and duration of follow-up showed no effect.  
Findings: Disease management programs showed a statistically significant difference in all-
cause readmissions for patients with CHF. Programs that were particularly effective at 
reducing readmissions were those that used face-to-face contact and those that employed 
MDTs. The meta-analysis also produced evidence that the impact of disease management 
programs increases when attempting to prevent subsequent admissions after the index or 
initial admission. In other words, targeting increasingly vulnerable transitional periods as a 





Evidence-Based Synthesis Program Evidence Brief: Effectiveness of Intensive Primary 
Care Programs (2013)28 
 
Type of study: Meta-analysis 
Number of studies: 20 
Population: Patients identified as high risk for hospital admission and/or death. No disease-
specific diagnosis required. This meta-analysis reviewed 20 studies. I focused my analysis on 
the two studies that were assessed as good quality (defined below), and which were 
successful in significantly reducing admissions and ED utilization: GRACE (Geriatric 
Resources for Assessment and Care of Elders) (N = 951) and PACE (program of all-inclusive 
care for the elderly) (N = 3889) studies.29,30  
The GRACE study was an RCT and the population was selected based on age (>65), low 
income level (<200% of the FPL) and low access to outpatient healthcare services (N = 951). 
Eighty-one percent of patients had hypertension, 34% diabetes, 22% chronic lung disease and 
13% heart failure. The mean age was 72. Almost half of the individuals were living alone and 
the majority of patients had functional disabilities. 
The PACE intervention targeted the Medicare population. The mean age was 80 years, and it 
is of note that most of the patients (74%) were female. The intervention targeted nursing-
home eligible individuals who were 55 or older. Half of the patients had deficiencies in 
activities of daily living. A control group of a similar population of community-dwelling frail 
elderly was used as a comparator. This study was observational.  
Quality: Quality of study bias was rated using the Cochrane Collaboration Tool. Internal 
validity was rated using DERP (Drug Effectiveness Review Project). Strength of evidence 
was rated using the Evidenced Based Practice Center Program from AHRQ. 
Intervention: The GRACE model was an RCT conducted on 951 patients split into a high-
risk subgroup. High risk was determined by a PRA (probability of repeated admission) score 
of .4 or higher. This score is determined by a questionnaire that gathers information on age, 
sex, comorbidity status, functional deficiencies, self-reported health status, recent utilization 
and social support. Control groups were matched using propensity score weighting on a 
Medicare population. 
The GRACE intervention integrated interdisciplinary teams including an advanced practice 
nurse and a social worker into the patient’s regular primary care practice to enhance care 
continuity for participants. The GRACE model delivered services at a free-standing clinic 
where more intense care was given to a select subgroup of patients based on need. A salient 
characteristic of the GRACE model was integration with pharmacy, mental health, home 
health, inpatient and community-based services. Further, it was noted that the GRACE model 
used an integrated electronic medical record system across all of its providers. There was a 
minimum of one in-home follow-up visit required followed by at least one subsequent 




The PACE model provided care management through an MDT approach consisting of 
PCP’s, nurse practitioners, social workers, dieticians, pharmacists, and lay community 
workers. Services were delivered inpatient, in home, and in adult day care centers. Visit 
frequency was not reported. For the PACE model, it is also of note that financing for the 
model was integrated through capitated per member, per month payments, similar to 
managed care/health maintenance organization models. This study was observational.  
Outcome: The GRACE model evidenced a significant reduction in ER visits (in Year 2) (p = 
.03) for the full sample of patients including the high-risk group, and a statistically significant 
reduction in hospitalizations in Year 2 (p = .03), but only in the high-risk subgroup. There 
were not statistically significant results for Year 1 outcomes in terms of reduced inpatient 
utilization in either group. PACE was shown to statistically significantly decrease acute 
hospitalizations by 48% over two years.  
Findings: The GRACE and PACE models are two examples of case management 
interventions that have successfully reduced readmissions and ED visits for the elderly 
population with chronic diseases. However, the observational nature of the trials may reduce 
their generalizability and increase the probability of a variety of biases. It is also of note that 
results for the GRACE model were not achieved until Year 2. Both of these studies were also 
identified as successful models in two other meta-analyses included in this literature review, 






Innovative Home Visit Models Associated with Reductions in Costs, Hospitalizations, 
and Emergency Department Use (2017)21 
 
Type of Study: Evidence Review 
Number of Studies: 3 out of 6 were relevant to the target population 
Population: Three studies in this review focused on Medicare home visitation models for 
patients with one or more chronic diseases. Mean age among studies was not reported.  
Quality: Quality was not reported in this evidence review due to the low number of studies, 
but the included studies are well-regarded in the literature as high-quality.  
Intervention: The interventions outlined in this review were primarily delivered through lay 
community workers, and in some cases either health educators or RN’s. All of the programs 
included home visiting as a component of the intervention. As the authors state, “some of the 
models used the home as a context for understanding beneficiary functioning, to inform 
person-directed care plans, and to address safety hazards by making modifications.” The 
relevant models analyzed were Johns Hopkins’, CAPABLE (Nursing Community Aging in 
Place, Advancing Better Living For Elders) (N = 171), DASH (Doctors Assisting Seniors at 
Home) (N = 1,112), and Indiana Universities’ ABC (Aging Brain Care) (N = 1,244). Out of 
the three relevant models analyzed, registered nurses led two (CAPABLE and DASH). 
DASH offered home-visits as needed and its purpose was to help older adults avoid ED 
utilization. CAPABLE delivered 10 home-visits over a 5-month period with the objective of 
improving functional home safety to delay nursing home placement and reduce 
hospitalizations and ED visits. Of note, DASH and CAPABLE also serviced dual 
beneficiaries, and concentrated on supporting the connection to the primary care provider. 
All models included a care coordination component, which meant that home visit staff share 
information obtained from the home visit with the patient’s clinicians, including the primary 
care physician. All models also offered some form of health education. Two of the models 
(ABC, DASH) offered disease management. For one model (DASH) this included 
medication reconciliation. Two models offered referrals to other community-based services 
(CAPABLE, DASH), and two models offered home assessments which identified and 
addressed hazards in the home (ABC and CAPABLE). The review period was 2010-2015. A 
control group was created using one-to-one propensity matching as well as matching 
individuals with similar geographic areas, and clinical (hierarchical condition category), and 
social factors. A difference-in-difference approach was used to evaluate model outcomes for 
two years before the model and up to three years after beneficiary enrollment in the model. 
All models were adjusted for demographic characteristics, comorbidities, and cost and 
utilization.  
Outcomes/Findings: The DASH model included care coordination, education, community-
based referrals, and advanced care planning, but not environmental assessment or home re-
design. Statistically significant reduction (p < .05) in hospitalizations and ED visits were 
shown in the DASH model over a three-year period. The CAPABLE model included care 
coordination, education, community-based referrals and an environmental assessment and re-




for the CAPABLE model (p<.05) over a 2-year period. The authors note that home-visits 
were one of the most observable common trends among successful components of the 
models in terms of reducing ED visits and hospitalizations for these populations. No relevant 





Clinical Service Organisation for Heart Failure: A Cochrane Review (2012)24 
 
Study Type: Meta-analysis 
Number of studies: 25 
Population: The mean age was 67 years old. This review targeted RCT studies on adult CHF 
patients that had been admitted to the hospital for the condition within the past 12 months.  
Quality: Quality of the studies were assessed based on the Cochrane Risk of Bias criteria: 
sequence generation, allocation concealment, and selective reporting. Additionally, the 
quality of studies were reported using the Delphi quality assessment. All of the included 
studies discussed below were determined to be at low-risk for bias and to have outcomes of 
interest relevant to this literature review. 
Intervention: The studies were broken up into case management postdischarge interventions 
(17 studies), postdischarge clinic interventions (6 studies), and multidisciplinary 
interventions (2 studies). Case management interventions included a combination of 
postdischarge home visits and follow-up telephone calls.  
Case management was defined as “the active management of high-risk people with complex 
needs, with case managers (usually nurses) taking responsibility for caseloads working in an 
integrated system.” These studies primarily involved telephonic case management support 
with goals such as weight management, and health education. 
Outcomes: Results were reported through odds ratios, which is a measure of association 
between outcome (inpatient utilization) and exposure (intervention participants). Case 
management interventions reduced CHF related readmissions over 6 months (N = 655, three 
studies, I2 = 0%). However, in studies that included HF readmissions beyond 6 months (N = 
1726, seven studies), it is also important to note that these latter studies showed substantial 
statistical heterogeneity, through the I2 statistic (I2 = 76%), which downgrades the evidence 
level. All-cause readmissions for greater than 6 months follow-up were significantly reduced 
(N = 2199), with an odds ratio confidence interval of .75 (.57 to .99, p = .05). 
Multidisciplinary interventions were defined as “a system of coordinated healthcare 
interventions and communications for populations with long-term conditions in which patient 
self-care is significant.” Five studies were delivered by MDTs of two or more professionals, 
but only two had outcomes of interest. Out of these two studies the treatment group showed a 
statistically significant decrease in both all-cause (p = .0002) and heart failure related 
readmissions at 12 month follow-up. Additionally, the multidisciplinary interventions 
significantly reduced readmissions and showed a statistically significant reduction in hospital 
bed days 6 months post index hospitalization.  
Eight studies (N = 1868) were deemed as having the most intense interventions (duration and 
frequency of services provided), 10 studies were deemed moderately intensive (n = 3126), 
and the rest low intensity. There was no statistical difference in reduction of utilization 




A heart failure specialist nurse led the intervention in twelve of the studies. Specialist nurse 
led studies primarily included home visits. Of those studies that reported readmissions with 
specialist nurses (6 studies, n = 1381), they were found to decrease heart failure related 
admission in five out of the six studies. (p = .002). Three studies were led by community 
pharmacists and one out of three showed an effect on heart failure related readmissions (p = 
.04).  
Six studies reviewed the efficacy of heart failure clinics, of which there were no significant 
outcomes. There were no other reported significant effects in the subgroup analyses.  
Findings: Case management and MDT interventions with two or more professionals in 
different fields may decrease readmissions for patients with heart failure. Additionally, the 
skills of heart failure specialist nurses may be particularly useful in preventing heart-failure 





Transitional Care Interventions to Prevent Re-admissions for Persons with Heart 
Failure: A Systematic Review and Meta-analysis (2014)31 
 
Study type: Meta-analysis 
Number of Studies: 47 
Population: This review focused specifically on the transitional care period post 
hospitalization to community settings in adults hospitalized for HF. The mean age was 70 
years old with moderate to severe HF. The age and reason for inclusion in studies (HF related 
admission) makes this population generalizable to Medicare beneficiaries. All patients 
enrolled in the study were recruited within one week of an index hospitalization for HF. 
Patients with severe cardiovascular disease and/or end-stage renal disease were excluded 
from the studies.  
Quality: Studies were rated for quality based on the AHRQ methodology and each study was 
determined to be low, medium, high or unclear in terms of risk of bias. Studies with high or 
unclear bias were excluded from the meta-analysis.  
Intervention: All studies involved some type of transitional postdischarge intervention from 
an acute inpatient facility. The categories of interventions analyzed in this study were 
differentiated by mode of delivery including home-visitation programs, structured telephone 
support (with set clinical goals and number of calls), tele-monitoring, outpatient clinic, 
educational, and other (studies that did not fit into the aforementioned categories). Fourteen 
studies used home-visitation and five of these used only one comprehensive visit, while the 
remainder had several home visits. In the trials that had home visits almost of them required 
nurses to conduct home visits within seven days of discharge. Thirteen trials used structured 
telephone support compared with usual care, and most trials averaged one to two calls. Eight 
trials studied tele-monitoring evaluations, seven used outpatient clinic models, and four used 
patient education based strategies. 
Outcomes: Outcomes were reported in terms of risk ratios. The outcomes of interest reported 
were HF-specific readmission over 30 days and over 3–6 months, and all-cause readmissions 
over 30 days and over 3–6 months. Not all studies reported all of these outcomes.  
The authors concluded that home visitation programs were effective in reducing 30 day all-
cause readmissions. Home-visitations were successful in reducing all-cause (NNT = 9, N = 
1563) and HF-specific readmissions (NNT=7, N = 282) measured over a period of 3–6 
months, as well as all-cause readmissions measured over a period of 30 days (NNT = 6, N = 
418). Additionally, a high-intensity (8 planned home visits, the first within 24 hours of 
discharge) home visit intervention performed better when compared to medium (more than 
one episode of patient contact) and low intensity (one episode of patient contact). 
Telephonic support reduced HF specific readmissions over 3–6 months (N = 1790), but not 
all-cause readmissions for any time period. Of additional interest, the subgroup analysis 
conducted on home-visitation programs that reported HF specific readmissions over 3–6 




outcome (eight studies) showed that the NNT to prevent one HF related readmission via 
telephone support was 14, and for home visits that number decreased to seven. This is a 
relative 100% increase in efficacy. This further corroborates the effectiveness of home visits 
when compared to telephonic only management in regards to the outcome metric 30 day all-
cause readmission.  
Findings: Home visits may prevent all-cause readmissions in heart failure patients over 30 
days and over 3–6 months. Home visitation is approximately twice as effective as preventing 
HF specific readmissions over 3–6 months when compared with structured telephonic 
support. Structured telephone support was not effective in preventing HF specific admissions 
over 30 days (but was for HF specific admissions when measured over 3–6 months), nor was 





Comparative Effectiveness of Transitional Care Services in Patients Discharged from 




Number of Studies: 53 
Population: At the time this review was published in 2016, it represented the largest 
collection of RCT’s evaluating comparative effectiveness for heart failure (HF) transitional 
interventions. This review focuses specifically on transitional care models. Since a majority 
of disease management models employ some form of high-risk stratification based upon 
recent inpatient utilization, transitional care will be an important component to many care 
management models, making this review relevant and applicable to the current body of 
evidence in chronic disease management.  
Mean patient age per study ranged from 53 to 85. Studies originated from 17 different 
countries.  
Quality: The authors assessed the quality of the included studies using standard quality 
indicators such as appropriateness of randomization, blinding, description of loss to follow-
up and likelihood of bias (using Begg’s Funnel plot).  
Intervention: The review focused on transitional care activities for patients hospitalized and 
subsequently discharged to community settings for heart failure related conditions. The 
follow-up/transitional period measured was at least one month post discharge. The 
comparator group was drawn from the same population as the intervention group, utilizing 
the same enrollment criteria, but only given the standard of care treatment with the absence 
of the supplemental transitional care activities.  
The transitional care activities were broken down into several categories including education 
alone (4 studies, 3 US based), pharmacist interventions (4 studies, 1 US based) , tele-
monitoring (9 studies, 5 US based), telephone support (9 studies, 4 US based), nurse home 
visits (6 studies,0 US based), nurse case management (which consists of a variety of 
activities including both telephone support and home visits)(10 studies, 5 US based) , and 
disease management clinics (consisted of follow-up visits at a clinic with MDT providers and 
support staff such as nurses, cardiologists, geriatricians, dieticians) ( 10 studies, 1 US based). 
Readmissions were measured from pooled data across these categories.  
Outcomes: This review utilized a network meta-analysis approach to evaluate the effect of 
interventions on inpatient utilization. This approach allowed investigators to directly assess 
comparative effectiveness among multiple transitional activities and rank the activities in 
relation to one another using IRR (incident rate ratio). 
Out of the aforementioned intervention categories, nurse home visits produced the highest 
(best) significant IRR (incident rate ratio) for decreasing all-cause readmissions. This was 
followed by nurse case management (which is a combination of the aforementioned 




home visits evidenced the highest IRR, or largest reduction in readmissions, there was no 
statistically significant difference in efficacy among the three intervention activities (home 
visits, nurse case management and DCM). All three of these intervention activities involve 
face-to-face contact, and nurse case management overlapped significantly with the nurse 
home visit category as nurse case management also included home visits in addition to 
telephone support. Specifically for the nurse case management category, seven of the 10 
studies involved postdischarge home visits, while the remaining three included integrated 
clinic visits with follow-up telephone calls. This differs from many other studies’ and meta-
reviews’ descriptions of nurse case management, as nurse case management commonly does 
not involve a home visitation component and traditionally relies only on telephone contact 
with patients. There was no evidence of significantly varied effectiveness between the two 
nurse-led interventions. Further, because some of the nurse case management interventions 
involved clinic visits, there was additional overlap between DCM and nurse case 
management. The only difference is that DCM occurred primarily in the clinic sitting (8 out 
of 10 studies), and nurse case management primarily utilized the home for in-person visits. 
The benefits of reduced readmissions were not enhanced by longer follow-up times 
indicating that many of the benefits are derived in the beginning of the intervention soon 
after discharge. The duration of readmission (e.g., 30, 60, or 90 day) was not reported in this 
review. The authors did not include HF specific readmission or admissions because of 
suspected classification bias.  
Tele-monitoring, telephone support, and pharmacist interventions did not lead to statistically 
significant reductions in readmission. Other activities included in a majority of the successful 
interventions were self-care and education, and proactive optimization of medications, but 
these interventions were not found to be effective on their own, only when combined with 
other care activities such as multidisciplinary care and home visits. 
Because of the minimal amount of US based studies in the transitional care activity 
categories, generalizability to US populations should be carefully considered. Further since 
this meta-review was only conducted among HF patients, this population may vary in 
significant ways from the high-risk Medicare and Medicaid populations who may have a 
different pattern of chronic disease prevalence. Nevertheless, this meta-review comprises a 
worthwhile comparison across study activities.  
Findings: Nurse home visits and disease management clinics may reduce all-cause 
readmissions in heart failure patients after a heart failure related hospitalization. It was noted 
in the discussion of the study that HF related only management generally misses more than 
half of the readmission—which are non-HF related. Therefore, programs which target only 
HF related issues may not be as an effective form of transitional care when compared to 
programs that include a larger scope of potential readmission causes. Additionally, the 
authors discuss the lack of efficacy of remote support in high-risk HF patients, with evidence 







APPENDIX B: DEFINITIONS 
Case management. A collaborative process of assessment, planning, facilitation, care 
coordination, evaluation, and advocacy for options and services to meet an individual's and 
family's comprehensive health needs through communication and available resources to 
promote quality, cost-effective outcomes.46 
Exclusive physician. A physician who is only offering services to one managed care 
organization, regardless of how they are paid (salaried, capitated, etc.). 
Independent physician association. An independent physician association (IPA) is a 
business entity organized and owned by a network of independent physician practices for the 
purpose of reducing overhead or pursuing business ventures such as contracts with 
employers, accountable care organizations (ACO) and/or MCOs.8 
IPA central administration. The administrative portion of the IPA where business 
processes occur. This is distinct from the providers contracted in the IPA network  
IPA network. The providers contracted with the IPA.  
Index admission. The initial hospitalization in a series of hospitalizations. 
Intervention. An activity intended to change the trajectory of health outcomes for a 
patient. These activities predominantly involve a form of interaction with the patient or 
families. 
Managed care organization. Delivers quality healthcare through an organized system 
designed to enhance efficiencies and reduce costs (includes PPO, HMO, IPA, or plan).  
Pay-for-performance. Pay-for-performance is reimbursement based on quality of 





Physician engagement. Physician engagement means the involvement of a physician 
above the care normally provisioned as the standard of care, in the absence of the 
intervention. It may be both active (guiding care plans), or passive, simply mentioning the 
intervention to their patient. In the context of this dissertation the term does not require the 
physician have active involvement. 
Risk stratification. A tool for identifying—and predicting—which patients are at high 
risk or likely to be at high risk—and prioritizing the management of their care to prevent 
worse outcomes.47 The process traditionally involves using population or individual-level 
information (which may include: disease diagnoses, demographics, socioeconomic status, 






APPENDIX C: TOPIC INTRODUCTION 
Key Informant Topic Introduction 
Through my research I have identified six evidenced-based practices that led to 
decreases in inpatient utilization such as emergency department (ED) visits, admissions or 
readmissions in elderly populations with chronic disease. The six best practices are as 
follows:  
• Risk stratification: Risk-stratification refers to targeting interventions to higher-
risk patient populations or those most likely to benefit from the intervention 
(“impactable”). Risk stratification often includes characteristics such as diagnostic 
history, demographics, and recent utilization.  
• Face-to-face contact: Face-to-face interactions involve in-person interactions 
between the care team and the patient at either a community location, clinic or 
most frequently, in the home.  
• MDTs: MDTs may include nonclinical individuals, but generally require two or 
more healthcare professionals. Most of the successful interventions included nurse 
care managers, but many also included social workers. 
This interview will focus on the two best practices most commonly correlated with 
positive health outcomes (reduced inpatient utilization). These are face-to-face contact, and 
MDTs. My study will focus on implementation challenges and facilitators of these two 
identified best practices in an independent physician association (IPA) model. Your insights 
will help guide the development of the broad implementation framework for how these 




APPENDIX D: SCREENING QUESTIONS 
1. Has your organization attempted to use or successfully used face-to-face visits 
with patients (beyond standard care) to managed chronic disease in elderly 
Medicare or dual beneficiaries?  
2. Has your organization attempted to use or successfully used MDT models 
(beyond standard care) to manage chronic disease in elderly Medicare or dual 
beneficiaries?  
Definitions of Best Practices 
• Face-to-Face visits: involve in-person interactions between the care team and the 
patient at either a community location, clinic (e.g., postdischarge appointment, 
high-risk clinic outside of standard care) or most frequently, in the home. The 
duration of each visits, length of intervention and intensity in regards to number 
of visits may vary. However, each face-to-face visit per patient involved in the 
intervention needed to happen at least once per patient, for a minimum of 30 
minutes each.  
• MDTs: may include nonclinical individuals, but must require two or more 
healthcare professionals that each have some level of direct interaction with the 
beneficiary. Often multidisciplinary teams include medical professionals (such as 
physicians, nurse practitioners, or physician assistants), and other health 






APPENDIX E: INTERVIEW GUIDE 
INTRODUCTION  
I am a student in the Executive Doctoral Program in Health Leadership at the 
University of North Carolina at Chapel Hill Gillings School of Global Public Health. As you 
know, I want to speak with you about your experience with adapting best disease 
management practices for Medicare and dual beneficiaries into IPA settings. The purpose of 
the interview is to learn more about the facilitators and barriers to implementation of 
evidenced based best practices in IPA MCOs. I have identified six best practices from the 
available literature pertinent to reducing costs and increasing quality for elderly individuals 
with chronic diseases. I would like to obtain your opinion on strategies for adapting two of 
these best practices to IPA-based MCOs. The interview should take less than one hour. The 
interviews will be strictly confidential. The comments and answers you provide will not be 
linked to your identity.  
If you agree, I would like to record our conversation to make sure I accurately capture 
your comments. Tape recordings and transcribed notes will be stored in a secure location and 
destroyed upon completion of this study.  
• At this time, do you have questions about the study or the interview session?  
• Do you consent to be interviewed? 
• Do I have your permission to record the interview? 
(Turn on the tape recorder and ask the same questions again for the recording)  
• May I begin?  
(Background by participant group including: medical directors/case managers at IPA MCOs 





Background: Medical Directors 
What is your current title/role at your organizations?  
How long have you been working in a managed care IPA environment?  
What proportion of your network is IPA-based versus staff model (employees)?  
Researcher says: Please only answer the rest of these questions as it pertains to the IPA 
portion of your organization.  
Approximately how many Medicare and Dual beneficiaries does your organization deliver 
care for?  
Are you involved in selecting which disease management programs are implemented in your 
organization?  
Background: Healthcare Executives/Administrators 
What is your current title/role at your organizations?  
How long have you been working in a managed care IPA environment?  
Approximately how many Medicare and Dual beneficiaries does your organization deliver 
care for?  
What proportion of your network is IPA-based versus staff model (employees)?  
Researcher says: Please only answer the rest of these questions as it pertains to the IPA 
portion of your organization.  
Background: Care Managers 
What is your current title/role at your organizations?  
How long have you been working in a managed care IPA environment?  
Approximately how many Medicare and Dual beneficiaries does your organization deliver 




What proportion of your network is IPA-based versus staff model (employees)?  
Researcher says: Please only answer the rest of these questions as it pertains to the IPA 
portion of your organization.  
EVALUATION OF BEST PRACTICES 
I have identified six best practices from the literature that have shown to improve 
inpatient utilization outcomes and decrease cost. I will be focusing on two of these best 
practices as a topic of this interview. The two best practices are face-to-face contact and 
MDTs. I would like to ask you a set of questions about implementing one or both of these in 
an IPA managed care network. Specifically, I am interested in understanding the challenges 
that MCOs may face, if any, in implementing these models in an IPA network where the 
individual practices may have multiple contracts with different MCOs, and each individual 
practice may only care for a small number of the MCO’s members. 
First, let’s discuss face-to-face visits. By face-to-face visits, I mean I mean planned 
face-to-face interaction with patients outside of standard care visits—for example, in their 
home or other community setting.  
1. In my first set of questions we will discuss the structure of face-to-face visits in 
your organization.  
i. How do you decide who receives a face-to-face visit?  
ii. What services are typically provided during face-to-face visits? 
iii. How often does a patient receive face-to-face visits, and how is that 
decision made?  




i. If results were positive: What do you think are the primary reasons this 
best-practice was successful in reducing inpatient utilization?  
ii. If not: Why do you think this was not successful?  
3. Based on your experience, do you think the use of face-to-face interaction will 
improve health outcomes and/or reduce unnecessary utilization in an IPA-model 
MCO? Why or why not?  
4. Are there any unique challenges to implementing face-to-face visits in an IPA-
model network? If so, what are they?  
5. Do you think face-to-face visits are a cost-effective strategy to reduce inpatient 
utilization in an IPA-model MCO? Why or why not?  
6. What resources are needed in the practices or practice networks to successfully 
implement this best-practice in IPA model networks (e.g., data, IT systems, 
staffing at the provider level, etc.) [Probe: If they talk about data—ask what type 
of data they would need. If they talk about staffing, ask what type of staffing would 
they need.]  
7. What internal leadership structures and supports are needed to make this best-
practice work?  
8. What milestones would you use to evaluate progress and success?  
9. Do you believe this model can be scaled cost-effectively? 
Now I’m going to ask you a similar questions as it relates to multidisciplinary teams, 
this means that there are two or more clinical or nonclinical health professionals on the team. 
This could include some combination of clinicians such as physicians, NPs, and/or PAs, and 




workers. I’d like to discuss how these multidisciplinary teams can be successfully 
implemented in an IPA-network MCO for the elderly with chronic disease.  
1. In the first set of questions we will discuss the structure of the MDTs.  
a. Do you use MDTs in your IPA model managed care organization for 
elderly Medicare beneficiaries with chronic illnesses? If so, please 
describe these teams. [Probe: What type of clinical or nonclinical 
professional is on the team?] 
b. How did you determine which disciplines to include in your 
multidisciplinary team? 
c. Do all members of the multidisciplinary team directly interact with the 
patient?  
d. How often does the patient see members of the MDT?  
e. Does this vary by patient? Please Explain? 
2. Do you have any results from interventions that have used these MDTs?  
i. If results were positive: What do you think are the primary reasons 
this best-practice was successful in reducing inpatient utilization?  
ii. If not: Why do you think this strategy was not successful?  
3. Based on your experience, do you think the use of MDT models as a best-practice 
strategy will improve health outcomes and/or reduce unnecessary utilization in an 
IPA-model MCO? Why or why not?  
4. Are there any unique challenges to implementing MDT models in an IPA-model 




5. Do you think MDT models are a cost-effective strategy to reduce inpatient 
utilization in an IPA-model MCO? Why or why not? 
6. What resources are needed in the practices or practice networks to successfully 
implement this best-practice in IPA model networks (eg, data, IT systems, staffing 
at the provider level, etc.) [Probe: If they talk about data—ask what type of data 
they would need. If they talk about staffing, ask what type of staffing would they 
need.]  
7. What internal leadership structures and supports are needed to make this work?  
8. What milestones would you use to evaluate progress and success? 
9. Do you believe this model can be scaled cost-effectively?  
ADDITIONAL BEST PRACTICES 
Does your IPA use interventions that include: 
• Risk stratification (if so, please explain) 
o Does this risk stratification method include social determinants? If so, 
what kind?  
• Disease-specific care (if so, please describe briefly) 
• Physician engagement (physician involvement above that which would be 
provided as the standard of care in the absence of the intervention)  
• Transitional care 
Do you think that successful initiatives have to include a combination of these efforts? If so, 






• Are there any additional comments you would like make regarding the 
implementation of best practices in IPA-based MCOs?  
• Have we covered everything that you think is important?  
• Do you have any questions for me at this time?  
• If you would like to contact me after our discussion today, please feel free to do so. I 





APPENDIX F: E-MAIL OUTREACH SCRIPT 
This e-mail template will serve as a guide for initial outreach to proposed 
interviewees, requesting their participation in the study.  
 
Mr./Ms./Dr. ___________, We are conducting interviews with key industry leaders to 
get their thoughts on how to implement best care management practices for Medicare and 
Dual beneficiaries in independent physician association based managed care organizations. 
For your reference, I have attached a brief project description to this e-mail. We would 
genuinely appreciate the opportunity to speak with you, as we believe your perspectives 
could offer great insights for my project. If you are willing to participate, I wish to schedule a 
phone call that will last no more than one hour at a time that is convenient you in the next 
couple of weeks. Please note that your participation in this project is voluntary and should 
you agree to participate, you can decline to answer any question. Additionally, I will not 
attribute any statements to you by name when reporting results. I look forward to hearing 
from you and hope you will agree to participate.  
 
All the best,  
 
 
Jennifer Dunphy, Doctoral Candidate  
Department of Health Policy & Management 




If you have additional questions about this study, please contact Pam Silberman, DrPH, at 
psilberm@email.unc.edu.  
 
The University of North Carolina IRB has approved this research study; if you have 
questions about this process, please contact the UNC IRB office 
720 Martin Luther King Jr. Blvd. Bldg  
#385, Second Floor, Chapel Hill, NC, 27599  




APPENDIX G: FACT SHEET FOR ADULT PARTICIPANTS IN A RESEARCH 
STUDY, UNIVERSITY OF NORTH CAROLINA-CHAPEL HILL  
IRB Study #_____________________ 
Consent Form Version Date: November 2017 
Title of Study: The implementation of evidenced-based care management practices among 
elderly public program beneficiaries 
Principal Investigator: Jennifer Dunphy, MBA, MPH 
UNC-Chapel Hill Department: School of Public Health, Department of Health Policy and 
Management 
UNC-Chapel Hill Phone number:  
Faculty Advisor: Pam Silberman JD, DrPH 
Study Contact telephone number:  
Study Contact email:  
 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  
Your participation is completely voluntary. You may refuse to join, or you may 
withdraw your consent to be in the study, for any reason, without penalty or loss of benefits 
to which you are otherwise entitled.  
Research studies are designed to obtain new knowledge. This new information may 
help people in the future. You may not receive any direct benefit from being in the research 
study.  
Details about this study are discussed below. It is important that you understand this 
information so that you can make an informed choice about being in this research study.  
You will be given a copy of this consent form. You should ask the researchers named 







What is the purpose of this study?  
The purpose of this research study is to learn about how to effectively implement best 
practices in elderly populations with costly chronic disease to both lower cost and improve 
quality.  
You are being asked to be in the study because you have professional experience 
related to implementing disease management programs for public program beneficiaries.  
 
How many people will be interviewed for this study? 
If you decide to be interviewed for this study, you will be one of approximately 15-20 
people interviewed for this research study. 
 
How long will your part in this study last?  
If you decide to be interviewed for this study, you will be asked to meet in-person or 
by telephone for a 45-60 minute interview. If you agree, you may also be contacted by e-mail 
or telephone to address follow up questions or clarifications if needed. 
 
What will happen if you take part in the study? 
Participation in interviews for this study will involve the following steps: 
Read this fact sheet and the information enclosed to determine your interest in 
participating in this study 
Contact the researcher listed on the first page of this form with any questions or 




Schedule a time to participate in a 45-60 minute interview (interviews may be 
conducted in-person or over the telephone) 
Participate in a 45-60 minute interview in-person or over the telephone 
Address follow up questions or clarifications if needed after the interview. 
 
What are the possible benefits from being in this study? 
You may benefit from participation in this study by learning about best practices 
identified by the researcher. This research is designed to benefit society by gaining new 
knowledge. You may not benefit personally from being in this research study. 
 
What are the possible risks or discomforts involved from being in this study? 
There are no known or expected risks to participating in this study.  
 
How will your privacy be protected? 
The researcher listed on the first page of this form is the only person who will have 
access to information that links individual participants to the responses from their interviews.  
Participants will be asked for permission before being identified in any report or 
publication about this study.  
Records of the interview will be stored electronically in password protected files.  
At the time of the interview, participants will be asked for permission to record the 
interview for transcription. If an interview is recorded, a transcript will be made and the 




Any hardcopy information linked to an individual’s responses to interview questions 
will be stored in a locked file cabinet.  
 
Will you receive anything for being in this study? 
You will not receive anything for taking part in this study. 
 
Will it cost you anything to be in this study? 
Other than your time, there will be no costs for participating in the study. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this 
research. If you have questions, or concerns, you should contact the researcher listed on the 
first page of this form. Any questions related to the rights of humans subjects should be 
directed to the UNC IRB.  
 
What if you have questions about your rights as a research participant? 
All research with human volunteers is reviewed by a committee that works to protect 
your rights and welfare. If you have questions or concerns about your rights as a research 
participant you may contact, anonymously if you wish, the Institutional Review Board at 




APPENDIX H: TELEPHONE OUTREACH SCRIPT 
The following scripts provide guidelines for scheduling interviews with participants 
based on whether the potential interviewee picks up the telephone. Calls will be placed as a 
follow-up to an initial outreach e-mail if the proposed participant does not respond within a 
few days. 
If leaving a voicemail:  
Hello, Mr./Ms./Dr.________ I am following-up on an e-mail I sent you on ________ 
regarding a study I am conducting for my doctoral dissertation on the adaptation of best care 
management practices for Medicare beneficiaries in independent physician association based 
managed care organizations. Part of my research includes a series of interviews with key industry 
leaders, and I believe your perspectives could offer great insights for this study.  
Your participation is voluntary, and the interview would take place via phone, lasting no 
more than one hour. I would like to schedule the interview to take place in the next ____weeks at a 
time that is convenient for your schedule. Additionally, I will not attribute any statements to you by 
name when reporting results. You can reach me at 949-933-5362 or by e-mail at 
jennora@live.unc.edu. I look forward to hearing from you and hope you are willing to participate. 
 
If speaking with a contact:  
Hello, Mr./Ms./Dr.________ I am following-up on an e-mail I sent you on ________ 
regarding a study I am conducting for my doctoral dissertation on the adaptation of best care 
management practices for Medicare beneficiaries in independent physician association based 
managed care organizations. Do you have a couple minutes to talk?  
Part of my research includes a series of interviews with key industry leaders and I believe 
your perspectives could offer great insights for this study. Your participation is voluntary, and the 
interview would take place via phone, lasting no more than one hour. I would like to schedule a 
discussion with you in the next ____weeks at a time convenient to your schedule. Would you be 
willing to participate in this study?  
 
Individual agrees: Excellent. As I mentioned, I would like to schedule a discussion in the 
next ______ weeks. Offer 2-3 time slots in the desired date range. Are you available during any of 
these times? Schedule the interview.  
 
If individual asks to think about it: Thank you for considering my request. I attached a brief 
project description to the e-mail I sent on ________, which I will resend following our call.  
If I don’t hear back from you in a few days, I will follow up again. Do you prefer that I 
contact you via e-mail or phone?  
Thank you – I look forward to hearing from you.  
 




APPENDIX I: PROJECT OVERVIEW 
Ninety-nine percent of spending for Medicare, and 100% of spending for dual 
beneficiaries in 2010 was attributed to spending on people with chronic conditions. 
Controlling healthcare costs for these populations is an important component of reducing 
national healthcare costs. 
Sixty-five percent of Medicaid recipients and 15% of Medicare recipients are in 
managed care plans delivered through Managed Care Organizations (MCOs). Most MCOs 
employ IPA or Independent Practice Association network models to manage their patients. 
Out of American’s participating in plans through an MCO (35%), 54% are part of an IPA 
model (Independent Physician Association) MCO. Because IPA’s usually contract with more 
than one managed care plan, it is challenging to streamline care initiatives for members, who 
are spread across many physician practices. Integration of best care management practices 
into the IPA setting will allow for a large national impact in managed care.  
To satisfy the first aim of this dissertation, I will conduct a series of key informant 
interviews with managed care industry leaders including medical directors, executive health 
plan or group administrators working in IPA settings. The purpose of these interviews will be 
to effectively adapt and disseminate best care management practices derived from the 
literature review into IPA-based managed care organizations.  
Discussions will explore three themes:  
• Barriers/Challenges to adapting best care management practices into an IPA MCO 
environment 
• Facilitators which aid the dissemination process of best practices into the IPA 




• Implementation/adaptation strategies that may be specific in adapting in each best 
practice into the IPA environment  
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